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ABSTRACT
The aim of this thesis was to investigate nucleotide 
sequence diversity of HLA class II genes in Australian 
Aborigines and indigenous peoples of Asia-Oceania. Nineteen 
study populations represented eight major ethnic groups 
including Australian Aborigines, Papua New Guinean 
highlanders, coastal Melanesians, Polynesians, Micronesians, 
Javanese, southern and northern Chinese, and a minority group 
from northwestern China. Using PCR-based technologies, the 
nucleotide sequence polymorphism in exon 2 DRB1, DRB3, DRB5, 
DQA1 and DQB1 genes was examined in all these populations. The 
DPB1 exon 2 polymorphism was examined in Australian Aborigines 
and a Chinese population.
Six novel HLA class II alleles including four DRB1, one 
DRB5 and one DPBl were discovered in this study by the 
occurrence of unusual hybridization patterns in the PCR-SSO 
typing procedure and were confirmed by DNA Sequencing. These 
new alleles, DRB1*0412, 1408, 1409, 1410, DRB5*0203 and 
DBP1*2201 have been recognized by the WHO Nomenclature 
Committee. The nucleotide sequences and the deduced amino acid 
sequences of the novel class II alleles indicated that 
multiple molecular mechanisms were involved in generating 
these alleles including point mutation and hypermutational 
events of segmental transfer and intra-exonic recombination.
In two cases (DRB1*0412 and DRB1*1410), hypermutational events 
have created unique peptide binding sites which are 
drastically different from all their putative progenitor 
molecules. Five of the six novel alleles were found in 
Australian Aborigines and four novel DRB1 alleles were 
detected in 45% of the Aboriginal individuals tested.
PCR-SSO typing revealed some HLA class II polymorphisms 
previously difficult or impossible to detect with more 
traditional typing techniques. Remarkable differences in the
Vclass II HLA allele frequency distributions, especially in the 
subtypes of major DR antigen groups, were observed between the 
study populations. Australian Aborigines showed the most 
divergent class II HLA profile; most of their DRB1 alleles did 
not overlap with other study populations. PNG highlanders and 
Javanese were highly homogeneous with quite restricted class 
II HLA distributions. Other Oceanic populations of 
Polynesians, Micronesians and coastal Melanesians were each 
characterized with unique class II HLA distribution but shared 
common features which indicated their historical ties. 
Distinctive HLA distributions were observed between Chinese 
populations from southern and northern China, while the 
minority group from northwestern China demonstrated a mixed 
ancestry of both Caucasoids and Orientals.
Further information came from the analysis of HLA-DR, -DQ 
haplotypes. A total of 80 three-locus or four-locus DR-DQ 
combinations including 16 DR2-related, 12 DR4-related, 11 DR5- 
related, and 24 DR6-related haplotypes were inferred from the 
study populations. Haplotype frequencies were used to 
calculate genetic distances between these populations and to 
reconstruct population phylogeny, which proved a sensitive 
indicator of population affinities. The unusual linkage 
relationships detected in the study populations also had 
important implications for the understanding of MHC evolution.
Knowledge of the nucleotide sequence polymorphism of HLA 
class II genes in general populations has fundamental 
importance in HLA-related clinical investigations. The 
apparent lack of susceptible alleles in the HLA gene pool of 
native Australians and Pacific islanders, or the high 
frequency of protective alleles, might partly explain the 
extremely low incidence of autoimmune diseases in these 
populations.
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CHAPTER 1
GENERAL INTRODUCTION
11.1 History
Characterization of the HLA system dates back to 1958 when 
Dausset reported the first human leucocyte antigen "Mac" 
identified in leucoagglutination assays. By analyzing 
monozygotic and dizygotic twins, Dausset also proved that the 
"Mac" antigen was genetically determined. Years before the 
designation of "Mac", it had been known that leucoagglutinins 
exist in the serum of polytransfused patients (Dausset 1952, 
1954). In 1958, Payne & Rolfs and van Rood et al. 
independently found that leucocyte allo-antibodies could also 
be detected in the sera of multiparous women. Using computer 
analysis of leucoagglutination reaction patterns, van Rood was 
able to define the first leucocyte group system (van Rood 
1962 ; van Rood & van Leeuwen 1963) . These early findings 
eventually led to the recognition of an extremely polymorphic 
immunogenetic system now known as HLA (human leucocyte 
antigen). Our understanding of the HLA system was greatly 
enhanced by international collaborative efforts through 
periodic histocompatibility workshops initiated in 1964 by 
Amos (Amos 1965). In the early 1970s, the gene region 
controlling HLA expression was mapped to chromosome 6 by 
linkage with another chromosome 6 locus PGM3 (third isoenzyme 
of phosphoglucomutase) (Lamm et al 1971; Jongsma et al 1973 ; 
Lamm et al 1974).
The recognition of class II HLA antigens resulted from the 
mixed lymphocyte culture (MLC) test, initially developed by 
Bach et al (Bach & Hirschhorn 1964, Bach & Voynow 1966) . 
Shortly after the establishment of MLC, it was found that the 
genetically controlled mixed lymphocyte reaction (MLR) is HLA- 
related (Bach et al 1969) and was determined by a separate 
locus closely linked to HLA-B (Yunis & Amos 1971; Mempel et al 
1972, 1973a). The MLC-associated antigen system was 
characterized following the development of the HTC (homozygous 
typing cell) typing procedure (Mempel et al 1973a, 1973b; Van
2den Tweel et al 1973) and was officially designated HLA-D in 
1975 (Thorsby & Piazza 1975). The HLA-DR antigen system, 
designated in the 7th IHW in 1977 (Bodmer et al 1977), was 
established in the attempt to define HLA-D antigens with 
serology (van Leeuwen et al 1973; van Rood et al 1975) which 
was analogous to the procedure in detecting la antigens in the 
mouse (Saches et al 1975). HLA-DQ antigens were designated in 
the 9th IHW in 1984 (Albert et al 1984) as the result of 
intensive analysis of the MT and MB specificities detected in 
class II serology (Duquesnoy et al 1979 ; Park et al 1980) . In 
the effort to positively characterize MLC antigens by primed 
lymphocyte test (PLT) (Sheehy et al 1975; Fradelizi & Dausset 
1975), it was found that the secondary MLR stimulation in the 
PLT test was largely contributed by a separate HLA-D locus 
(Shaw et al 1980) which was designated HLA-DP in the 9th IHW 
in 1984 .
During the last decade, molecular biological techniques 
have been introduced into this field. Extensive efforts have 
been made to investigate the structure and function of HLA 
molecules (Section 1.2), the genomic organization of HLA class 
II genes (Section 1.3), the molecular evolution of HLA class 
II genes (Section 1.4), and the implication of HLA 
polymorphisms for clinical medicine and population phylogeny 
(Section 1.5). This chapter reviews recent advances in these 
areas, with particular emphasis on the significance of HLA 
class II nucleotide sequence polymorphisms, and discusses 
current procedures for detecting these polymorphisms (Section 
1.6). The development of sequence specific oligonucleotide 
(SSO) typing of PCR (polymerase chain reaction) amplified DNA 
fragments has permitted large-scale typing for HLA class II 
alleles in indigenous peoples of Australia and the Pacific 
(Section 1.7).
31.2 HLA structure and peptide presentation
HLA molecules are polymorphic glycoproteins expressed at 
the cell surface. Class I molecules (HLA-A, -B and -C) , 
expressed on all nucleated cells, are composed of a 44,000 D 
transmembrane heavy chain and a 12,000 D non-covalently 
associated light chain known as ß2-microglobulin (Cresswell et 
al 1973; Grey et al 1973; Peterson et al 1974). The heavy 
chain has a cytoplasmic tail, a transmembrane region and three 
extracellular domains (al, a2 and a3). HLA class II molecules 
of DR, DQ and DP consist of an a chain with a molecular weight 
about 34,000 D and a ß chain about 29,000 D (Cresswell & Geier 
1975; Humphreys et al 1976; Klareskog et al 1977). The two 
chains are non-covalently bound and each contains four 
domains, two of them extracellular (al, a2 and ßl, ß2) . The 
distribution of class II molecules is rather restricted, 
confined to B lymphocytes, antigen presenting cells (APC) 
including monocytes, macrophages, Langerhans1 cells, dendric 
cells, and activated T lymphocytes.
The function of HLA molecules is to stimulate immune 
responses by presenting antigens to T cells. Class I molecules 
mainly select antigens of intracellular origin and present 
them to CD8-positive cytotoxic T lymphocytes (CTL). Class II 
molecules preferentially deal with antigens of extracellular 
origin and pass them to CD4-positive T helper (TH) cells. The 
antigens are recognized by T cell receptors (TCR) on the 
surface of CTLs and TH cells in the context of appropriate MHC 
molecules on the surface of APCs, a phenomenon known as MHC- 
restriction (Kindred 1972; Zinkernagel & Doherty 1974). 
Antigens, MHC molecules and TCRs form a tripartite interaction 
with the assistance of CD4 (for class II) or CD8 (for class I) 
coreceptors. As the result of this interaction, the CTLs will 
be activated and be able to recognize the cells with the same 
antigen and destroy them by releasing lymphokines, while the 
activated TH cells will trigger further humoral or cellular
4immune responses.
Antigenic proteins are first degraded in APCs into peptide 
fragments (Grey et al 1982; Shimonkevitz et al 1983; Townsend 
& Bodmer 1989; Harding & Unanue 1990). A single peptide 
binding site on the MHC molecule physically associates the 
antigenic peptides and presents them to T cells (Buus et al 
1986, 1987; Guillet et al 1986). Three-dimensional models of 
both class I and class II molecules strongly support the above 
interpretations. In their pathbreaking work using X-ray 
crystallography, Bjorkman et al. (1987a, 1987b) determined the
molecular structure of HLA-A2/A68. The computer elucidated 
model showed that on the top of the HLA class I molecule, the 
polymorphic al and a2 domains of the heavy chain form a deep 
groove which is bounded by two a helices and underlain by a 
single eight-stranded ß-pleated sheet. The groove was 
identified as the peptide binding site. Furthermore, 
electronic density revealed in the cleft a peptide-like 
structure which was co-purified and co-crystallized with the 
HLA-A2 molecule. The class II model predicted from the HLA-A2 
crystal structure and from the comparison between class I and 
class II sequences showed the similar formation except that 
the class II peptide binding site is formed by the first 
domains of both a and ß chains (Brown et al 1988). Direct 
binding of peptides to class II (Babbitt et al 1985) and class 
I (Chen & Parham 1989) molecules has also been demonstrated.
The essential questions to be answered by the current 
functional investigations are the interaction between peptides 
and MHC molecules, involving antigen processing; peptide 
transportation, selection and binding to MHC molecules; MHC 
assembly and expression; as well as the presentation of 
antigenic peptides to T cells.
The data emerged in recent years from both human and 
animal models suggest that endogenous antigenic proteins are 
degraded in the cytosol by proteasomes. The latter may be a
5complex associated with LMP (low molecular mass polypeptide) 
subunits which is encoded by genes mapping to the MHC class II 
region (Monaco & McDevitt 1982, 1984, 1986). The resulting 
peptides (both antigenic and self peptides) are transported 
into the endoplasmic reticulum (ER) by peptide transporters 
(Townsend et al 1989; Kleijmeer et al 1992), a dimeric protein 
encoded by TAPI and TAP2 genes which also map to the class II 
region (Salter & Cresswell 1986; Cerundolo et al 1990; Monaco 
et al 1990; Deverson et al 1990; Trowsdale et al 1990; Spies 
et al 1990; Kelly et al 1992). In the ER, the peptides 
associate with newly synthesized class I molecules. Then the 
peptide-class I heavy chain-ß2M complex is expressed on the 
cell surface via the Golgi (Townsend et al 1989). The class II 
presentation adopts a different pathway. Degradation of 
internalized extracellular antigens occurs in acidified 
lysosomes (Harding et al 1991) which can be inhibited by 
lysosomotropic agents (Ziegler & Unanue 1982; Unanue 1984). 
Nascent class II chains are assembled in the ER and 
transported through the Golgi to a post-Golgi compartment 
(Germain & Hendrix 1991) with the escort of invariant y chains 
(Claesson-Welsh & Perterson 1985) . After the y chain is 
degraded by endosomal proteases the released class II 
molecules will bind the exogenous peptides in an undefined 
location and be expressed on the cell surface (see DeNagel & 
Pierce 1992; Neefjes & Ploegh 1992a, 1992b). However, most of 
these scenarios are still hypotheses and need to be proven 
with empirical evidence. Similar to the situation of class I, 
normal class II molecular conformation and the related peptide 
processing and presentation depend on the expression of some 
unknown gene(s)(Mellins et al 1990) also mapped to the MHC 
class II region but different from TAP genes (Mellins et al 
1990a, 1990b; Ceman et al 1992) .
Peptide binding to MHC molecules is another focus of 
recent interest. MHC molecules have some specific requirements
6for the peptide structure. Class I molecules preferentially 
bind short peptides with nine residues. The affinity of class 
I molecules to nonamers was 100-1,000 fold higher than longer 
peptides (Schumacher et al 1991). MHC molecules of different 
allotypes may select different amino acid residues at certain 
positions of the peptide (Jardetzky et al 1991; Hunt et al 
1992). This allele-specific selectivity for peptide binding is 
determined by the feature of the peptide binding groove which 
is formed by the most polymorphic portion of the HLA molecule 
(Bjorkman et al 1987a, 1987b). By analyzing the three 
dimensional structure of class I MHC molecules and their 
interaction with synthetic and naturally processed peptides, 
it has been demonstrated that class I molecules bind peptides 
through several peptide binding pockets (subunits) in the 
peptide binding groove of class I molecules (Matsumura et al 
1992). The pockets at both ends of the groove are highly 
conservative and structurally closed; they tether the NH2- and 
COOH-termini of each peptide. The alle; -specific middle 
pockets bind one or two residues in certain positions of the 
peptide, referred to as anchor residues. The type of anchor 
residues and thus the type of peptides is selected by the 
special requirement of the allele-specific pockets. The 
optimal length of a peptide (a nonamer) has the greatest 
affinity to class I molecules but a slightly longer peptide 
(decamer) can fit into the peptide binding site by bulging out 
of the groove in the middle (Fremont et al 1992) . These 
pockets bind the peptide by forming hydrogen bonds with the 
backbone structure of the end and anchor residues, ignoring 
side chains and most other residues of the peptide. Such a 
peptide binding scheme explains why MHC molecules of very 
limited allelic types in an individual can bind a large 
variety of peptides.
The interaction between class II MHC molecules and 
peptides is less clear. However, the general principles of the
7class I peptide binding may hold true also for class II. The 
hypothetical molecular structure indicates that the class II 
molecule can bind longer peptides (Brown et al 1988).
Naturally processed peptides with 13-17 residues (Rudensky et 
al 1991, 1992) or 16-18 residues (Hunt et al 1992) eluted from 
mouse class II molecules and peptides with 13-25 residues 
bount to HLA-DR1 (Chicz et al 1992) have been determined. 
Peptide binding data on truncated synthetic peptides indicate 
that the length of class II peptides can be shortened without 
loss of binding activity. These results suggest that the class 
II peptide binding groove can be open to allow both ends of 
the peptide to protrude from the groove (Rudensky et al 1991). 
Different murine class II molecules (IAb, IAd, IAS and IEd) have 
different structural requirements in selecting peptides with 
certain amino acid residues occurring at particular positions 
in the peptides binding to a given class II molecule (Rudensky 
et al 1992). For example, a six-amino acid core region in the 
peptide has been implicated as a crucial motif for binding by 
IAd (Sette et al 1987), while the IEd molecules select peptides 
with different amino acid sequence patterns (Adorini et al 
1988a; Sette et al 1989) . The peptide binding to class II 
molecules appears to be irreversible, which may maximize the 
opportunity for the interaction between T cells and antigens 
(Lanzavecchia 1992) .
In addition to meeting the MHC requirements, the peptide 
repertoire may also be selected by other mechanisms. A 
hypothetical model of the class I presentation (Monaco 1992) 
postulated that instead of making all possible peptides from a 
given antigen, the LMP complex may preferentially produce 
nonamers. Furthermore, both the LMP genes (Monaco & McDevitt 
1984, 1986) and the peptide transporter proteins (Bahram et al 
1991; Colouna et al 1992; Spies et al 1992) have allelic 
variants. If the polymorphism or any aberration caused by 
mutations is functionally meaningful, it may result in
8different peptide repertoires derived from the same antigen in 
different individuals. A recent observation in rats did show 
that the polymorphism of the peptide transporter was 
associated with an altered spectrum of bound peptides (Powis 
et al 1992a, 1992b). The peptide selection could potentially 
cause individually biased immune responsiveness to a 
particular pathogen, diverse tolerance induction and 
differential susceptibility to autoimmune diseases. This 
individual variation may or may not have an apparent 
association with HLA phenotypes (Faustman et al 1991) .
Peptide binding is not only necessary to the T cell 
recognition but also essential to MHC assembly (class I), 
molecular conformation, expression and stability (Townsend et 
al 1989; Silver et al 1991; Stern & Wiley 1992; Sadegh-Nasser 
& Germain 1991; Kelly et al 1992) . Under normal circumstances, 
MHC molecules with an unoccupied peptide binding groove are 
rarely seen on the cell surface. In fact, an 'empty' MHC 
molecule on the cell surface tends to be easily lost (Townsend 
et al 1989). A recent study (Fremenot et al 1992) using x-ray 
crystallography has demonstrated the first evidence that MHC 
molecules of the same allelic type but binding different 
peptides have small but significant conformational changes, 
which is important for the T cell receptor recognition and MHC 
restriction. A better understanding of the interaction between 
MHC molecules and peptides relies on the characterization of 
the polymorphism of allelic MHC molecules in the peptide 
binding groove as well as the peptides bound by allelic MHC 
molecules.
1.3 Gene organization of the HLA class II region
The genes encoding HLA proteins are located in the MHC on 
the short arm of chromosome 6. The chromosomal organization of 
this region has been subject to periodic modifications. 
According to a recent version (Trowsdale et al 1991), the
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entire MHC spans a fragment of DNA about 4,000 kb and can be 
divided into three regions, namely class I, class II and class 
III.
The class I region, bearing the HLA-A,-B and -C loci 
and the nonclassical class I genes of HLA-E,-F,-G,-H and -X as 
well as class I pseudogenes, occupies a fragment of about 
1,700 kb at the telomeric end of MHC. The class II region 
(Figure 1.1) encompassing a stretch of about 1,000 kb is 
located at the centromeric end. At least 30 genes, including 
the genes encoding HLA-DR, DQ and DP molecules, have been 
identified in the class II region. Between the class I and 
class II gene loci is the class III region occupying a segment 
of 680 kb with at least 36 genes including genes encoding 
complement components, TNF, Hsp 70 and 21-OH, as well as genes 
of unknown function.
A typical class II gene contains five (A genes) or six (B 
genes) exons separated by introns of various length. The size 
of the total exon-intron structure ranges from 5.7 kb (DQA) to 
19 kb (DRB) (Andersson et al 1987; Jonsson et al 1987;
Gustafsson et al 1987). Of the a chain-encoding A genes, exon 
1 corresponds to the 51 untranslated (UT) region and the 
signal peptide. Exons 2 and 3 encode the first and the second 
domains respectively. Exon 4 produces the connecting peptide, 
the transmembrane region, the cytoplasmic segment and a part 
of the 3' UT region while exon 5 is responsible for the 
remaining 3' UT region (Jonsson et al 1987). Similar exon- 
intron arrangements are found in the ß chain-making B genes 
except that the core of the cytoplasmic tail is encoded by 
exon 5 while a sixth exon is responsible for making the 3 1 UT 
region and a part of the cytoplasmic tail (Anderson et al 
1987). Up stream in the 5' flanking sequence is the promoter 
region with the conservative W, X, Y, CAAT and TATA boxes 
which are critical for the recognition of peptide binding 
proteins (Boss & Strominger 1986; Sherman et al 1987; Shewey
11
et al 1992) .
Pseudogenes are found throughout the class II region. The 
sequence and the exon-intron structure of these genes are very 
similar to their functional counterparts but they are unable 
to produce gene products either because they have been 
truncated or due to some deleterious mutations in their exons 
(Larhammar et al 1985).
1.3.1 HLA-DR genes
HLA-DR loci at the telomeric end of the class II region 
start with a DRA jene encoding the DR a chain. The number of 
polymorphic ß chain-encoding B genes varies on different HLA 
haplotypes. HLA-DR1, -DR8, and -DRIO-related haplotypes have 
only one functional DRB gene, the DRB1 gene, while other DR 
haplotypes have a second expressed DRB gene in addition to 
DRBl. The additional DRB genes are not allelic and the loci 
are designated DRB3, DRB4 and DRB5. The DRB3 locus encoding 
DR52-related specificities is associated with HLA-DR3, -DR5 
and -DR6; the DRB4 locus encoding the DR53 specificity is on 
HLA-DR4, -DR7 and -DR9 haplotypes; and the DRB5 locus is 
associated with HLA-DR2. The number of DRB pseudogenes is also 
haplotype-dependent. A single pseudogene DRB6 exists on the 
HLA-DRl, DR2 and DR10-associated haplotypes. DRB2 is the only 
pseudogene found on the DR52-associated haplotypes. On the 
DR53-associated haplotypes two pseudogenes, DRB7 and DRB8, 
have been identified, whereas DR8 haplotyes have no DRB 
pseudogene. The haplotype-dependent genomic organization is 
also reflected in the length polymorphism of this chromosome 
region. Pulsed field gel electrophoresis has revealed that the 
DRB5-sharing DR2 haplotypes, the DRB3-linked DR3, 5, 6 
haplotypes and the DRB4-associated DR4, 7, 9 haplotypes are of 
similar size within each group but between groups the length 
of the DR-DQ complex can vary up to 100 kb (Hardy et al 1986; 
Lawrance et al 1987; Dunham et al 1989). The exon homology
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between different DRB genes is 83% to 100% while a homology of 
91% was observed on a DR4 haplotype between the second exons 
of the functional DRB1 gene and the DRB7 pseudogene (Anderson 
et al 1987) .
1.3.2 HLA-DQ genes
The HLA-DQ subregion, about 300 kb long, is centromeric to 
the DR subregion. DQA1 and DQB1 genes are organized in a tail- 
to-tail orientation and separated from the closest DRB gene by 
50 kb. Centromeric to them, DQA2 and DQB2 genes are clustered 
in the same manner (Jonsson et al 1987). Telomeric to the DQA2 
there is a truncated pseudogene designated DQB3 (Ando et al 
1989). DQAl and DQB1 encode the serologically recognizable DQ 
antigens and both of them are highly polymorphic. DQA2 and 
DQB2 genes have integrated gene structure, high sequence 
homology to DQAl and DQB1 and remarkably conserved coding 
regions, suggesting that they are not pseudogenes (Berdoz et 
al 1989). Spliced DQA2 mRNA detected in human B cell lines has 
been reported (Yu & Sheehy 1991) but extensive efforts have 
failed to identify any expressed protein. Recent data have 
indicated that the lack of apparent DQB2 products may be due 
to variation in the upstream regulatory elements which result 
in differential expression of these genes (Shewey et al 1992) . 
The DNA sequence homology between the two pairs of DQA and DQB 
genes ranges from 83% for exon 2 to 97% for exon 4 (Jonsson et 
al 1987).
1.3.3 HLA-DP gene
Genes encoding HLA-DP molecules are located in the 
centromeric part of the class II region (Erlich et al 1986 ; 
Hardy et al 1986), separated from the closest DQ gene by a 300 
kb chromosome fragment. DPA1 and the highly polymorphic DPBl 
genes are clustered in a head-to-head manner which is 
different from DR and DQ loci. Centromeric to them is a pair
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of DP pseudogenes, DPA2 and DPB2, organized in the same 
orientation (Trowsdale et al 1984; Okada et al 1985; Gorski et 
al 1984) . The exons of the two DPA genes share a DNA sequence 
homology of 76% while the homology between the DPB genes 
varies from 77% for the exons encoding the first domain to 94% 
for the second domain exons (Gustafsson et al 1987) .
1.3.4 Other genes in the class II region
Two more pairs of HLA-D genes have been identified in this 
region. HLA-DNA and -DOB are located between DPA1 and DQB2 and 
separated from each other by a gap of 200 kb (Tonnelle et al 
1985; Trowsdale & kelly 1985). They have normal gene 
structures. A correctly processed 1.1 kb full lenth HLA-DNA 
mRNA has been isolated (Young & Trowsdale 1990) but the 
protein product of neither of the two genes has been detected. 
Their partner genes, needed to form a class II heterodimer if 
they are indeed expressed, are also yet to be identified since 
the two genes themselves are most unlikely to be paired 
(Tonnelle et al 1985) .
HLA-DMA and -DMB, mapped close to each other between DNA 
and DOB are also intact class II genes with transcripts 
detectable in B cells but not in T cells. The proteins encoded 
by DMA and DMB have not been identified but they are predicted 
to be 261 and 263 amino acids respectively and to form a 
heterodimer (Kelly et al 1991).
In addition to the HLA-D and -D-like genes, the class II 
region also contains the class I antigen presentation-related 
TAP and LMP genes mapping between the HLA-DMB and -DOA loci in 
a closely linked manner (Glynne et al 1991; Martinez & Monaco 
1991; Kelly et al 1991). Given the remaining gaps in the class 
II region, it is possible that more new genes are yet to be 
discovered. Candidate genes could include those involved in 
class II antigen presentation.
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1.4 Molecular evolution of HLA class II genes
The HLA system has been particularly interesting to 
evolutionary biologists because of its extremely high 
polymorphism, strong linkage disequilibrium and population- 
dependent distributions. During the last decade, an enormous 
amount of information has been accumulated regarding the 
genomic organization, DNA sequences, molecular structures and 
the biological functions of the HLA system and of MHCs in 
animals. The questions that evolutionary biologists are 
concerned with are: how and when were the HLA genes and 
alleles generated? how and why has the HLA polymorphism been 
maintained in the population?
It has been suggested that gene families in the class II 
MHC region originated through a series of duplications from 
ancestral genes (Cepellini et al 1967; Bodmer 1972; Klein 
1975), which might have happened more than 70 million years 
(myr), before speciation of the mammals (Rask et al 1990) . A 
nucleotide sequence fragment resemble the MHC class I a-like A 
gene (Hashimoto et al 1992) and an a gene capable of encoding 
typical mammalian-like MHC class II a chains (Kasahara et al 
1992) have been isolated from different species of sharks. 
These results indicate that not only the emergence.of the MHC, 
but also the subsequent divergence into class I and II may 
have predated the appearance of the cartilaginous fish which 
branched off from other vertebrates more than 400 myr ago.
Different loci in each class II gene family have different 
ages and emerged at different stages in biological evolution. 
Phylogenetic trees reconstructed on the basis of DNA sequences 
and of deduced amino acid sequences from humans and non-human 
primates have indicated that the contemporary HLA-DR loci 
including pseudogenes predate speciation of primates. 
Duplications of a DRB-like ancestral gene happened at least 5 
myr ago before humans separated from other hominoid species 
and most DRB loci were more than 20 myr old (Gyllensten et al
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1991a). Haplotype-dependent DRB loci might have arisen on 
different ancestral haplotypes. For example, the DRB3 locus 
was generated on (or gave rise to) a DR3, 5, 6-like haplotype, 
while DRB4 and DRB5 were generated on other DRBl-like 
haplotypes (Gyllensten et al 1991a). The DR8 haplotype which 
has neither a second functional DRB locus nor DRB pseudogenes 
may have arisen by an unequal crossing-over or a deletion 
between the DRB1 and DRB3 loci (Gorski 1989a). Phylogenetic 
analysis has also confirmed that the main allelic branches in 
the extant HLA-DR loci were established before speciation of 
hominoids and passed through species boundaries into different 
evolutionary lineages, a hypothesis first proposed by Klein 
(1980). Some of these allelic branches may have existed for 
over 20 myr (Gyllensten et al 1991a).
Trans-species polymorphism is also evident in the 
evolution of HLA-DQ genes. At the DQA locus, four allele 
branches have been established in primates. HLA-DQA1*02 seems 
to have been arisen in the human lineage (Gyllensten et al 
1989). The other three allele branches detected in humans 
(HLA-DQA1*01, 03 and 04) have counterparts in other hominoid 
species of chimpanzees and gorillas with minimal changes over 
5 myr. Two of them probably have existed before the separation 
of homonoids and old world monkeys (more than 20 myr) (Renter 
et al 1992). At DQB loci, five out of eight trans-species 
allele branches (including DQB2) detected in primates are at 
least 30 myr old, because they have been found in both 
hominoid and Old World primate species (Otting et al 1992) .
One of them has also been found in New World monkeys, 
indicating a minimum age of 45 myr. In hominoid species, four 
major DQB1 allele branches were detected, namely DQB1*01, 02, 
03 and 04 (Gyllensten et al 1990 ; Otting et al 1992) . They 
were differentially lost from different species and only in 
humans are all represented. Unlike DQA1, considerable DQB 
diversification has been accumulated after speciation of
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primate lineages.
Little is known about the evolutionary history of DP 
genes. Preliminary analysis has suggested that the DPBl locus 
is most closely related to DRB1 (Larhammar et al 1985; Rask et 
al 1990). Based on the unusual orientation and the intron 
mutation frequency of the HLA-DP genes, it was postulated that 
the current DP region arose by two independent duplications 
from a primordial a-ß gene pair about 50 myr and 30 myr ago. 
After the first duplication, the nascent DPB gene was lost 
while the second duplication was followed by the deletion of 
the novel DPA gene (Rask at el 1990) .
The molecular mechanisms involved in the generation of 
class II allelic polymorphisms may vary between loci. The high 
similarity of DQA1 alleles between primate species indicates 
that with a few exceptions (such as HLA-DQA1*02) point 
mutation has been the main mechanism in the allelic 
diversification of DQA1 during this time span (Gyllensten & 
Erlich 1989). DQB1 allelic types show more diversification 
after speciation. It seems likely that both point mutation and 
segmental exchange including recombination and gene conversion 
have contributed to the generation of HLA-DQBl alleles 
(Gyllensten et al 1990). The allelic polymorphism at the HLA- 
DPB1 locus is characterized by a unique pattern: there are no 
allele-specific sequence segments; all the alleles appear to 
have resulted from hypervariable region shuffling. This 
feature may suggest that the segmental exchange between 
alleles played a vital role in the evolution of the DPBl 
polymorphism (Bugawan et al 1988) .
The evolution of DRB genes is more complex. DRß chains can 
be divided into ß-pleated sheet and a-helix subdomains on the 
three dimensional molecular structure (Brown et al 1988) . The 
two subdomains seem to have different evolutionary histories. 
In the gene region encoding the ß-pleated sheet, alleles of 
different allele branches tend to share the same first and
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second hypervariable regions (HVR). Identical HLA sequence 
patchwork can also been seen in the DRB genes of chimpanzees 
and gorillas (Gyllensten et al 1991b), indicating that this 
region has been highly conserved during post-speciation 
evolution. Allelic diversity is essentially confined to the 
third HVR in the a-helix subdomain. In this gene region, 
identical sequence patchwork can be seen in alleles of 
different allele branches. Furthermore, between the two 
subdomains, a consensus sequence segment has been identified 
as the binding site for a specific DNA binding protein (Wu et 
al 1986; Collick et al 1990), which therefore, could be the 
signal sequence promoting recombination between the two 
subdomains (Wu et al 1986; Gyllensten et al 1991b). These 
findings indicate that inter-allelic sequence exchange might 
have played an active role in addition to point mutation in 
the allelic diversification of DRB1. Other molecular 
mechanisms have also been proposed such as a reciprocal 
exchange between DRBl and DRB5 on the DR2 haplotype (Wu et al 
1986), interlocus gene conversion between the DRBl and DRB3 on 
a DR6 haplotype creating DR3 (Gorski & Mach 1986), and unequal 
recombination or deletion giving rise to DR8 (Gorski 1989a).
Linkage disequilibrium is another subject that may have an 
explanation in evolutionary history. Linkage disequilibrium 
exists between many HLA and non-HLA loci. However, 
particularly strong linkage relationships are observed in the 
class II region of DR and DQ. The two functional DRB loci in 
the three haplotype families appear to have been frozen within 
families. The DRB3 locus is confined to its related DR3, 5 and 
6 haplotypes, DRB4 to DR4, 7 and 9 haplotypes, and the DRB5 
locus to DR2 haplotypes respectively. One isolated case has 
indicated that DRB5 may also exist on a DRB1*01 haplotype 
(Tautz et al 1992) . Interlocus recombination in the DR and DQ 
region seems to have happened at haplotype-dependent sites 
(Gregersen et al 1988). Evolutionary analysis has demonstrated
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that major DRB1 allelic lineages were established on 
independent ancestral haplotypes long before primate species 
diverged. Genetic exchange between these allelic lineages has 
been hindered by the haplotype-specific length polymorphism of 
the chromosome structure in the class II region (Tokunaga et 
al 1989; Dunham et al 1989; Inoko et al 1989; Kendall et al 
1991). In non-human primates, however, interlocus 
recombination in the DR subregion can be found between 
different allelic lineages, which may suggest that the 
recombination barriers in humans arose shortly after the 
divergence of humans from other hominoid species (Gyllensten 
et al 1991a). As far as the HLA-DR and -DQ region is 
concerned, varied chromosome structures may be the major 
factor for maintaining the linkage relationship within each of 
the haplotype families (Klein et al 1991), but it does not 
necessarily exclude other mechanisms such as selection and 
population admixture (Bodmer 1972) .
Several hypotheses have been proposed to explain the 
extraordinary HLA polymorphism, such as an unusually high gene 
mutational rate (Bailey & Kohn 1965), trans-species 
polymorphism (Klein 1980), selective mating (Serjeantson 
1989a), gene conversion or inter-locus genetic exchange 
(Widera & Flavell 1984; Mengle-Gaw & McDevitt 1985), and 
positive selection. There is no evidence showing that the HLA 
system has an accelerated gene mutation rate, while other 
factors may have a combined influence on the HLA evolution. It 
is now generally accepted that positive selection is the main 
driving force in generating and maintaining the MHC 
polymorphism. Among several proposed selection models, 
overdominant selection or heterozygous advantage (Doherty & 
Zinkernagel 1975) has drawn more attention. Heterozygous 
advantage can enhance amino acid substitution rate of the 
antigen recognition site on the MHC molecule by saving rare 
alleles from extinction by genetic drift, which has been
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demonstrated by Hughes and Nei (1988, 1989) in both class I 
and class II genes. This model also explains the high degree 
of the HLA polymorphism and the unusually long persistence of 
some very ancient alleles in the population (Hughes & Nei 
1988, 1989). Other selection models may have also contributed 
to the HLA diversity such as rare-allele advantage or 
frequency-dependent selection (Bodmer 1972) and divergent 
allele advantage (Wakeland et al 1990). The latter model 
preferentially favors the maintenance of highly divergent 
alleles in a population.
It is likely that the positive selection is caused, at 
least in part, by pathogens. The coexistence and coevolution 
of pathogenic organisms and their hosts may have shaped the 
current HLA system (Klein 1991). However, the species of the 
pathogenic organisms and the exact way in which they interact 
with MHC molecules remain open questions.
1.5 HLA polymorphism: implications for clinical medicine and 
population studies
Polymorphism is the most prominent feature of the HLA 
system. Since the first HLA antigen was identified, the number 
of detected HLA alleles has been growing rapidly. In the 
latest^Nomenclature report (Bodmer et al 1992), 65 HLA-DR, DQ, 
DP, and Dw specificities have been officially recognized by 
traditional serological or cellular typing methods; class II 
alleles defined by DNA sequencing number more than 150. The 
dramatically increased detectable polymorphism, together with 
the knowledge of the structure and function of HLA molecules, 
has provided an unprecedented opportunity to re-evaluate some 
traditional fields in the study of HLA.
1.5.1 HLA matching and transplantation
The impetus for understanding the HLA system is largely 
due to its expected impact on clinical transplantation. The
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large scale Collaborative Transplantation Study of multiple 
centers has consistently shown a significant effect of HLA 
matching on graft outcome (Opelz 1985, 1989, 1991) .
Evaluation of HLA-matching effect is influenced by many 
factors, such as transfusion, immunosuppression therapy, 
follow-up care and center effect. Since more information on 
the molecular structure and the DNA polymorphism of HLA has 
become available and the DNA-based technologies have began to 
emerge, the quality of HLA matching itself, including typing 
errors and antigen resolution, has attracted more attention. 
Typing error is particularly a problem in serological HLA-DR 
matching (Mytilineos et al 1990; Tiercy et al 1991a). An 
analysis of 1,500 individuals routinely typed for HLA-DR 
revealed that 11% of the serological typings were technically 
unsuccessful or doubtful. In the remaining cases there was a 
serological error rate of 25%. In contrast, all the samples 
could be typed by the DNA-based RFLP (restricted fragment 
length polymorphism) typing procedure (Mytilineos et al 1990) .
Resolution of HLA matching is another factor that needs to 
be considered. The serological HLA matching of antigen 
subtypes already demonstrated clearly improved graft outcome. 
The established HLA nucleotide sequence polymorphisms have far 
outnumbered the serologically defined or RFLP-defined HLA 
specificities. Some class II HLA polymorphisms, previously not 
included in the routine matching such as DQ subtypes and DP, 
have also been demonstrated as important factors for graft 
outcome (Odum et al 1987; Sengar et al 1990). With all known 
HLA class II polymorphisms technically detectable now, it is 
reasonable to expect that the DNA-based high resolution HLA 
matching will eventually clarify the role played by HLA in 
clinical transplantations and further improve graft survival. 
At this stage, DNA typing is considered an important and 
practical option for the HLA-matching procedure for the 
unrelated bone marrow transplantation (Mach & Tiercy 1991;
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Tiercy et al 1991b). It is estimated that less than 30-40% of 
the patients who need a bone marrow transplantation have an 
HLA-matched sibling while others need to find a donor from 
unrelated individuals (Beaty et al 1991; Hansen et al 1989). 
For the latters, clinical outcome can be greatly improved by 
optimal HLA matching especially those functional epitopes not 
recognized by routine serology (Hansen 1990; Anasett et al 
1990; Tiercy et al 1991a).
Based on the growing knowledge at the molecular level, an 
alternative to the present HLA-matching strategy, termed 
epitope matching or peptide matching has been proposed 
(Terasaki et al 1990 ; Takemuto & Terasaki 199 0) . Among HLA 
mismatched donor-recipient pairs, various compatibilities 
exist due to various degrees of epitope matching. That is to 
say, different HLA alleles may share certain antigenic 
determinants; on the other hand, a given molecular motif can 
form different conformational determinants in the context of 
different allelic sequences (Akkoc & Scornik 1991; Mickelson 
et al 1991) . If these shared epitopes between HLA alleles can 
be determined, epitope matching at the molecular level for 
patients without a perfectly matched donor could be the 
optimal option.
1.5.2 HLA and autoimmune diseases
The structural knowledge of HLA molecules and nucleotide 
sequence polymorphisms of HLA genes have benefited the 
investigation of HLA-associated autoimmunity. Recent studies 
have focused on specific nucleotide contributions, shared 
epitopes, and the interaction between peptides and HLA 
molecules. Analysis at the molecular level has revealed 
disease-specific polymorphic residues with much higher 
relative risk for certain diseases (Todd et al 1988; Nepom & 
Erlich 1991) . For instance, the HLA contribution to the 
susceptibility or resistance to insulin-dependent diabetes
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mellitus (IDDM) in Caucasoids has been hypothetically located 
to particular amino acid residues on HLA-DQß and -DQa 
molecules (Todd et al 1987; Horn et al 1988; Sterkers et al 
1988; Morel et al 1988; Khalil et al 1990). On the basis of 
sequence information, a shared HLA-DRß epitope has been 
proposed as the predisposing factor for the sero-positive 
rheumatoid arthritis (RA)(Gregersen et al 1987; Nepom et al 
1987 ; Stastny et al 1991) . The direct involvement of HLA 
molecules in disease susceptibility is further suggested by 
the observation that certain disease-specific HLA epitopes but 
not haplotypes exist in populations of different ethnic 
backgrounds. In RA, the putative predisposing epitope in the 
third HVR of the DRß first domain from amino acid position 65 
through 75 is carried by different DR molecules or haplotypes. 
The distribution of these DR haplotypes can differ in 
different ethnic groups. However, a consistent correlation 
between the RA-specific epitope and RA susceptibility has been 
demonstrated in almost all ethnic groups studied (Wordsworth 
et al 1989; Gao et al 1990b, 1991a, 1991b; Willkens et al 
1991; Boki et al 1992; Nelson et al 1991, 1992; Takeuchi et al 
1989) .
The mechanism of HLA-associated autoimmunity is not clear. 
Available knowledge on the structure and function of HLA 
molecules suggests that the disease-specific residues or 
epitopes in the putative peptide binding site of HLA molecules 
may change some motifs critical to normal self peptide binding 
and conformation. This may trigger the immune system to attack 
self components either due to a defective presentation of a 
self peptide to T suppressor cells or via TH cell recognition 
of self peptides derived from certain tissues, such as 
pancreatic beta cells in the case of IDDM, or synovial 
membranes in the case of RA (Todd et al 1988). Alternatively, 
peptides with homologous sequences from some environmental 
organisms, such as Epstein-Barr virus, could induce immune
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tolerance to the infecting organism or cause cross-reactivity 
by molecular mimicry (Roudier et al 1989, 1991) . In addition, 
as mentioned in section 1.2, preliminary information suggests 
that the polymorphism of MHC-encoded LMP and TAP genes 
involved in antigen processing and presentation may also 
contribute to the HLA-associated autoimmunity.
The ultimate goal of studying autoimmunity is to develop 
practical approaches to prevent or treat autoimmune diseases. 
Several strategies have been proposed for this purpose, such 
as using antibodies to block specific TCRs (Acha-Orbea et al 
1988; Owhashi & Heber-Katz 1988; Urban et al 1988) or using 
peptides with high affinities but no cross-reactivity with the 
autoimmunity-inducing peptides to occupy the peptide binding 
site of MHC molecules (Guillet et al 1987; Adorini et al 
1988b; McDevitt et al 1989). These approaches will become 
possible only when the mechanism of the interaction between 
peptides, HLA molecules, and TCRs is clarified. The knowledge 
of the exact residues or epitopes of HLA molecules involved in 
autoimmunity and the distribution of the molecular 
polymorphism of HLA alleles in general populations will help 
to assess individual susceptibilities to HLA-associated 
diseases in high risk groups, such as relatives of IDDM 
patients, and thus to prevent the disease before it-has >' 
developed (Baisch et al 1990).
The evidence for the direct participation of HLA in 
autoimmune diseases does not exclude the possibility that 
other HLA-linked genes also contribute to the HLA association 
with diseases, especially those antigen processing and peptide 
transportation-related new genes found in the MHC class II 
region. In fact, the development of most HLA-associated 
autoimmune diseases are influenced by multiple factors. 
Candidates of these factors include HLA genes, HLA-linked 
genes, other genes, and environmental factors.
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1.5.3 HLA and population studies
The HLA system has been evolving in parallel to the 
evolution of Homo sapiens. The extraordinarily high level of 
polymorphism makes it particularly useful in population 
studies. Since the DNA-based methodology was widely adopted in 
the HLA study and revealed further polymorphisms at the 
nucleotide sequence level, this potential has become more 
appealing. Compared to the serologically defined HLA class II 
specificities, the nucleotide sequence-defined polymorphisms 
have further expanded the known variation of major allelic 
groups. For example, the single serological specificity DR4, 
which has five MLC-defined Dw specificities, has been further 
discriminated by DNA sequencing into 12 subtypes. Similarly,
15 nucleotide sequences have been identified in the 
serological DR6 group (Bodmer et al 1992). Most of these 
subtypes have confined distributions in races, ethnic groups 
or populations, indicating that HLA class II genes have been 
undergoing continued diversification after the human lineage 
was established. The differentiated distribution of HLA 
alleles can be used as a powerful tool in anthropological 
studies.
The HLA polymorphism in populations can be examined in 
several dimensions: (1) Many HLA alleles, especially those DNA
sequencing-defined subtypes of major allelic groups, are 
confined to particular ethnic groups or populations. It is 
likely that in some less-well studied human groups, more HLA 
alleles with population-specific distributions are yet to be 
discovered; (2) Under combined evolutionary forces of genetic 
drift, bottlenecks, gene flow and selection, common HLA 
alleles represented in all or most human groups can have 
significant variations in their frequency distributions; (3) 
Linkage disequilibrium is  ^another indicator for population 
affinity, because the DR-DQ lineage relationships have 
resulted from non-random interlocus recombination and the DR-
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DQ haplotype frequencies are highly diversified in human 
groups. Examination of all these aspects of the HLA 
polymorphism will add valuable information to the general 
understanding of the origin, migration, and admixture of human 
populations, the relationships between contemporary human 
groups, and the evolutionary history of Homo sapiens.
Extensive investigation of the nucleotide sequence 
polymorphism of HLA genes in human groups is of fundamental 
importance for HLA-related basic and clinical research.
1.6 Evolving methodology for HLA typing
A good HLA typing method should be accurate, rapid and 
reliable. It should be easy to perform and require small 
samples of blood and be suitable for clinical practice. These 
criteria are particularly challenging for class II HLA typing. 
The typing methods developed during the past 30 years can been 
sorted into two categories: traditional serological and 
cellular assays detecting HLA antigens; and DNA-based 
technologies examining HLA genes.
Serology is the corner stone of the study of HLA and has 
played the most significant role in HLA research and clinical 
application. The complement-dependent lymphocyte 
microcytotoxicity test developed in the 1960s by Terasaki 
(Terasaki & McClelland 1964) has since been used by most 
clinical and research HLA laboratories and is still a standard 
method in clinical tissue typing for both class I and class II 
antigens. Although the serological typing method is fairly 
easy to perform and the result can be reported within one 
working day, the high typing error rate, high percentage of 
blank and low resolution in the class II typing limit its 
potential in both research and clinical applications.
Cellular methods, including MLC for HLA-Dw typing and PLT 
for HLA-DP typing, discriminate more specificities than 
serology. Unfortunately, cellular typing has poor reliability,
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high percentages of blank, and is labor-intensive and time- 
consuming. This makes them impossible options either for 
routine HLA matching or for large-scale research projects. 
Moreover, both serological and cellular typing methods rely on 
living cells, which adds more complexity to the sample 
collection, transportation and preservation.
RFLP is a DNA-based technology. It uses probes derived 
from cDNA or genomic DNA to hybridize homologous genes in the 
genome. The DNA polymorphism is determined by the presence or 
absence of enzyme-cutting sites in both introns and exons. 
Compared to traditional class II typing methods, RFLP is 
considered more reliable with a lower typing error rate and 
very few blank (Mytilineos 1990) . However, its ability to 
discriminate HLA polymorphisms is not much greater than 
serology, since most class II subtypes were generated from 
their progenitors by point mutations or small segmental 
transfers without extensive changes to the whole gene.
Recent development of the PCR (polymerase chain reaction) 
technology (Saiki et al 1985) provides new options for HLA 
typing. Several PCR-based typing procedures for HLA class II 
polymorphisms have been developed including PCR-SSO (sequence 
specific oligonuleotide)(Saiki et al 1986), PCR-RFLP (Inoko 
1990), PCR-SSCP (single strand conformation
polymorphism)(Hoshino et al 1992), and PCR-sequencing (Scharf 
et al 1986; Santamaria et al 1992). The relative merits of 
these new methods are yet to be evaluated but several obvious 
advantages of the PCR-SSO technique have made it the most 
popular option for class II HLA typing in research 
laboratories.
The relationship between the HLA class II specificities 
detected by different methods has long been an issue of 
consern. It has now been well established that both the T 
cell-defined Dw and the serologically defined DR specificities 
are determined by the polymorphism of DR ß chains encoded by
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DRB genes. However, they may be determined by different sets 
of epitopes on the DR molecule. Monoclonal antibody reaction 
patterns correlate the DR polymorphism with the first domain 
of DR molecules (Marsh & Bodmer 1989), and with the second 
domain (Gorski 1989b) of DR ß chains, whereas T cells 
recognize the polymorphism of the first domain (Brown et al 
1988). Serologically defined DQ antigens may be determined by 
the first domain of either the DQa or ß chain encoded by DQA1 
and DQBl genes respectively (Marsh & Bodmer 1989). The PLT- 
defined DP polymorphism is determined by the first domain of 
the DPß chain encoded by the DPB1 gene (Bugawan et al 1988) .
1.7 Indigenous peoples of Australia and Pacific
Australia has been occupied for more than 50,000 years 
(Roberts et al 1990) . The origin of the Australian Aboriginal 
people is still debated by anthropologists (Bellwood 1989) . 
Anthropometric and cranial diversification observed in both 
living populations and in fossils has led to the multiple 
origin hypothesis. This theory postulates that three (Birdsell 
1977) or two (Thorne 1980) ancestral groups from the original 
people of Java (such as Oceanic Negritos) and of Southeast 
Asia (long before Mongoloid expansion into these areas) 
settled in Australia. Other anthropologists favor a one- 
founder-settlement by the original people from Java, followed 
by regional diversification within Australia (Habgood 1985; 
Brown 1987). Linguistic analysis of Australian languages has 
failed to identify any traceable influence from other 
languages (Bellwood 1989).
Since their early settlement in Australia, the Aboriginal 
people have been isolated and evolved in this continent into 
an independent race known as Austroloid. Before Europeans 
arrived 200 years ago, the Aboriginal hunter-gatherer tribes 
had scattered across the entire continent and Tasmania (Kirk 
1981). The estimated Aboriginal population was 250,000-300,000
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at the time of first European contact (Radcliff-Brown 1930).
Traditional inhabitants in the Pacific were classified by 
early European voyagers as Melanesians, Micronesians and 
Polynesians, a terminology adopted from their geographical 
distributions. Except for New Guineans, all these populations 
speak Austronesian languages. Austronesian languages are also 
spoken by certain island and coastal populations of New 
Guinea. Anthropological, linguistic, and archeological 
evidence indicates that the colonization of Pacific islands 
might have happened in two waves. The dominant view among 
anthropologists is that New Guinea highland people share with 
Australian Aborigines the same ancestral group, who arrived in 
the then Sahulland (Australia-New Guinea continent) from Java 
about 40,000-50,000 years ago and evolved locally in their 
adopted home land. Much later, about 4,000 years ago, a second 
wave of immigrants of southern Mongoloid origin migrated from 
island Southeast Asia into the Pacific and eventually occupied 
the whole area of Micronesia and Polynesia (Bellwood 1989,
1991). The populations in the Papua New Guinean coastal area 
and Melanesian islands may have been influenced by peoples of 
both origins (Serjeantson & Hill 1989).
The indigenous peoples of Australia and Pacific have been 
of interest for human genetics studies because of unique 
patterns of migration and efficient isolation from other human 
groups due to the special geographical environment. Their 
genetic connections with other peoples in island Southeast 
Asia, Mainland Asia, and even South America have also been of 
interest. The knowledge of the genetic background of the 
indigenous peoples will permit study of possible influence of 
recent population mixing on the increased susceptibility to 
certain diseases, and may explain the reason for the near 
absence of some well established HLA-associated autoimmune 
diseases in these populations, such as ankylosing spondylitis, 
IDDM and RA (Richens et al 1988). Further, the knowledge of
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the HLA allele distribution in these populations will permit 
development of strategies for HLA matching in unrelated organ 
or bone marrow transplantations involving indigenous 
recipients or donors.
Valuable information has been accumulated from previous 
studies of HLA in these populations (Serjeantson 1989b). 
However, the class II HLA in these peoples analyzed by 
serology and very limited number of MLC typings left high 
levels of blank. RFLP studies have provided more reliable data 
compared to serological and cellular methods (Kohonen-Corish & 
Serjeantson 1986; Davies 1990), but as mentioned in section 
1.6, RFLP typing does not discriminate many more HLA 
specificities than serology. HLA class II polymorphisms at the 
nucleotide sequence level are virtually unknown in these 
peoples, although the high percentages of blank in previous 
MLC studies in Australian Aboriginal populations have 
indicated novel Dw specificities (Kashiwagi & Kaneko 1986; 
Honeyman et al 1986) .
Recent development of PCR technology has made it feasible 
to analyze HLA class II genes in large number of samples and 
examine the polymorphism at the nucleotide sequence level.
This thesis, using PCR-based typing and sequencing methods as 
described in Chapter 2, examines HLA class II genes in 
Australian Aborigines and other indigenous populations of 
Asia-Oceania including Melanesians, Micronesian, Polynesians, 
Javanese, and southern and northern Chinese. The geographical 
distribution of the study populations is shown in Figure 1.2. 
Chapter 3 examines the nucleotide sequence polymorphism of HLA 
class II genes and the distribution of class II alleles in 
Australian Aborigines. Novel HLA class II alleles defined in 
Australian Aborigines, their nucleotide sequences, possible 
molecular mechanisms and their implications for the class II 
HLA evolution are described and discussed. The distribution of 
HLA class II alleles in populations of Asia-Oceania is given
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in Chapter 4. Linkage disequilibrium of the HLA-DR and -DQ 
haplotypes is another subject of the thesis. In Chapter 5, all 
DR-DQ combinations found in the study populations are listed; 
ethnic-group-specific or population-specific haplotypes are 
identified; hypothetical inter-locus recombination sites are 
discussed; and population affinity is analyzed on the basis of 
DR-DQ haplotype frequencies. Finally in Chapter 6, PCR-based 
typing and sequencing methods are evaluated and the 
implication of the nucleotide sequence diversity of HLA class 
II genes for HLA-related autoimmune diseases in the study 
populations and for the donor-recipient matching for 
transplantation involving these peoples is discussed.
CHAPTER 2
MATERIALS AND METHODS
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2.1 Introduction
A total number of 1,319 random donors from populations of 
Australia, Oceania and Asia were examined for the nucleotide 
polymorphism of HLA class II genes. The details of these 
populations and sample collection are described in Chapter 3 
and Chapter 4. This chapter describes the PCR-based 
experimental technologies used in the work of the thesis and 
the SSO typing strategies for discriminating HLA class II 
alleles. These typing and DNA sequencing protocols are able to 
discriminate finest nucleotide sequence variations including 
single base-pair substitutions of known HLA class II alleles 
and to define novel alleles potentially existing in the study 
populations.
All DNA samples were typed using the PCR-SSO technology 
for the polymorphic DRB1, DQAl and DQB1 genes. DRB3 and DRB5 
loci were examined in relevant samples. DRB alleles were first 
typed for the broad specificities of DR1 to DR10 following 
generic PCR amplification. Subtypes of major allele groups 
were further discriminated by SSO hybridization following 
group-specific amplifications. For the DQAl and DQBl analysis, 
locus-specific amplifications were performed. The DPB1 
polymorphism was examined in Australian Aborigines and a 
northern Chinese population using both generic and group- 
specific amplifications. PCR-RFLP and PCR-SSCP were used as 
supplementary methods to confirm some unusual results from SSO 
typing.
PCR-sequencing was performed to examine the entire exon 2 
of new class II HLA alleles revealed by unusual SSO 
hybridization patterns. Major allele types of DRB1, DQBl and 
DPB1 detected by SSO in Australian Aborigines were also 
subject to DNA sequence analysis.
2.2 DNA preparation
Genomic DNA was prepared from buffy coats or peripheral
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blood leukocytes (PBL). Some of the DNA samples analyzed in 
this thesis were prepared in previous studies using the 
routine method of pheno/chloroform extraction (Maniatis et al 
1982). DNA preparation of additional samples for the work of 
this thesis (Cape York Aborigines, Papua New Guinean 
Highlanders, and Chinese) was a salting-out procedure (Miller 
et al 1988) .
For the salting-out method, PBL were resuspended in Tris 
ethylenediaminetetraacetate (TE; 10 mM tris-HCL, 0.2 mM 
Na2EDTA, pH 7.5) mixed with 1% sodium dodecyl sulphate (SDS) 
and 0.1 mg/100 |il proteinase K, and incubated at 37°C 
overnight or at 52°C for 2-4 h. Then saturated Na acetate, 250 
|il/ml, was added and the tube was shaken vigorously for 15 sec 
to allow precipitation of proteins. After centrifugation, the 
supernatant was transferred to an Eppindorf tube. DNA was 
precipitated by addition of an equal volume of isopropyl 
alcohol, transferred with a plastic pipette to a fresh tube, 
dried under vacuum, and resuspended in TE.
2.3 PCR amplification
PCR amplifications were performed in most cases in a 50 |il 
volume consisting of 0.2 |ig genomic DNA, 15 pmoles of each 
primers, 0.1 mM each of dATP, dCTP, dGTP, and dTTP, 1 unit of 
the Taq polymerase (Promega Biotech, Madison, WI), 5 ptl of 
dimethylsulfoxide (DMSO), and an adequate volume of water. The 
DR8 and DR52-related DRBl amplification and the DPBl generic 
amplification were performed in a 100 |il volume with doubled 
amounts of all components in the reaction. The reaction 
mixture was covered with mineral oil to avoid evaporation. 
Thirty-five amplification cycles were performed for all PCR 
amplifications on a thermal cycler (Bartelt Instruments, 
Victoria, Australia) with each cycle consisting of three steps 
including denaturation of DNA templates, annealing of primer 
to target DNA sequences, and extension of polymerase
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synthesis. For the DQB1 amplification, each cycle was composed 
of 1 min of denaturation at 95°C, 2 min of annealing at 54°C, 
and 2 min of extension at 72°C. For the amplification of other 
class II genes, 1 min was used for all three steps. The 
temperatures of denaturation and extension were the same as in 
the DQB1 amplification, but the annealing temperature (Ta) 
varied according to the primer used; these are given in 
relevant sections of this chapter.
2.4 Oligonucleotide hybridization
2.4.1 Electrophoresis and blotting of PCR products
PCR products were electrophoresed on 8% agarose gels in 
TBE buffer (89 mM Tris-Borate, 89 mM Boric acid and 2 mM 
EDTA). To accommodate a large number of samples, multiple rows 
of loading wells were made on each gel by using several combs, 
each having 30 teeth. Aliquots of PCR products were loaded in 
different blocks of the gel. The number of samples loaded on 
each gel was further enlarged by loading different samples in 
the same wells after previously loaded samples have been well 
separated on the gel by electrophoresis (about 5 min at 200 
V). Usually, a 5 X 7 cm block on a gel contained' 96 different 
samples (two batches of PCR) in 7 rows with 14 samples in each 
(12 samples in the last row). Six blocks could be arranged in 
a 20 X 20 cm gel, or eight blocks on a 20 X 25 cm gel.
After electrophoresis, the gel was stained with ethidium 
bromide to examine the outcome of PCR amplifications under UV 
with a photograph taken as a record. The gel was then soaked 
in 0.4 N NaOH for 20 min and double-blotted on two Biotrace 
membranes (Gelman Sciences, Ann Arbor, MI) with each membrane 
touching one of the two surfaces of the gel and sandwiched 
between Whatman papers and paper towels for at least 5 h.
This procedure was designed to handle large number of 
samples. The number of blocks in each gel and membrane 
depended on how many probes would be needed for hybridization.
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For example, in DQA1 typing, six blocks were arranged on a 20 
X 20 cm gel with 12 filters available for hybridization with 
12 probes. In the case of DR8 and DR52-related DRBl subtyping, 
for which 27 probes were used, PCR products of 100 fil volume 
were distributed in 14 blocks arranged on two gels, with 28 
filters available after blotting.
2.4.2 End-labelling of SSO with 32p
Prior to use in hybridization experiments, oligonucleotide 
probes were end-labeled with 32p. For the end-labelling, seven 
pmoles of probes were mixed with 0.33 mCi of 732p-labelled 
adenosine 5 1-triphosphate (4,000 Ci/mmole; Bresatec A.C.N.),
10 units of T4 polynucleotide kinase (Pharmacia, USA), 3 |J.l of 
10X reaction buffer supplied with the T4 kinase, and water to 
a total volume of 30 |Ul. The labelling reaction was carried 
out at 37°C for 3 0 min and was stopped by adding 2 |il of 0.25 M 
EDTA.
2.4.3 SSO Hybridization
The blotted filter was prewetted with 3X SSC (SSC; 2.6% 
NaCL, 0.6% Na3 citrate) and incubated in a 10 ml plastic tube 
with 2 ml of a solution containing 15% formamide, 10% of 50 X 
Denhardt's solution, 5 X saline sodium phosphate-EDTA (SSPE;
750 mM NaCL, 50 mM NaH2P04, 5 mM Na2EDTA pH 7.4), 1% SDS, 5% 
dextran sulphate, and 0.2 mg/ml of boiled salmon sperm DNA. 
Prehybridization was carried out at 42°C in a revolving 
hybridizer for 2 h and the 32p-labelled probe was then added 
into the solution. Hybridization was continued for 1-2 h at 
42°C.
2.4.4 Washing
The hybridized filter was removed from the tube, rinsed 
twice in 3X SSC for 10 min at room temperature and washed in a 
solution containing 3 M TMAC (tetramethylammonium chloride),
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50 mM tris-HCL (pH 8.0), 2 mM Na2EDTA, and 0.1% SDS for 30 
min. The washing temperature, which is critical to the 
specificity of SSO binding, was strictly controlled at 59°C in 
most cases to permit optimal discrimination of single-base- 
pair variations under the condition used in this study. TMAC 
in the washing solution allows use of a single washing 
condition for multiple probes of the same length but with 
different AT/GC compositions, which greatly facilitates the 
washing procedure. After washing, the filter was dried at 50°C 
for 30 min.
2.4.5 Autoradiography
The washed filter was mounted on a Whatman paper, covered 
with a piece of plastic wrap, and exposed to a Fuji RX x-ray 
film in a cassette at -70°C. The film was developed after 1 h 
to 16 h exposure depending on the radioactivity on the 
membrane, as detected with a radioaction monitor after 
washing. Sometimes, a second exposure was needed if the signal 
on the first film was too weak or too strong. The time of the 
second exposure was adjusted to get a proper record of 
positive signals and a weak background from negative samples. 
The latter was helpful to correctly locate the positive 
samples on the film. An example of the PCR-SSO typing result 
is shown in Figure 2.1.
2.4.6 Positive and negative controls for SSO hybridization
In the present study, large numbers of samples were 
blotted on the same filter, usually involving 96 samples. 
Positive and negative controls are important when a small 
number of samples per filter (per probe) is concerned or most 
samples in a hybridization are from the same ethnic group. 
Under these circumstances, DNA samples with known allele 
types, either the 10th IHW cell lines or previously defined 
samples were added to the study samples. Positive controls
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Figure 2.1 SSO hybridization of PCR-amplified HLA class II 
genes.
A: PCR products from 96 samples after electrophoresis in an 
agarose gel and stained with ethidium bromide; B: One hour 
exposure after SSO hybridization of the filter blotted from A; 
C: Same filter after exposure for two hours; the background 
signal of negative samples allows correct localization of 
positive samples on the filter.
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were chosen to ensure that all probes in a given experiment 
were properly labelled, while negative controls discriminate 
genuine positive hybridizations from cross-reactions, which is 
particularly important when single-base-pair mismatches are 
concerned.
2.5 SSO typing for HLA class II alleles
Variation in the nucleotide sequence of the second exon of 
HLA class II genes was detected by generic or group-specific 
PCR amplifications and SSO hybridizations. Alleles were 
assigned by appropriate SSO hybridization patterns. New 
alleles, indicated by unusual SSO patterns, were further 
analyzed by DNA sequencing. Typing strategies and 
oligonucleotide probes were designed originally on the basis 
of class II sequences available at the time (Marsh & Bodmer 
1990). Primers and probes were constructed on a 380B 
synthesizer (Applied Biosystem, Foster City, CA) by the ANU 
Biomolecular Research Faculties. Table 2.1 gives sequences, 
specificities and references of all primers used in this 
study. To facilitate the washing procedure, all probes were 
designed as 19mers. Their sequences, corresponding codons and 
specificities are shown in the following sections.
Principally, the four-digital nomenclature for HLA alleles is 
used throughout this thesis unless a five-digital name needs 
to be mentioned for special purposes.
2.5.1 Generic DRB typing
Generic DRB typing defines broad DR types, which are 
equivalent to serologically detected specificities. For 
generic DR typing, the second exons of DRB genes, including 
DRB1, DRB3, DRB4 and DRB5, were amplified by a pair of 
primers, SRP-1 and SRP-2 (Ta 56°C) , corresponding to coding 
regions which are conserved in all DRB alleles. The fifteen 
probes used to detect DR types from DRl to DR10 are given in
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Table 2.2 and Figure 2.2. Two DR7 subtypes, DRB1*0701 and 
DRB1*0702 which differ in exon 3 but have identical exon 2 
nucleotides, were both assigned DRB1*07 by this protocol. The 
newly designated DRB1*09012 has a silent mutation from 
DRB1*09011 at codon 57. To detect this variation, an 
additional probe, not included in this protocol is required. 
DRB1*0901, assigned in this study, included both DR9 subtypes.
At the time when this generic DRB typing protocol was 
designed, nucleotide sequences for intron 1 were not 
available. This meant that the variation in the first HVR 
(positions 8-16) of the DRB1 gene could not be used for 
generic typing. Recently, more has been known about intronic 
sequences flanking exon 2 of different DR allele types, which 
has made it possible to use an intronic 5' primer, known as 
GH46 (Scharf et al 1988), for the generic DRB amplification 
permitting SSO typing according to the first HVR nucleotide 
variations.
2.5.2 Subtyping for DRl-related DRBl alleles
There are three known alleles in this group including 
serological DRl-related DRB1*0101 and 0102 genes encoding Dwl 
and Dw20 specificities respectively, and the DwBon-related 
DRB1*0103 allele. DRl-positive samples were identified by 
positive hybridization of probe SR-1 in generic typing. DR1 
genes were selectively amplified using a DRlDRBl-specific 
primer, SRP-DR1 (Ta 59°C) , and hybridized with eight probes as 
shown in Table 2.3 and Figure 2.3.
2.5.3 Subtyping for DR2-related DRBl and DRB5 alleles
DR2 is encoded by DR2-related DRBl and DRB5 genes with 
five DRBl and four DRB5 alleles designated. DR2-positive 
samples were screened for both DRBl and DRB5 genes with probes 
SRB5 and SR-2 in generic typing. For subtyping, both DR2- 
encoding DRBl and DRB5 genes were subject to specific PCR
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amplification using primers SRP-5 (Ta 58°C) and SR5P (Ta 56°C) 
respectively. SR5P also amplifies DRBl*0901/ but the DR9 
sequence does not interfere in the subsequent SSO typing. 
DRB5*0201 and 0202 have identical exon 2 nucleotides, and were 
both assigned DRB5*02. The eleven probes used in DR2 subtyping 
are shown in Table 2.4 and Figure 2.4.
2.5.4 Subtyping for DR4-related DRBl alleles
The DR4 group had nine known alleles (Bodmer et al 1990) 
when this protocol was designed. The number was later 
increased to 11 (Bodmer et al 1991) . DR4-positive subjects 
were detected in generic typing by probe SR-4, and amplified 
using a DR4-specific primer SRP-4 (Ta 59°C) . The DR4 subtyping 
protocol including eight probes as shown in Table 2.5 and 
Figure 2.5 is able to discriminate all eleven DR4 subtypes. An 
extra probe was later added according to a new DR4 allele 
defined in this study, as described in Chapter 3.
In individuals with two DR4 haplotypes, SSO hybridization 
patterns could be identical between different subtype 
combinations when the difference is confined to the dimorphic 
position 86. For example, the SSO pattern of a DRB1*0405 
homozygote can not be distinguished from that of a 
DRBl*0405/0408 heterozygote; a DRB1*0401/0410 heterozygote is 
expected to have the same SSO pattern as DRB1*0409/0410 or 
DRBl*0404/0409 heterozygotes. However, in a particular 
population, the chance of having these DR4 combinations is 
very small. In fact, there was no such case encountered in 
this study. Since only in three cases DRB1*0408 was 
independtly detected in this study, the samples showing the 
DRBl*0405/0405 or DRBl*0405/0408 pattern were assigned 
DRB1*0405 homozygotes.
2.5.5 Subtyping for DR8 and DR52-related DRBl and DRB3 alleles
In the nomenclature of HLA factors, 1989 (Bodmer et al
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1990), the DR8 and DR52-related alleles included 13 DRBl and 
four DRB3 alleles. One year later, the number of DRBl alleles 
in this group increased to 24 (Bodmer et al 1991) . The typing 
protocol, given in Table 2.6 and Figure 2.6, uses primers SRP- 
6 (Ta 56°C) and SR3P (Ta 60°C) to selectively amplify the DR8 
and DR52-related DRBl and DRB3 alleles respectively. Twenty- 
eight probes are able to detect 22 DRBl and four DRB3 alleles.
A probe needed to distinguish DRB1*1102 from DRB1*1103 is not 
included in this protocol, since both alleles are absent in 
the study populations. DRB1*08022 cannot be distinguished from 
DRB1*08021 because of a silent mutation in codon 90 in the 
region of 3'primer SRP-2. DRB1*08032 reportedly differs from 
DRB1*08031 with a silent substitution in codon 36, which can 
be detected by positive hybridization with probe SR-82, 
although subsequent analysis of the cell-line TAB in which 
DRB1*08031 was originally reported showed that DRB1*08031 is 
probably a DNA sequencing error (Kimura et al 1992) . Three 
novel DRl4-related alleles were found in this study. Two of 
them require modified typing protocols, which are described in 
Chapter 3.
Two pairs of allele combinations can not be distinguished 
by SSO typing because of the dimorphic codon 86. These 
combination pairs are: DRBl*1104/0802 vs DRBl*1101/0804 and 
DRBl*1301/0802 vs DRB1*1302/0804. Except for DRB1*1101, other 
alleles in these combinations only sporadically occurred or 
are absent from the study populations. Therefore, the 
inability to discriminate these combinations is not a problem 
in this study.
2.5.6 Typing for DQAl alleles
DQA1 alleles were amplified using locus-specific primers 
SE-43 and SE-49 (Ta 56°C) . Eleven probes were used to define 
eight alleles as shown in Table 2.7 and Figure 2.7. The newly- 
designated DQA1*03012 and DQA1*0302 are not distinguishable
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from DQA1*03011 either because the variation is outside the 
amplified fragment (DQA1*0302) or because an additional probe 
needed is not included in this protocol (DQA1*03012). Three 
DQA1*0503 subtypes, with variation either outside the 
amplified fragment or in exon 3, were all assigned DQA1*0503 
in this study.
2.5.7 Typing for DQBl alleles
DQB1 alleles were amplified using primers SE-17 and SE-8A 
(Ta 56°C). In some DQ3 or DQ4-positive samples, group-specific 
amplification was performed using primer SE-39 (Ta 56°C) to get 
better PCR and SSO hybridization results. Fourteen probes 
shown in Table 2.8 and Figure 2.8 detect 16 out of 17 DQBl 
alleles. DQB1*03032 is not distinguishable from DQB1*03031 
with this protocol because an additional probe required to 
detect a silent mutation in codon 21 is not included. 
DQB1*05032, which is not listed in Table 2.8 and Figure 2.8, 
can be discriminated from DRB1*05031 by positive hybridization 
with probe SQB-6 instead of SQB-7 as in the case of 
DQBl*05031.
2.5.8 Typing for DPB1 alleles
Both generic and group-specific amplifications were applied 
for DPB1 typing. After generic PCR amplification using primers 
SPBP-1 and SPBP-2 (Ta 56°C) , DPB1 alleles were divided by three 
probes into two groups, group A (probes SPB-2 and SPB-3) and 
group B (probe SPB-81). Group-specific amplifications were 
performed using primers SPBP-3 (Ta 63°C) for group A and SPBP-4 
(Ta 63°C) for group B. PCR products of generic and both group A 
and group B amplifications were then hybridized with 24 probes 
covering all variation in exon 2 of the 19 known DPBl alleles 
(Bodmer et al 1990) as shown in Table 2.9 and Figure 2.9. The 
newly-designated DPB1*02012, which differs from DPB1*02011 by 
a silent mutation in codon 12, is not included in this
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protocol.
By this DPB1 typing protocol, only one pair of allele 
combinations in group B is not discriminated: DPB1*0901/1601 
vs DPB1*0801/1701. These alleles are rare or absent in the 
study populations examined for the DPBl polymorphism and the 
questionable allele combinations were not seen.
2.6 DNA sequencing of HLA class II genes
DNA sequencing was performed for all major allelic types 
of HLA-DRB1, DQB1 and DPBl defined by SSO typing in Australian 
Aboriginal samples and for those new alleles revealed by 
unusual PCR-SSO hybridization patterns to examine the entire 
exon 2 sequence of these alleles. The method used was direct 
sequencing of double-stranded (ds) PCR products amplified from 
exon 2 using flanking primers.
2.6.1 PCR amplification for DNA sequencing
The second exons were amplified using intronic primers 
with M13 tails. A 100 |il volume of PCR amplification was 
performed to get ds templates. The conditions of PCR were the 
same as described in section 2.3.2. Primers used for 
sequencing analysis of DRBl, DQB1 and DPBl genes are listed in 
Table 2.1.
2.6.2 Purification of double-stranded templates
To remove the remaining primers and dNTPs from ds PCR 
products, the PCR mixture was added to a Centricon-100 
microconcentrator (Amicon Division of Grace, Danvers, MA) 
containing 1 ml water and spun in a high speed centrifuge at 
7,000 rpm (3,000 xg) for 10 min. A second centrifugation 
followed at 10,000 rpm (7,000 xg)for 10 min after adding an 
additional 1 ml water. Purified ds templates were collected in 
about 35 |il volume by spinning the microconcentrator at 1,500 
rpm (500 xg) for 5 min and an aliquot was examined by
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electrophoresis and staining with ethidium bromide on a mini 
agarose gel. Removal of excess primers from ds templates is 
critical for a successful sequencing reaction. The procedure 
using the Centricon 100 was satisfactory for removing most 
primers shorter than 45 nucleotides in length.
2.6.3 Cycle sequencing reaction with dye primers
Approximately 1.5 |4g of ds templates were mixed with 3 |il 
DMSO and water to a total volume of 7 |il and boiled for 5 min. 
Boiled templates were divided into four Eppindorf tubes, each 
containing one of the four deoxynucleotide
triphosphate/dideoxynucleotide triphosphate (d/ddNTP) mixtures 
(A, C, G or T), fluorescent Ml3 dye primers, either forward 
(ABI 401131) or reverse (ABI 400929) sequencing direction, Taq 
polymerase (Promega Biotech, Madison, WI) and PCR buffer to a 
total volume of 5 |4l for tubes A and C, and 10 |4l for tubes G 
and T. The mixtures were covered with mineral oil to avoid 
evaporation. The amount of each component in the mixture 
followed ABI recommendations.
Sequencing reactions were carried out on a thermal cycler 
following a two-stage programme with 15 cycles in each stage. 
The sequencing cycle in the first stage consisted of 30 sec at 
95°C, 30 sec at 55°C and 1 min at 70°C, while the cycle in the 
second stage was 30 sec at 95°C and 1 min at 70°C.
After thermal cycling, reaction mixtures in the four tubes 
were transferred into a 0.5 ml microcentrifuge tube and 
precipitated with 100 pil 100% ethanol and 3 |4l 3 M sodium 
acetate. The tube was stored at -70°C for a couple of hours to 
allow proper precipitation of small fragments before 30 min 
centrifugation. The precipitates were rinsed with 70% ethanol 
and dried under vacuum.
2.6.4 Sequence analysis on automated nucleic acid sequencer
The precipitated sequencing mixture was resuspended in
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Figure 2.10 An example of direct sequencing of ds PCR 
products: the exon 2 sequence of the DRBl*1409-associated 
DQB1*0402 allele from an Aboriginal donor.
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6 |il de-ionized formamide with 50 mM EDTA (pH 8.0), heated at 
9 0°C
for 2 min, and cooled on ice before loaded on a 6% 
polyacrylamide gel. Electrophoresis was controlled in an ABI 
373A nucleic acid sequencer. Fluorescent sequence signals were 
automatically scanned by the sequencer and retrieved by a 
computer. An example of the sequence obtained from this 
procedure is shown in Figure 2.10.
2.7 PCR-RFLP
PCR-RFLP was used as a supplementary assay to confirm some 
unusual SSO hybridization patterns. Ten |il of amplified PCR 
products were mixed with 2-3 units of appropriate restriction 
enzymes, digestion buffer, and water to a total volume of 
20 |4l. Digestion was carried out in a 500 |4l microcentrifuge 
tube for at least 5 h at 37°C. Digested fragments were 
separated by electrophoresis on a 10% polyacrylamide gel at 8 
v/cm for 4h and visualized by staining the gel with ethidium 
bromide. Alleles were assigned by comparing the observed 
number and size of DNA fragments to the patterns predicted 
from class II sequences and enzyme cutting sites.
2.8 PCR-SSCP
PCR-SSCP was used as another alternative to verify unusual 
nucleotide variations detected by SSO hybridizations. One |il 
of PCR products were denatured in 20 f_ll of a solution 
containing 0.4 N NaOH and 2 mM EDTA, loaded on a 7%-8% 
polyacrylamide gel with or without 10% glycerol. 
Electrophoresis was carried out at 2 mM/cm in circulating TBE 
buffer at 4°C for 8 h for the gel without glycerol and at 20°C 
for 16 h for the gel with glycerol. Single-stranded nucleotide 
fragments were visualized by silver staining. For silver 
staining, the gel was washed twice with 10% ethanol and 0.5% 
acetic acid for 3 min and stained in 0.1% AgN03 for 10 min.
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After washing with water, silver stains were developed by 
soaking the gel in a solution containing 1.5% NaOH , 0.01%
NaBH4 and 0.15% formaldehyde for 20 min. The gel was finally 
rinsed with 0.75% Na2C03 and dried in a gel drier.
2.9 Statistics
Gene frequencies and haplotype frequencies presented in 
this thesis were calculated by direct counting. Hardy-Weinberg 
equilibrium in study populations and linkage disequilibrium 
between HLA class II loci were evaluated by the Chi-square (%2) 
test. Phylogenetic analyses were based on genetic distances 
between study populations calculated with HLA-DR, -DQ 
haplotype frequencies. More specific statistical details are 
described in relevant chapters.
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CHAPTER 3
NUCLEOTIDE SEQUENCE DIVERSITY 
OF HLA CLASS II GENES 
IN AUSTRALIAN ABORIGINES
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3.1 Introduction
In Australian Aborigines, only a limited number of studies 
have been recorded for the HLA class II polymorphism. MLC 
typing using HTCs of non-Aboriginal sources has been 
incomplete, marked by 45% to 70% of the alleles undefined 
(Honeyman 1986; Kashiwagi & Kaneko 1986) . Serological typing 
has demonstrated that the HLA-DR specificities in Aborigines 
are comparatively restricted. An early study using sera 
detecting DR1 to DR8 has shown that DRl, DR3, DR5 and DR7 were 
absent from Aboriginal individuals (Termijtelen et al 1980). 
The same report also suggested that some DR alleles in 
Aborigines had different DQ association compared with 
Caucasoids, and indeed was definitive in defining HLA-DQ as a 
locus separate from HLA-DR. A later investigation with more 
sophisticated class II serology (Hay et al 1986) revealed that 
in populations from central and northern Australia, DR 
specificities were confined to DR2, DR4, DR5, DR6, and DR8, 
with DR8 the most common allele while DRl, DR3, DR7, DR9 and 
DR10 were absent from the two populations. A novel split of 
DR6, which is neither European DR13 nor DR14, was suggested by 
an unusual reaction pattern of antisera. The polymorphism at 
the DQ locus was marked by DQ1, DQ4, and DQ7, whereas DQ8 only 
sporadically occurred and DQ2 was absent. However, 
considerable levels of blank were left in both DR (35%) and DQ 
(57%) loci. More recently, HLA-DR and -DQ RFLP analysis was 
performed in two Aboriginal populations from the Kimberley 
region of northwestern Australia and from Cape York Peninsula 
of northeastern Australia (Davies et al 1990). In both 
populations, the RFLP-defined DR polymorphism was essentially 
confined to DR2, DR4, DR6, and DR8, which was consistent with 
the earlier serological data of central and northern 
Australians except that DR5 was absent from the Kimberley 
population and only sporadically occurred in Cape York 
samples. The possibility that a novel DR6 allele existed in
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Aborigines, as demonstrated earlier by serology was further 
suggested in the RFLP study by the finding of approximately 
25% of tested individuals with an unusual DR and DQ 
combination. However, the DR6 RFLP pattern could not be 
distinguished from some other DR52-related alleles. No study 
has ever been reported regarding the HLA-DP polymorphism, 
either by PLT or by RFLP, in Australian Aborigines.
These earlier studies have shown that HLA-DR and DQ 
antigens can be successfully detected by allo-antisera of non- 
Aboriginal sources with very little discrepancy. RFLP analysis 
has also indicated that the genomic organization of DR and DQ 
genes are the same as in other ethnic groups. However, both 
serology and RFLP mainly recognize broad HLA specificities, 
with limited ability to discriminate class II subtypes which 
are usually more informative for population and disease 
studies. DNA sequencing has revealed, within the framework of 
major allele groups, many variations which are ethnic-group- 
specific or population-specific. Given the fact that the 
Australian Aboriginal people have been isolated and 
independently evolving for at least 50,000 years, and given 
the high percentage of undefinable Aboriginal samples in MLC 
typing, it is very likely that certain unique variation exists 
at the nucleotide sequence level in these people.
The study described in this chapter characterizes 
nucleotide sequence diversity of HLA class II genes in 
Australian Aboriginal populations. Variation including single 
nucleotide substitutions of exon 2 of HLA-DRB1, DRB3, DRB5, 
DQAl, DQB1, and DPBl genes is examined using PCR-based 
sequencing and typing techniques. Unusual class II alleles 
resulted from multiple molecular mechanisms are described. 
Comparison of gene frequencies distributions of class II 
alleles defined by SSO typing may help to identify previously 
unexpected diversity between Aboriginal populations from 
different regions. This chapter and the following Chapter 4
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and Chapter 5 also show that characterization of the 
nucleotide sequence diversity permits more accurate assignment 
of class II haplotypes which provide more valuable information 
for the assessment of population affinity and admixture.
3.2 Study populations
A total number of 212 DNA samples from three Aboriginal 
populations was examined. One population (N=82) was from the 
Kimberley region of Western Australia. The other two 
populations were from East (N=74) and West (N=56) Cape York 
Peninsula of Queensland.
Kimberley samples were collected in a study of blood 
genetic markers in the late 1970s (Blake & Spargo 1986) . Two 
groups of Aboriginal donors with similar tribal backgrounds 
provided blood samples by venepuncture at the mission 
settlements of Kalumburu and Mowanjum. As far as it was 
possible to ascertain, persons resident at the missions were 
predominantly of full Aboriginal descent. The West Cape York 
series included 56 samples. Thirty-one were collected in the 
Coen area in 1988 by Mr. Ray Pace of the Royal Brisbane 
Hospital Foundation, Clinical Research Centre, from stockmen 
originating from central and western Cape York. The remaining 
25 West Cape York samples were from a settlement on the west 
coast of Cape York, collected in 1990 by Dr. Anthony Veale of 
National Centre for Epidemiology and Population Health, the 
Australian National University. Gene frequency distribution in 
the west coast and stockmen samples did not differ and were 
pooled as the "West Cape York" series. The East Cape York 
group included 74 samples, also collected in 1990 by Dr. Veal 
from a region north of Cairns. The precise locations and 
origins of donors sampled by Dr. Veale are protected under 
Protocol m902, ANU Ethics in Human Experimentation Committee, 
1990 and 1992. The Aboriginal populations in Cape York 
Peninsula are known to have a recent history of extensive
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admixture with Caucasoids, Chinese and Melanesians. Samples 
from the two Cape York groups used in this study were randomly 
chosen without pre-screening at the time of blood collection.
Some of the samples from Kimberley and Coen have been 
typed for HLA-DR and DQ in an earlier study using RFLP (Davies 
et al 1990). For the Kimberley series, genomic DNA was 
extracted from haemolysates using the phenol/chloroform method 
in earlier studies by Dr P. T. Yenchitsomanus formally of John 
Curtin School of Medical Research, the Australian National 
University. DNA for the Coen sample was extracted by Mr R.
Pace, from buffy coats using the pheno/chloroform methods. The 
salting-out procedure was used in the work of this thesis to 
extract DNA from the additional Cape York specimens (buffy 
coats) collected by Dr. Veale.
3.3 Results
3.3.1 Novel class II alleles found in Aborigines
The nucleotide sequence polymorphism of HLA-DRB1, DRB3, 
DRB5, DQA1, DQB1, and DPB1 were first analyzed by PCR-SSO 
typing. Five novel alleles, including four DRB1 and one DPB1, 
were identified by the occurrence of unusual SSO hybridization 
patterns. Direct DNA sequencing was then performed to examine 
the entire exon 2 of these new alleles. The five novel class 
II sequences have been submitted to the WHO Nomenclature 
Committee for factors of the HLA system, and have been 
designated HLA-DRB1*0412, 1408, 1409, 1410 and HLA-DPB1*2201 
respectively (Bodmer et al 1992). In the following sections 
the SSO typing and DNA sequencing results of the new alleles 
are presented; their extended class II haplotypes and 
population distributions are described; and the possible 
mechanisms for the generation of these alleles are proposed.
In the PCR-based sequencing techniques, PCR artefacts may 
affect sequencing results. It has been noticed that PCR 
amplification errors can create false mutations (Barnes 1992).
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In the present experiments, several precautions were taken to 
ensure correct sequencing results for the novel alleles.
First, novel alleles were originally recognized by SSO 
hybridization patterns, from which the new sequences have been 
predicted; the sequencing procedure was to confirm these novel 
variations and the entire exon 2. Second, the sequenced 
samples with novel alleles were carefully chosen for their 
genotypes. They were either well established homozygotes of a 
novel allele or heterozygous with a known allele which would 
not be amplified by the primers used for sequencing. Third, 
instead of using cloned nucleotide templates, the direct 
sequencing procedure used purified ds PCR products for the 
sequencing reaction, so that in the sequence analysis, the 
signals contributed by any artefact would be absorbed into the 
background because of their low percentage in the total PCR 
products. Finally, novel nucleotide sequence variations 
revealed in the sequencing procedure were further confirmed in 
the original samples and populations with probes designed 
accordingly. In the present experiments, the possibility that 
the novel HLA class II alleles resulted from PCR artefacts can 
be ruled out.
3.3.1.1 DRB1*0412
DRB1*0412 was first noted in 11 DR4, DR6 heterozygous 
samples which reacted additionally with the DR8-specific probe 
SR-8 in generic DR typing. In the subsequent DR4 subtyping, 
all these samples, together with some other DR4-positive 
subjects were found to have an unusual SSO pattern. They had 
positive hybridization with probes SR-4 (codons 28-34), SR-45 
(codons 54-60), and SR-85 (codons 83-86), but failed to 
hybridize with any of the four probes detecting all known DR4 
variations in the third HVR. Three more probes, SR-8 (codons 
69-75), SR-33 (codons 66-72), and SR-38 (codons 66-72), were 
then added to the DR4 subtyping protocol. SR-33 and SR-38
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detect the two variations in codon 67 shared by all DR8- 
related sequences. All those samples with a previously 
undetected third HVR were positively hybridized by probes DR-8 
and SR-38, which meant that the new allele detected in these 
samples had a third HVR identical to DRB1*0803.
To confirm the SSO typing result and to examine the entire 
exon 2, two samples, 1078 and AB028, both showing a homozygous 
SSO pattern of the new allele, were chosen for direct 
sequencing. Codons 7 to 93 were amplified with the 5' primer 
GH46 plus the M13 universal forward sequence and the 3' primer 
CRX37. The sequencing results from both samples were identical 
and confirmed the novel DRB1 allele predicted from the SSO 
hybridization pattern, now known as DRB1*0412. As shown in 
Figure 3.1, DRB1*0412 shares identical nucleotides in the 
first and the second HVRs with all known DR4 subtypes except 
for DRB1*0406 which has a single nucleotide substitution in 
codon 37 in the second HVR. Codon 57 of DRB1*0412 is AGC (Ser) 
which is the same as codon 57 of DRB1*0405, 0410 and 0411. In 
the third HVR from codon 67 to codon 74, DRB1*0412 has a 
sequence identical to DRB1*0803 but not found in any of the 
known DR4 subtypes. Codon 86 of DRB1*0412 is GGT (Val).
DRB1*0412 was detected in 21 out of 29 DR4-positive 
individuals including two homozygotes in the population from 
the Kimberley region with a gene frequency of 14%. All 
DRB1*0412-positive individuals shared an identical extended 
haplotype, DQA1*0301-DQB1*0402-DRB1*0412, a typical DR, DQ 
combination on Aboriginal DR4 haplotypes as shown in Section 
3.6 of this chapter.
DRB1*0412 apparently originated from a segmental transfer 
event. This hypothesis is supported by several pieces of 
evidence. (1) The analysis of extended HLA class II haplotypes 
confirmed that DRB1*0412 has a typical Aboriginal DR4-related 
DR, DQ combination. In a separate study, a DRB4 sequence has 
been determined in a DRB1*0412-homozygous Aboriginal donor,
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which showed an exon 2 identical to DRB4*0101 (Serjeantson, 
unpublished data). Previous RFLP analysis in the same 
population has also indicated a typical DR4-related gene 
organization in the DR subregion of all DR4 haplotypes (Davies 
et al 1990). (2) The putative donor gene DRB1*0803 is the most
common DRBl allele in Aborigines with a gene frequency of 26% 
in the Kimberley series (Section 3.3.3.1). (3) Candidate
recipients DRB1*0405 or DRB1*0410 are also well represented in 
Aboriginal populations. Although DRB1*0410 was not found in 
the Kimberley region, it is considered the likely recipient 
because it shares Val-86 with DRB1*0412. The reciprocal allele 
of any segmental exchange was not detected in this study, nor 
any intermediary alleles that would indicate two independent 
recombination events. (4) Compared with other Aboriginal DR4 
alleles (DRB1*0405 and 0410), DRB1*0412 has six nucleotide 
substitutions, which seems too large a number expected from 
accumulated point mutations and there were no intermediary 
alleles bridging DRB1*0412 (or 0405) and DRB1*0803 in the 
Aboriginal gene pool. 5) The codon usage of DRB1*0412 in the 
third HVR is identical to the putative donor DRB1*0803 
including a silent nucleotide substitution in codon 69. These 
data strongly indicate that DRB1*0412 was generated in a 
segmental transfer event rather than by independent point 
mutations. The boundaries of the putative segmental transfer, 
however, are difficult to locate, because the putative donor 
gene DRB1*0803 shares with DRB1*0412 an identical sequence 
between codons 34 to 85; the segmental boundaries could be 
extended from the third HVR to any point within this area.
3.3.1.2 DRBl*1408
The DR6-related new allele DRB1*1408 was first noted in 
generic DR typing by the frequent occurrence of a DRBl blank 
allele which was invariably associated with DQA1*0101 and 
DQB1*0503, a DQ combination otherwise mainly found on the
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DRB1*1401 haplotype. In the DR8 and DR52-related DRB1 
subtyping this allele was successfully amplified by primer 
SRP-6. SSO subtyping showed that this allele shared with 
DRB1*1401 an identical SSO typing pattern in the second and 
the third HVRs as well as codon 86, with positive 
hybridization of probes SR-81 (codons 25-31), SR-19 (codons 
34-40), SR-33 (codons 66-72), and SR-85 (codons 83-86), but 
failed to hybridize with any of the five probes detecting all 
known variations in codons 54-62 including SR-14 which detects 
DRB1*1401 in both generic DR typing and the DR52-related DRBl 
subtyping.
Sample HV858 having the genotype, DRBl*14(new 1)/DRB1*1501 
was sequenced using the same procedure and primers as in the 
case of DRB1*0412. Only the DR14-related new allele was 
amplified, since the 31 primer CRX37 selectively amplifies 
DRBl alleles which are not DR2, DR7 or DR9 (Scharf et al 
1991). The results, as presented in Figure 3.2, showed that 
exon 2 of the new allele is otherwise identical to DRB1*1401 
except for a single-base-pair substitution. The new allele has 
GAT (Asp) instead of GCT (Ala) at position 57. Probe 14.8, 
with sequence 51-GCGGCCTGATGCGGAGCAC-31 corresponding to 
codons 54-60 of the new allele was designed and added to the 
SSO subtyping protocol. It positively hybridized all samples 
with the new allele predicted from the SSO hybridization 
pattern. This allele has been designated DRB1*1408.
DRB1*1408 was detected in all three Aboriginal 
populations. Individuals with this allele shared the same 
extended class II haplotype, DQB1*0503-DQA1*0101-DRB1*1408- 
DRB3*0202. Point mutation seems the most likely mechanism for 
the generation of DRB1*1408 from a DRB1*1401 haplotype or the 
reverse. Though point mutations are difficult to distinguish 
from short segmental transfers, codon 57 of DRB1*1408 and the 
neighbouring codon 58 form a unique segment which is not 
shared by any known DRB allele. The related DRB1*1401 allele,
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either a derivative or a progenitor of DRB1*1408 seems very 
old, which is represented in most ethnic groups examined, 
while DRB1*1408 is apparently confined to Australia and 
Oceania as described in Chapter 4. In Aborigines, DRB1*1401 is 
overwhelmingly linked with DRB3*0201 which is different from 
the DRBl*1408-associated DRB3*0202. However, an intermediary 
haplotype, DRBl*1401-DRB3*0202, was detected in one of the 
tested donors.
3.3.1.3 DRBl*1409
DRB1*1409 was detected as DR6 in generic typing. In the 
subtyping for DR52-related DRB1 alleles, it was revealed by a 
novel SSO hybridization pattern which was otherwise the same 
as the pattern for DRB1*1402 except for one discrepancy. The 
new pattern had positive hybridization with probes SR-6 
(codons 32-38), SR-83 (codons 54-60), SR-44 (codons 69-75), 
and SR-86 (codons 82-86), but in codons 25-31 it showed 
positive hybridization of probe SR-81 instead of SR-29 as 
expected for DRB1*1402. The new pattern meant that codons 25- 
31 of the new allele were the same as most other DR8 and DR52- 
related alleles but different from DRB1*1402. The SSO-pattern- 
predicted new sequence fitted the sequencing result of a 
fragment of exon 2 derived from an Aboriginal donor in an 
earlier sequencing effort by Serjeantson (unpublished data).
To examine the entire exon 2, sample 1080, selected by the 
novel SSO pattern and having a genotype of DRB1*14(new 
2)/DRB1*1502, was amplified with primers GH46 and CRX37 and 
sequenced. The new allele has been designated DRB1*1409. The 
sequencing result given in Figure 3.3 confirmed that 
except for codon 28, DRB1*1409 was identical to DRB1*1402. 
Codon 28 in the DRB1*1402 sequence is GAG (Glu) whereas in 
DRB1*1409 GAC (Asp) was observed instead. The single-base-pair 
substitution could also be detected by PCR-SSCP, in which it 
showed a slightly changed migration rate of a single-stranded
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Figure 3.4 Single nucleotide substitution between DRB1*1402 
and DRB1*1409 detected by PCR-SSCP. Under same experimental 
conditions, the single-base mismatch between DRB1*1401 and 
DRB1*1408 could not be recognized.
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DNA fragment amplified from DRB1*1409 when compared with the 
fragment of DRB1*1402 (Figure 3.4).
DRB1*1409 was detected exclusively in the Kimberley where 
it had a gene frequency of 24% and was invariably detected on 
the same haplotype, DQB1*0402-DQA1*0501-DRB1*1409-DRB3*0101. 
Like DRB1*1408, a point mutation seems responsible for the 
generation of DRB1*1409. DRB1*1402 was detected overwhelmingly 
in the Cape York populations. Only three donors in the 
Kimberley were found to have this allele. However, the 
DRB1*1402 found in Cape York was associated with DQB1*0301 
which is different from the DQ association of DRB1*1409, 
whereas the three DRB1*1402-positive Kimberley samples all had 
the same DQ association as DRB1*1409, which could been the 
intermediary form bridging the two haplotypes. Although it is 
difficult to tell whether DRB1*1402 or 1409 is the donor gene, 
the rather confined distribution of the latter may indicate a 
more recent origin.
3.3.1.4 DRB1*1410
DRB1*1410 was detected with a DR6-related probe SR-14 in 
generic DR typing, but failed to amplify with primer SRP-6 
which amplifies DR3, DR5, DR6 and DR8 alleles. This phenomenon 
was first observed in two donors positive also for DRB1*1502 
and in two donors positive also for DRB1*0405. The new allele 
was further suggested by its unique DQ association: DQA1*0301 
and DQB1*0402, a combination otherwise restricted to DR4 
haplotypes in Aborigines. In PCR amplification using the DR4- 
specific primer SRP-4, all these samples were successfully 
amplified. The SRP-4-amplified PCR products were then subtyped 
following the DR52-related DRB1 typing protocol. An SSO- 
hybridization pattern identical to DRB1*1401 was observed 
in all these samples with positive hybridization of probes SR- 
81 (codons 25-31), SR-19 (codons 34-40), SR-14 (codons 55-61), 
SR-34 (codons 69-75), and SR-85 (codons 83-86).
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DNA sequencing using primers GH46 and CRX37 was performed 
in a heterozygous sample, ABCC31 with a genotype of 
DRBl*14(new 3)/DRB1* 1502. In this case, an M13 reverse 
sequence was added to the 3'-end primer CRX37 to determine the 
complementary strand of the coding sequence. The results, as 
presented in Figure 3.5, showed that the new allele, now known 
as DRB1*1410, has a first HVR identical to DRB1*04, but the 
remaining sequence of exon 2 is the same as DRB1*1401.
DRB1*1410 was represented in all three Aboriginal 
populations and had an extended HLA class II haplotype of 
DQAl*0301-DQB1*0402-DRB1*1410-DRB3*0101. The mechanism giving 
rise to DRB1*1410 was quite different from those involved in 
DRB1*0412, 1408 and 1409. Exon 2 of DRB1*1410 is a combination 
of DRB1*04 and DRB1*1401. Upstream of the DR4-like HVR 1 was a 
DQ haplotype otherwise associated only with DR4 in Aborigines, 
while downstream of the DRBl*1401-like sequence was a DR52 
allele (DRB3*0101). Such a special gene arrangement clearly 
shows that the new allele was generated in anintra-exonic 
recombination event between a DRB1*04 and a DRB1*1401 allele, 
together with the linked DQ and DRB3 gene loci. The location 
of the recombination should be somewhere between the first and 
the second HVRs. In codon 19, the putative progenitor 
DRB1*1401 has a silent nucleotide substitution compared with 
all DR4 subtypes. This variation also exists in the new allele 
DRB1*1410. Therefore, the putative recombination site could be 
further located between codons 13 (the boundary of the first 
HVR) to 19. Because of the special sequence combination, 
DRB1*1410 may be useful to identify relevant serological and 
T-cell recognition epitopes. Although it has been assigned to 
the DR14 group, its serological and MLC specificities are yet 
to be determined.
3.3.1.5 DPBl*2201
DPB1*2201 was first recognized by a novel SSO
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hybridization pattern in DPB1 typing. The new allele was 
positively hybridized by probe SPB-81 after the generic DPB1 
amplification, and was subsequently amplified by the group-B- 
specific primer SPBP-4. In the DPB1 typing for group B, six 
probes, SPB-4, SPB-31, SPB-52, SPB-61, SPB-71, and SPB-81 were 
positive, a pattern otherwise identical to that seen for 
DPB1*0501, except that at the fourth probed region of codons 
66 to 72, the new allele was recognized by probe SPB-61 
instead of SPB-65 as expected for DPB1*0501. PCR-RFLP also 
identified a restriction pattern which was not expected from 
any of known DPBl alleles but fitted the sequence predicted 
from the novel SSO pattern.
To confirm the SSO-defined new allele, DNA sequence 
analysis of exon 2 was performed in two samples, HV152 and 
HV385, both showing a homozygous novel SSO pattern. For DNA 
sequencing of DPBl, codons 8 to 90 were amplified with the 
same primers used for the generic amplification (SPBP-1 and 
SPBP-2) but with an M13 forward sequence added to either 
primer in order to sequence both strands. The DNA sequence of 
the new allele, designated DPB1*2201, and the deduced amino 
acid sequence are given in Figure 3.6. The sequencing data 
confirmed the novel SSO and the PCR-RFLP patterns and revealed 
that DPB1*2201 had a DNA sequence identical to DPB1*0501 
throughout exon 2 except for a nonsynonymous change of codon 
69 due to a single nucleic acid substitution. DBP1*2201 had a 
codon GAG (Glu) at position 69 instead of AAG (Lys) as in 
DPBl*0501.
DPB1*2201 was found in all three Aboriginal populations. 
The gene frequency ranged from 9% to 22%. It could have been 
generated from DPB1*0501 by a single point mutation in codon 
69. Alternatively, it could have been generated from DPB1*0202 
by shuffling HVR 6 (codons 84-87) . Although in the latter case 
four nucleotide substitutions would be involved to generate 
the new allele from DPB1*0202 (or the reverse) it could also
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be accomplished in a single segmental exchange event as 
apparently happened frequently in the evolution of HLA-DPB1 
(Bugawan et al 1988). However, the distribution of DPB1 
alleles in Aboriginal populations (Section 3.3.3.3) indicates 
that the DPB1*0202 scenario is unlikely. In all three 
Aboriginal populations examined, DPB1*0501 is the most common 
DPB1 allele, whereas DPB1*0202 is absent.
3.3.2 DNA sequencing of other class II alleles detected in 
Aborigines
In addition to the five novel class II alleles, some DRB1, 
DQB1, or DPB1 types detected in Aborigines by PCR-SSO typing 
and showing expected hybridization patterns of known alleles 
have also been chosen for DNA sequencing to examine the entire 
exon 2 sequence. The results are described in the following 
sections.
3.3.2.1 DRB1 alleles
Three major DR4 subtypes were detected in the DR4 SSO 
subtyping in addition to the novel DRB1*0412. DRB1*0410, a 
variant of DRB1*0405, was frequently detected by SSO typing in 
Aborigines from Cape York Peninsula. DRB1*0411, another 
variant of DRB1*0405, was found in four of the Aboriginal 
individuals tested.
Samples ABCC71 (DRBl*0410/DRBl*0410) and HV846 
(DRB1*0411/DRB1*07) were chosen for sequencing the entire exon 
2. The resulting DNA sequences, given in Figure 3.7 confirmed 
the SSO typing results, showing that DRB1*0410 had a single 
amino acid switch from DRB1*0405 at position 86 (Val instead 
of Gly) involving two nucleotide substitutions, while 
DRB1*0411 had an additional amino acid replacement at position 
74 (Glu instead of Ala) caused by a single nucleotide 
mutation.
DRB1*0405 and DRB1*0410 are apparently closely related in
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the study populations; both of them were associated with 
DQB1*0402. A segmental exchange around codon 86 may have given 
rise to DRB1*0410 from 0405, or the reverse. The origin of 
DRB1*0411 was more difficult to define, since it is associated 
with DQB1*0302. It could be generated from a DRB1*0403 
haplotype by a segmental transfer around codon 57. However, in 
the Aboriginal populations examined, DRB1*0403 was rare and is 
considered non-Aboriginal (see Section 3.5 and Section 3.6).
At the same time when DRBl*0410 and 0411 were 
characterized in this study, they were officially designated 
by the WHO nomenclature committee (Bodmer et al 1991) on the 
basis of DNA sequences determined in single Hispanic 
individuals (Petersdorf et al 1991). In the present 
experiments, the first HVR sequence of both alleles were 
obtained by selecting samples of appropriate genotype for 
sequencing and using DRBl-specific intronic primers.
Other DRBl alleles sequenced in this study included 
DRB1*1401 (sample P1174) and DRB1*1402 (sample HV398) .
Together with a previously sequenced DRB1*08032 (Serjeantson 
unpublished data), most major Aboriginal DRBl allele types 
detected in this study have been examined. The exon 2 
nucleotides of these sequenced alleles were identical to 
published ones.
3 .3 .2.2 DQBl alleles
In the present study, the class II HLA typing in 
Aboriginal populations revealed some unusual DR-DQ haplotypes 
including those bearing newly-defined DRBl alleles. The DQBl 
alleles detected on these haplotypes were chosen for 
sequencing analysis of the entire exon 2. Table 3.2 lists the 
samples, together with DR-DQ haplotypes, selected for 
sequencing analysis of DQBl exon 2. The sequenced DQBl types 
included DQB1*0503, 0601, and 0402. Direct sequencing was 
performed using primers SE-38 (with an Ml3 forward sequence)
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and DB131. All DQBl sequences derived from this study were 
identical to the published ones. DQBl sequencing of the 
DRB1*0803-associated DQB1*0503 in three samples (HV647, HV519 
and 1086) showed an identical sequence of DQB1*05031 which was 
not distinguishable from two other DQB1*0503 subtypes by the 
SSO typing protocol of this study.
Table 3.1 Samples sequenced for DQBl alleles
Sample P o p u l a t i o n H a p l o t y p e
HV647 East C.Y. D Q A 1 * 0 1 0 3 - D Q B l * 0 5 0 3 -DRB1*0803
HV519 East C.Y. D Q A 1 * 0 1 0 3 - D Q B l * 0 5 0 3 -DRB1*0803
1086 K i m b e r l e y D Q A 1 * 0 1 0 3 - D Q B l * 0 5 0 3 - D R B 1 * 0803
1086 K i m b e r l e y D Q A 1 * 0 1 0 3 - D Q B l * 0 6 0 1 - D R B 1 *0803
P1085 West C.Y. D Q A 1* 0 3 01-D Q B l * 0 4 0 2 -D R B 1*0405
1078 K i m b e r l e y D Q A 1 *03 0 1 - D Q B l * 0 4 0 2 - D R B 1 *0412
1097 K i m b e r l e y D Q A 1 * 0 5 0 1 - D Q B 1 * 0 4 0 2 - D R B 1 * 1 402-DRB3 *0101
ABO 3 8 K i m b e r l e y D Q A 1 * 0 5 0 1 - D Q B l * 0 4 0 2 - D R B 1 * 1 4 0 9 - D R B 3 * 0101
HV152 East C.Y. D Q A 1 *03 0 1 - D Q B l * 0 4 0 2 - D R B 1 * 1 4 1 0 - D R B 3 -0101
3.3.2.3 DPBl alleles
In addition to the new DPB1*2201 allele, three other major 
DPBl alleles detected by SSO typing in this study were also 
subjected to sequencing analysis including DPB1*0201 (sample 
HV152), DPB1*0401 (samples 1075 and P1159) and DPB1*0501 
(samples HV479 and 1078). All three DPBl alleles sequenced in 
this study had exon 2 sequence nucleotides identical to the 
published ones.
3.3.3 Distribution of HLA class II alleles in Aboriginal 
populations
The nucleotide sequence polymorphism of six HLA class II
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loci of DQA1, DQBl, DRB1, DRB3, DRB5 and DPBl was examined 
using the PCR-SSO typing procedure in three Aboriginal 
populations. Hardy-Weinberg test indicated that all examined 
loci were in equilibrium in the three populations. An example 
of Hardy-Weinberg analysis is given in Table 3.2 for HLA-DQAl.
3.3.3.1 Distribution of HLA-DRB alleles in Aborigines
Altogether, 26 DRB1, four DRB3 and 3 DRB5 alleles were 
found in the three Aboriginal populations. DRB1 variation was 
essentially confined to DR2, DR4, DR6 and DR8 allele types in 
all three groups. In the two Cape York populations, other 
allele types with much lower gene frequencies were also 
detected, whereas in the Kimberley series other allele types 
were rarely seen. Gene frequencies of DRB1, DRB3 and DRB5 
alleles in the three populations are given in Table 3.3.
In the DR2-related DRB1 group, DRB1*1502 was the dominant 
subtype in the Kimberley and the West Cape York populations, 
while in the East Cape York group, The frequency of DRB1*1502 
was lower than DRB1*1501. DRB1*1602 was sporadically seen in 
all three groups, whereas DRB1*1503 and 1601 were not 
observed. The DRB5 locus was dominated by DRB5*0101 which was 
found to be associated with both DR15 alleles. DRB5*0102 was 
detected in two DRB1*1502-positive samples from East Cape York 
while DRB5*02 was observed in four DRB1*1602-positive samples.
Seven DR4 subtypes including the newly-defined DRB1*0412 
were found in Aborigines. Among the three major DR4 subtypes, 
DRB1*0405 was frequently detected in all three groups. The 
other two, DRB1*0410 and 0412, showed marked population 
differences. DRB1*0410 had a gene frequency of 9% in the West 
Cape York group but was absent in the Kimberley region. 
DRB1*0412 had a gene frequency of 14% in Kimberley where it 
accounted for 74% of DR4 haplotypes, but was not found in 
either of the Cape York populations. Other DR4 subtypes 
detected in Aborigines included DRB1*0401, 0403, 0404 and
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0411. All them sporadically occurred in Cape York Peninsula, 
except that DRB1*0411 was also found in one Kimberley sample.
The DR5 allele group was mainly represented by DRB1*1201. 
Eight donors were positive for this allele and six of them 
were found in Kimberley.
DR6-related alleles were confined to DR14 subtypes 
including DRB1*1401, 1402, and the newly-defined 1408, 1409 
and 1410. Except for DRB1*1409, these alleles were detected in 
all three populations, although the frequency of DRB1*1402 in 
the Kimberley samples and DRB1*1408 in the West Cape York 
population were much lower than in the other two groups. 
DRB1*1409 was the most frequent DR14 subtype in the Kimberley 
and was found in this group only. DRB1*1301 was found in four 
subjects and three of them were from East Cape York Peninsula.
The most common DRB1 allele found in this study was 
DRB1*0803 with gene frequencies of 34% (East C.Y.), 34% (West 
C.Y.), and 26% (Kimberley). All the DRB1*0803 detected were 
DRB1*08032 without exception. DRB1*0801 was found in only one 
case.
Other DR allele types including DRl, DR3, DR7, DR9 and 
DR10 found this study were mainly confined to the two 
populations from Cape York Peninsula. Except for a. 
DRB1*0301/DRB1*07 heterozygous donor, these alleles were 
absent from the Kimberley series.
All four DRB3 alleles were detected in this study in DR3, 
DR5, or DR6-positive individuals. DRB3*0101 and 0202 were both 
commonly seen, whereas 0301 was detected only in one example. 
The linkage relationship of DRB3 alleles with major Aboriginal 
DRBl alleles detected in this study were: DRB3*0101 with 
DRB1*1402, 1409 and 1410; DRB3*0201 with DRB1*1401; and 
DRB3 *02 02 with DRB1*1201 and 1408.
A substantial proportion of DRBl gene frequencies was 
represented by the new alleles defined in Aborigines. This was 
best demonstrated in the Kimberley group which had been
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possibly screened for pure Aboriginal blood by choosing donors 
of resident in mission settlements. In this group, the four 
newly-defined DRBl alleles, i.e. DRB1*0412, 1408, 1409, and 
1410, had a combined gene frequency of 45%. In contrast, some 
other alleles occurred only once, such as DRB1*1602, 0301,
1301, and 07. It is likely that these rare alleles were non- 
Aboriginal. When extended class II haplotypes were examined, 
DRBl alleles with a recent foreign origin could be more 
clearly identified; this is shown in Section 3.6.
3.3.3.2 Distribution of HLA-DQ alleles in Aborigines
The detected DQ alleles and their distributions in the 
three Aboriginal populations are shown in Table 3.4. At the 
DQA1 locus, eight distinguishable alleles were found in this 
study. DQA1*0103, associated with DRB1*0803, was the most 
common DQA1 allele with gene frequencies of 34% (East C.Y.),
34% (West C.Y.), and 27% (Kimberley). Other alleles commonly 
seen in all three groups included the DRBl*1401-associated 
DQA1*0101, the DRBl*1502-associated DQA1*0102, and the DR4 and 
DRBl*1410-associated DQA1*0301. The distribution of DQAl 
alleles in the three groups was compatible with their 
associated DRBl alleles. DQA1*0401 and 0601 were observed only 
once in each case.
Twelve out of 16 detectable DQB1 alleles were found in 
Aborigines, but in the Kimberley group only four of them were 
observed more than twice. DQB1 alleles also showed strong 
linkage disequilibrium with DRBl. The three most frequent DQBl 
alleles were
the DR15 and DR8-DQB1*0601, the DR14 and DR8-associated 
DQB1*0503, and the DR4 and DR14-associated DQB1*0402. The most 
common DQBl allele was DQB1*0402 in the Kimberley group (43%) 
where it was found on DRB1*1402, 1409, and 1410 haplotypes and 
on all DR4 haplotypes except for one DRBl*0411-positive 
example. The unusual asscoiation of DQB1*0402 with DR4 alleles
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Figure 3.8 PCR-RFLP typing for the Aboriginal DR4-associated 
DQ4 subtypes
Group-specifically amplified DQB1 PCR products were digested 
with Cfol before separation by electrophoresis on a 
polyacrylamide gel.
296bp
187BP
185BP
109bp 
107bp
D O O O O M O O O O O O O U
Q 4 4 4 4 A 4 4 4 4 4 4 4 N
b o o o o r o o o o o o o c  
1 2 2 2 2 K 1  1 1 1 1 1 1 U
E T
d o o o o r o o o o o o o  
R 4 4 4 4  4 4 4 4 4 4 4
B 0 0 1 1  O O O O O O O
1 5 5 0 0  5 5 5 5 5 5 5
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was further confirmed using PCR-RFLP as shown in Figure 3.8
3.3.3.3 Distribution of HLA-DPB1 alleles in Aborigines
A total of 174 Aboriginal donors were typed for the DPBl 
polymorphism. The results are given in Table 3.5. Ten DPBl 
alleles, including the newly-defined DPB1*2201 were detected 
in this study. Among them, four dominant alleles, namely 
DPB1*0201, 0401, 0501 and 2201 accounted for 99% of the DPBl 
gene frequencies in Kimberley, 96% in West Cape York, and 89% 
in East Cape York. Except for one donor from Kimberley and two 
from West Cape York, samples having alleles other than the 
four common ones were only seen in the population from East 
Cape York, a population known to have extensive admixture with 
Caucasoids, Chinese, and Melanesians (Kirk 1973). Analysis of 
DPBl allelic associations with DR, DQ combinations showed that 
all the DPBl alleles other than the four dominant ones were 
associated with those non-Aboriginal DR-DQ haplotypes (see 
Section 3.6). Therefore, it is very likely that the DPBl 
allelic repertoire in indigenous Australian people was 
confined to DPB1*0201, 0401, 0501, and 2201 while other 
alleles observed in contemporary Aboriginal populations 
reflect more recent foreign admixture.
3.3.4 HLA class II haplotypes in Aboriginal populations
In the present study, family material was not available. 
Four or three-locus HLA class II haplotypes were inferred by 
the assessment of two-locus linkage disequilibrium and by the 
analysis of linkage patterns of class II alleles in homozygous 
and heterozygous individuals in a given population.
3.3.4.1 Linkage disequilibrium between DR and DQ loci in 
Abirigines
The two-locus linkage disequilibrium delta value was 
calculated according to Baur & Danilovs (1980) by the
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difference between the frequencies of an observed two-locus 
combination and of that expected from the relevant gene 
frequencies in a population. Significance of the delta value 
was evaluated by the 2 X 2  chi-square test. Strong linkage 
relationships were observed between DRB1, DQAl and DQB1 loci. 
DRB1-DQA1 and DRB1-DQB1 haplotypes showing positive linkage 
disequilibrium in Aborigines are listed in Table 3.6. The two 
DR15-related alleles DRB1*1501 and 1502 were in strong linkage 
disequilibrium with DQB1*0602 and 0601 respectively, and were 
both linked with a DQA1*0102 allele. DR4 subtypes were 
invariably linked with DQA1*0301 but had different linkage 
relationships at the DQB1 locus, including DQB1*0302, 0401, 
and 0402. DR14-related DRB1 alleles showed more complex 
linkage relationships involving DQA1*0101 (DRB1*1401 and 1408) 
or DQAl*0501 (DRB1*1402 and 1409), and DQB1*0503 (DRB1*1401 
and 1408), DQB1*0301 (DRB1*1402), or DQB1*0402 (DRB1*1409).
The newly-defined DRB1*1410 had a DQ linkage involving 
DQA1*0301 and DQB1*0402, a combination otherwise observed only 
in the DR4 group. DRB1*0803 was found in linkage 
disequilibrium with DQA1*0103, but at the DQBl locus it was 
linked with either DQB1*0601 or 0503. In general, the DRB1 
locus showed stronger linkage relationship with DQAl than with 
DQBl. In the present analysis, no DRBl allele was found to 
have significant linkage disequilibrium with more than one 
DQAl allele, whereas double linkage relationship with DQBl 
alleles was observed in several DRBl alleles, such as 
DRB1*0405, 07 and 0803.
3.3.4.2 HLA-DR, -DQ haplotypes in Aborigines
Based on two-locus linkage disequilibrium and allele 
associations in populations, four or three-locus DR, DQ 
haplotypes were deduced in Aborigines. Assignment of 
particular DQAl and DQBl alleles to DRBl types was facilitated 
by the occurrence of 30 DR, DQ homozygotes in the study
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populations. For individuals heterozygous at both DR and DQ 
loci the most likely allelic combinations were assumed, based 
on the most common haplotypes in the relevant populations.
A total number of 37 HLA class II haplotypes were inferred 
in the three populations (Table 3.7). The origin of these 
haplotypes were assessed on the basis of haplotype 
frequencies, population distributions, associated allele 
types, DPB1 associations and comparison with class II 
haplotypes detected in other ethnic groups (see Chapter 5). 
Under these criteria, the Aboriginal origin was obvious for 
some haplotypes, such as those associated with novel 
Aboriginal DRB1 alleles, the DRB1*1402, 0803-associated 
haplotypes, and the DQB1*0402-associated haplotypes. In the 
Kimberley group, 13 presumably Aboriginal haplotypes had a 
combined haplotype frequency of 98%. In Cape York populations, 
these haplotypes accounted for 85% (West C.Y.) and 66% (East 
C.Y.) of haplotype frequencies respectively. Some other 
haplotypes were apparently contributed by recent foreign 
admixture including DRl, DR3, DR13, DR7, DR9 and DR10- 
associated haplotypes. These apparently non-Aboriginal 
haplotypes were mainly found in Cape York populations, with 
only single instances detected in the Kimberley series. In 
some other cases, however, the haplotype origin was obscure. 
For example, DRB1*1501 was detected in Cape York populations 
only and was overwhelmingly associated with a haplotype 
(DRB1*1501-DRB5*0101-DQA1*0102-DQB1*0602) which is universally 
represented in most human groups. The absence of this 
haplotype in the Kimberley population and its linkage 
relationships with DPB1 alleles (Section 3.3.4.3) suggested 
that at least some of the DRBl*1501-associated haplotypes 
found in Aborigines were contributed by recent foreign 
admixture. A similar situation may also be true for the 
DQBl*0401-associated DRB1*0405 haplotype, except that the 
candidate donor populations of this haplotype (Asians and
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Melanesians) share a similar DPB1 distribution with 
Aborigines. Many of the Aboriginal DR, DQ haplotypes have 
unique gene arrangements and carry valuable information for 
the study of population phylogeny and class II HLA evolution. 
More detailed analysis of HLA class II haplotypes is performed 
in Chapter 5.
3.3.4.3 Population admixture reflected by DPBl associations
Linkage disequilibrium between DPBl and DR or DQ loci in 
Aboriginal populations performed in this study did not show 
any significant delta value. However, analysis of DPBl 
association with DR, DQ haplotypes in individual samples 
demonstrated convincing evidence for recent population 
admixture in Aborigines.
In the two populations from Cape York, HLA class II 
alleles with an apparent non-Aboriginal origin were frequently 
observed at both DRB1 and DPBl loci. In the 10 detected DPBl 
allelic types, six were considered non-Aboriginal, including 
DPBl*0101, 0301, 1101, 1301, 1501, and 1601. Table 3.8 gives 
class II HLA typing results of all individuals having these 
DPBl alleles and their deduced DR-DQ-DP haplotypes. Haplotype 
A of the 15 individuals carried one of the six presumably non- 
Aboriginal DPBl alleles and the DR, DQ combinations on these 
haplotypes were also considered to have a foreign origin, 
because they were not observed in the Kimberley samples but 
have been frequently detected in Caucasoids, Southeast Asians, 
Chinese or Melanesians (see Chapter 5). DRB1*1501 on these 
haplotypes had a classical DR, DQ combination (DQB1*0601- 
DQAl*0102-DRB1*1501-DRB5*0101) observed in most other ethnic 
groups including previously reported Caucasoids and the Asia- 
Oceanic populations examined in this thesis. Sample 11 (Table 
3.8) had a DRB1*1502, a common DRB1 allele in Aborigines, but 
its DQ combination (DQB1*0501 and DQA1*0101) indicated a
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Table 3.8 HLA-DR, -DQ and -DP associations in 15 Aboriginal 
individuals
No ID Haplotype A Haplotype B
DPB1-DQB1-DQA1-DRB1-DRB3-DRB5 DPB1-DQB1-DQA1-DRB1-DRB3-DRB5
1 HV361 0101-0201-0501-0301-0101 0501-0601-0103-0803
2 HV802 0101-0201-0501-0301-0101 0501-0601-0103-0803
3 HV024 0301-0501-0101-0101 2201-0601-0103-0803
4 HV007 0301-0602-0102-1501 -0101 2201-0601-0103-0803
3 HV298 0301-0201-0201-07 2201-0301-0501-1402-0101
4 HV3 83 0301-0201-0201-07 0501-0601-0103-0803
5 HV384 0301-0201-0201-07 0501-0503-0101-1401-0201
6 HV400 0301-0201-0201-07 2201-0503-0101-1401-0201
9 HV32 4 1101-0501-0101-0101 2201-0503-0101-1401-0201
10 HV574 1101-0201-0501-0301-0101 0501-0602-0102-1501 -0101
11 HV3 98 1301-0501-0101-1502 -0102 0501-0301-0501-1402 -0101
12 HV873 1301-0302-0301-0404 0501-0501-0101-1502 -0102
13 HV099 1501-0602-0102-1501 -0101 0401-0602-0102-1501 -0101
14 HV277 1601-0603-0102-1501 -0101 0201-0503-0103-0803
15 HV7 43 1601-0603-0103-1301-0101 0201-0401-0301-0405
Southeast Asian or southern Chinese origin. DRB1*0301 and 07 
haplotypes in these samples are among the most common class II 
haplotypes in Caucasoids, Southeast Asians and southern 
Chinese while DRB1*0101, 0404 and 1301 were probably derived 
from Caucasoids. The B haplotypes of these donors had one of 
the four dominant DPBl alleles in Aborigines and associated 
with a DR, DQ combination which was either Aboriginal or from 
foreign admixture. The latter could apply to the DRB1*1501, 
1502, and 0405 (DQB1*0401)-associated haplotypes with a 
DPBl*0201, 0401 or 0501, but not 2201. DRB1*0803 was the most 
common Aboriginal DRB1 allele, though the DQB1*0601 associated
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haplotype was also widely detected in populations of Asia- 
Oceania in the work of Chapter 4. The Aboriginal origin of the 
DRB1*1401 haplotype was suggested by the unique DRB3*0201 
association.
The apparently non-Aboriginal DR-DQ haplotypes also showed 
negative association with the unique Aboriginal DPB1*2201. In 
eight DPB1*2201 homozygotes detected in this study, none of 
the DR-DQ haplotypes with an apparent foreign origin was 
found.
3.4 Discussion
The Australian Aboriginal people have a long history of 
isolation and independent evolution, thus providing a unique 
opportunity in the study of HLA diversity. In the present 
experiments using PCR-based sequencing and typing techniques, 
nucleotide sequence variation of HLA class II genes detected 
in three Australian Aboriginal populations revealed previously 
unknown polymorphisms. Information derived from this study 
have important implications for the understanding of class II 
HLA evolution and of the Aboriginal people.
The relative age of an allele may be inferred from (i) its 
occurrence on heterogeneous haplotypes (ii) its population 
distribution and (iii) whether it has contributed, as donor or 
recipient, in generating new alleles. Under these criteria, 
DRB1*0412 is a relatively new allele, found on a single 
haplotype with limited distribution and clearly post-dating 
DRB1*0803 since it is a recipient of DRB1*0803 nucleotide 
sequences. In contrast, DRB1*1408 may be an ancient allele, 
widespread not only in Australia, but also in some Oceanic 
populations where it is associated with a different DRB3 
allele (see Chapter 4 and Chapter 5). Although DRB1*1408 could 
be either a derivative of or progenitor of DRB1*1401, the 
different DRB3 associations of the two alleles in contemporary 
Aborigines suggests a long history of divergence. Further, in
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hominoid phylogeny Asp-57 tends to diversify into non-Asp-57 
residues in both HLA-DQß and DRß molecules (Erlich &
Gyllensten 1991); under this scheme DRB1*1408 could predate 
DRB1*1401. The age of DRB1*1409 (Asp-28) is similarly 
speculative since it may be a progenitor or derivative of 
DRB1*1402 (Glu-28)/ but the alleles have different HLA-DQBl
associations and their population distributions in Australia 
now scarcely overlap. DPB1*2201 was one of the four dominant 
DPB1 alleles in all three Aboriginal populations and does not 
have significant linkage disequilibrium with any DR, DQ 
haplotype. Given that DPB1*2201 has not been reported in any 
other ethnic groups, it may be generated in the early stage of 
human occupation of Australia.
The finding of two examples of hypermutational events 
(DRB1*0412 and 1410) in one small (Kirk, 1981) population does 
not necessarily conflict with suggestions that the MHC 
polymorphism is very old; it does, however, suggest that 
generation of alleles with highly divergent antigen-binding 
sites may be more common than previously thought. The 
hypermutational events observed in this study also indicate 
that there is no structural limit to the sequence exchange at 
the DRB1 locus between DR4, DR8 and DR52-related allelic 
groups. The events could be recognized in a long-isolated 
population with a comparatively restricted polymorphism at 
HLA-DRB1. It is thought that recombination within class II 
alleles is uncommon (Kasahara et al 1990; Klein et al 1991a), 
with one intra-exonic recombination in the hominoid HLA-DQBl 
phylogeny still detectable after more than five myr 
(Gyllensten et al 1990). The crossing-over event observed here 
may be exceptional, occurring as it did, unusually (Gyllensten 
et al 1991b), within the segment encoding the ß-pleated sheet. 
In contrast, putative gene conversions of HLA-DRB1 alleles 
have been proposed before (Gorski & Mach 1986), although not 
shown as clearly as in this study. Indeed, a DRBl sequence
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segment in the third HVR from position 66 to 70 (ILEDE) shared 
by alleles of different allelic groups (DRB1*0103, 0402, 1102, 
1301 and 1302) with the identical codon usage may be one of 
the examples of inter-allelic DRB1 sequence exchange. The 
demonstration of inter-chromosomal, intra-locus, segmental 
transfer and intra-exonic events at HLA-DRBl presents further 
evidence that multiple mechanisms contribute to MHC diversity.
For all five novel class II alleles, there are candidate 
progenitors in the Aboriginal gene pool, but in three 
instances the new alleles have replaced the progenitors within 
regional subgroups. DRB1*0412 has replaced DRB1*0410 in the 
Kimberley region, DRB1*1402 has replaced DRB1*1409 in Cape 
York Peninsula (or else DRB1*1409 has replaced DRB1*1402 in 
the Kimberley), and DRB1*1401 is rare in the Kimberley region 
although its variant, DRB1*1408 is common. Novel DRBl alleles 
have substantially replaced the old alleles in Aboriginal 
populations. This is particularly evident in the Kimberley 
series: three of the novel alleles, DRB1*0412, 1409 and 1410, 
account for 42% of the DRBl gene frequency in this group. 
Overall, the four novel DRBl alleles were detected in 96 out 
of the 212 Aboriginal individuals tested. Whether positive 
selection contributes to this polymorphism turnover is 
difficult to evaluate, because in a small population, gene 
frequencies can change rapidly purely due to genetic drift 
(Bodmer & Cavalli-Sforza 1976). However, the two 
hypermutational events (DRB1*0412 and DRB1*1410) involving 
sequence exchanges between two different allelic groups have 
generated unique peptide binding grooves which are drastically 
different from their progenitors and all the pre-existing DR 
alleles in these populations. It has been suggested that most 
hypermutations creating HLA molecules with a profoundly 
changed function are deleterious and tend to be restrained in 
the population (Klein et al 1991b) unless the resulting 
molecule has selective advantage (Wakeland et al 1990). So the
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possibility cannot be ruled out that positive selection, 
especially the divergent-allele advantage model (Wakeland et 
al 1990), has contributed to the survival of the new alleles 
and to the maintenance of considerable gene frequencies in the 
Aboriginal populations. Further, in contrast to the finding 
that five class II mutations involving amino acid replacements 
might have occurred in Australia in a relatively restricted 
Aboriginal HLA gene pool, no new allele generated by silent 
mutations was found. This phenomenon is in accordance with the 
observation by Hughes and Nei (1988, 1989) that in the peptide 
binding site of HLA molecules, nonsynonymous substitutions 
occurred more frequently than synonymous substitutions.
While the Kimberley series demonstrated a relatively 
restricted distribution of HLA class II polymorphisms, 
extensive foreign admixture was reflected by the frequent 
occurrence of apparently non-Aboriginal class II haplotypes in 
Aborigines from Cape York Peninsula. In the East Cape York 
population about one third of the HLA gene pool is contributed 
by foreign admixture. DPB1 associations with other class II 
loci can be used as a supplementary parameter in the 
evaluation of recent population admixture. In the present 
study, such an analysis provided further evidence that the 
apparently non-Aboriginal HLA class II haplotypes were 
recently introduced into the Aboriginal populations. In fact, 
most intermarriage between Aborigines in these areas and other 
ethnic groups occurred in this century within the past three 
or four generations, a time insufficient to blur the original 
linkage relationships of haplotypes introduced into the host 
population.
For a small human group with a long history of isolation 
and occupying a wide geographical area as in the case of 
Australian Aborigines, local differentiation is inevitable. 
Previous studies of anthropology, blood groups, and languages 
have demonstrated significant diversity between Aboriginal
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tribes from different regions (Kirk 1981). The HLA class II 
polymorphism examined in this study showed a similar result. 
Aboriginal groups from the northwestern and northeastern areas 
of Australia have very different HLA class II distributions. 
Although these groups share common features which distinguish 
them from other races, a significant proportion of the 
Aboriginal class II repertoires do not overlap, indicating 
that after their separation and migration into different 
regions, local populations have undergone substantial 
diversification. Some mutually exclusive HLA-DRB1 alleles, 
including two newly-defined ones could be the result of either 
being lost from one group due to genetic drift or a more 
recent origin. It is therefore quite possible that unique 
Aboriginal HLA class II diversity, not observed in this study, 
exists in Aboriginal populations from other parts of 
Australia.
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A
DRB1*0412 
DRB1* 0 4 0 5 
DRB1*0410 
DRB1*0803
DRB1*0412 
DRB1* 0 4 0 5 
DRB1*0410 
DRB1*0803
DRB1*0412 
DRB1* 0 4 0 5 
DRB1*0410 
DRB1*0803
DRB1*0412 
DRB1*0405 
DRB1*0410 
DRB1*0803
DRB1*0412 
DRB1* 0 4 0 5 
DRB1* 0410 
DRB1*0803
10 15 20
T TTC TTG GAG CAG GTT AAA CAT GAG TGT CAT TTC TTC AAC GGG
T-C TC- -CG GG- ■T
25 30 35 40
ACG GAG CGG GTG CGG TTC CTG GAC AGA TAC TTC TAT CAC CAA GAG GAG TAC GTG CGC TTC
------------------------------------- - - -  --------------------------- ---------------------------
45 50 55 60
GAC AGC GAC GTG GGG GAG TAC CGG GCG GTG ACG GAG CTG GGG CGG CCT AGC GCC GAG TAC
65 70 75 80
TGG AAC AGC CAG AAG GAC ATC CTG GAA GAC AGG CGG GCC CTG GTG GAC ACC TAC TGC AGA
85 90
CAC AAC TAC GGG GTT GTG GAG AGC TTC ACA GTG CAG CGG 
----------------------G T -----------------------------
-GT
ß 10 20 30 40 50
DRB1*0412 FLEQ VKHECHFFNG TERVRFLDRY FHHQEEYVRF DSDVGEYRAV
DRB1 * 04 0 5 --- ----------- ----------- ----------- -----------
DRBl*0410 --- ----------- ----------- ----------- -----------
DRB1* 0803 -- Y STG--Y--------------- --N-------------------
60 70 80 90
DRB1*0412 TELGRPSAEY WNSQKDILED RRALVDTYCR HNYGWESFT VQR
DRBl*0405 ----------------- L--Q---A------------G-------
DRBl*0410 ----- L--Q---A---------------------
DRBl*0803 -------------------------------------- G--------
C DQBl DQAl
— 0402— — 0301------
0402 0301
0601 0101
DRBl(exon 2) DRB4
0803—i
-----0410 - — 0401-----
041 J 0101
Figure 3.1 Nuceotide sequences (A) and deduced amino acid 
sequences (B) of DRB1*0412 and putative progenitors of DRB1*0405, 
0410 and 0803. The shadowed region of DRB1*0803 indicates the 
area in which the proposed segmental transfer event (C) could occur.
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A
DRB1* 14 08 
DRB1*0401
10 15 20
T TTC TTG GAG TAC TCT ACG TCT GAG TGT CAT TTC TTC AAT GGG
25 30 35 40
DRB1 *0 4 08 ACG GAG CGG GTG CGG TTC CTG GAC AGA TAC TTC CAT AAC CAG GAG GAG TTC GTG CGC TTC 
DRB1*0 4 01 ------------------------------------------------------------------------------------
DRB1*0408 
DRB1*0401
DRB1*0408
DRB1*0401
45 50 55 60
GAC AGC GAC GTG GGG GAG TAC CGG GCG GTG ACG GAG CTG GGG CGG CCT GAT GCG GAG CAC--------------------------------------------------- c----------
65 70 75 80
TGG AAC AGC CAG AAG GAC CTC CTG GAG CGG AGG CGG GCC GAG GTG GAC ACC TAT TGC AGA
85 90
DRB1 *0 4 08 CAC AAC TAC GGG GTT GTG GAG AGC TTC ACA GTG CAG CGG 
DRB1*0401 ------------------------------------------------------
B
DRB1*1408
DRB1*0401
DRBl*1408 
DRB1*0401
10 20 30 40 50
FLEY STSECHFFNG TERVRFLDRY FHNQEEFVRF DSDVGEYRAV
60 70 80 90
TELGRPDAEH WNSQKDLLER RRAEVDTYCR HNYGWESFT VQR 
------ A ---------------------------------------- ----
Figure 3.2. Nucleotide sequences (A) and deduced amino acid 
sequences (B) of DRB1*1408 and the related DRB1*1401.
A
DRBl* 14 09 
DRB1* 14 02
DRBl*14 09 
DRBl* 14 01
DRB1*1409 
DRBl* 14 02
DRBl* 14 09 
DRBl*14 02
DRBl* 14 09 
DRBl* 14 02
10 15 20
T TTC TTG GAG TAC TCT ACG TCT GAG TGT CAT TTC TTC AAT GGG
25 30 35 40
ACG GAG CGG GTG CGG TTC CTG GAC AGA TAC TTC CAT AAC CAG GAG GAG AAC GTG CGC TTC
45 50 55 60
GAC AGC GAC GTG GGG GAG TAC CGG GCG GTG ACG GAG CTG GGG CGG CCT GAT GCC GAG TAC
65 70 75 80
TGG AAC AGC CAG AAG GAC CTC CTG GAG CAG AGG CGG GCC GCG GTG GAC ACC TAC TGC AGA
85 90
CAC AAC TAC GGG GTT GGT GAG AGC TTC ACA GTG CAG CGG
B
DRBl*1409 
DRBl* 04 02
DRBl*1409 
DRBl*0402
10 20 30 40 50
FLEY STSECHFFNG TERVRFLDRY FHNQEENVRF DSDVGEYRAV
-------------------------------------------E _ _ ---------------------------------------
60 70 80 90
TELGRPDAEY WNSQKDLLEQ RRAAVDTYCR HNYGVGESFT VQR
Figure 3.3 Nucleotide sequences (A) and deduced amino acid 
sequences (B) of DRB1*1409 and the related DRB1*1402.
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10 15 20
DRBl* 1410 T TTC TTG GAG CAG GTT AAA CAT GAG TGT CAT TTC 'TTC AAT GGG
DRBl*0410 _ — iic
DRBl*1401 -  - - -- T-C TC- -CG TC- -
25 30 35 40
DRBl* 1410 ACG GAG CGG GTG CGG TTC CTG GAC AGA TAC TTC CAT AAC CAG GAG GAG TTC GTG CGC TTC
DRBl*0410 
DRBl*1401
45 50
T-- C-- - -A
55
-A-
60
DRBl* 1410 GAC AGC GAC GTG GGG GAG TAC CGG GCG GTG ACG GAG CTG GGG CGG CCT GCT GCG GAG CAC
DRBl*0410 AGC --C — T- -
DRBl* 14 01
65 70 75 80
DRB1*1410 TGG AAC AGC CAG AAG GAG CTC CTG GAG CGG AGG CGG GCC GAG GTG GAC ACC TAT TGT AGA
DRBl*0410 ----A---- -C- --C
DRBl* 14 01
85 90
DRB1*1410 CAC AAC TAC GGG GTT GTG GAG AGC TTC ACA GTG CAG CGG
DRBl*0410 
DRB1*1401
B
DRB1*1410 
DRB1*0410 
DRB1* 14 01
DRB1*1410 
DRBl*0410 
DRBl* 14 01
10 20 30 40 50
FLEQ VTHECHFFNG TERVRFLDRY FYNQEEFVRF DSDVGEYRAV
--- ----------- ----------- -HH--Y----------------
-- Y STS------------------ ----------- -----------
60 70 80 90
TELGRPAAEH WNSQKDILER RRAEVDTYCR HNYGWESFT VQR
------S--Y--------- Q ---A---------------------
DQB1
Ö4Ö2
0503
0402
DQAl
€304
0101
0301
DRB3/B4
DRB4
DRB3
Figure 3.5 Nucleotide sequences (A) and deduced amino acid 
sequences (B) of DRB1*1410 and candidate progenitors, DRB1*0410 
and 1401. The shadowed region indicates the area in which the 
proposed recombination event (C) might have occurred.
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10 15 20
DPBl*2201 CTT TTC CAG GGA CGG CAG GAA TGC TAC GCG 'TTT AAT GGG
DRB1*0501 
DRB1*0 202
25 30 35 40
DPBl*2201 ACA CAG CGC TTC CTG GAG AGA TAC ATC TAC AAC CGG GAG GAG CTC GTG CGC TTC GAC AGC
DPB1*0501 
DPBl*0202
45 50 55 60
DPBl*2201 GAC GTG GGG GAG TTC CGG GCG GTG ACG GAG CTG GGG GGG CCT GAG GCG GAG TAC TGG AAC
DRB1*0501 
DRB1*0202
65 70 75 80
DPBl*2201 AGC CAG AAG GAC ATC CTG GAG GAG GAG CGG GCA GTG CCG GAC AGG ATG TGC AGA CAC AAC
DPB1*0501 
DPBl*0202
85
-- A- -
90
DPBl*2201 
DPBl*0501
TAC GAG CTG GAC GAG GCC GTG ACC CTG CAG
DPBl*0202 — — — -G- -G- C-- A-- ----- ------- —
10 20 30 40 50
DPB1*2201 LFQ GRQECYAFNG TQRFLERYIY NREELVRFDS DVGEFRAVTE
DPB1*0501 --- ----------- ----------- ----------- -----------
DPB1*0202 --- ----------- ----------- ----------- -----------
60 70 80 90
DPB1*2 2 01 LGRPEAEYWN SKQDILEEER AVPDRMCRHN YELDEAVTLQ
DPB1*0501 ------------------- K-----------------------
DPB1*0202 ------------------------------------ GGPM---
Figure 3.6 Nucleotide sequence (A) and deduced amino acid 
sequence (B) of DPB1*2201 compared with DPB1*0501 and 0202
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A
DRB1*0410 
DRB1*0411 
DRB1*0403 
DRB1*0405
DRB1*0410 
DRB1*0411 
DRB1*04 03 
DRB1*0405
DRB1*0410 
DRB1*0411 
DRB1*0403 
DRB1*0405
10 15 20
T TTC TTG GAG CAG GTT AAA CAT GAG TGT CAT TTC TTC AAC GGG
25 30 35 40
ACG GAG CGG GTG CGG TTC CTG GAC AGA TAC TTC TAT CAC CAA GAG GAG TAC GTG CGC TTC
45 50 55 60
GAC AGC GAC GTG GGG GAG TAC CGG GCG GTG ACG GAG CTG GGG CGG CCT AGC GCC GAG TAC
GAT
DRB1*0410 
DRB1*0411 
DRB1*0403 
DRB1*0405
65 70 75 80
TGG AAC AGC CAG AAG GAC CTC CTG GAG CAG AGG CGG GCC GCG GTG GAC ACC TAC TGC AGA------------------------------------------A-------------------
------------------------------------------A-------------------
85 90
DRB1 *0410 CAC AAC TAC GGG GTT GTG GAG AGC TTC ACA GTG CAG CGG
DRB1*0411 ---------------------------------------------------
DRB1*0403 ---------------------------------------------------
DRB1* 0 4 0 5 -------------------- G T ---------------------------
B
DRB1*0410 
DRB1*0411 
DRB1*0403 
DRB1*0405
10 20 30 40 50
FLEQ VKHECHFFNG TERVRFLDRY FHHQEEYVRF DSDVGEYRAV
DRB1*0410 
DRB1*0411 
DRB1*0403 
DRB1*0405
60 70 80 90
TELGRPSAEY WNSQKDLLEQ RRAAVDTYCR HNYGWESFT VQR------------------------- E---------------------
----- D------------------ E------------------------------------------------------- G-------
Figure 3.7 Nuceotide sequences (A) and deduced amino acid 
sequences (B) of DRB1*0410 and 0411 compared with DRB1*0403 and 0405.
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Table 3.2 Hardy-Weinberg fit of genotype distributions at 
the HLA-DQA1 locus in three Aboriginal populations
Kimberley East Cape York West Cape York
DQA1/DQA1 obs ,. exp. X 2 obs. exp. X 2 obs. exp. Hr 2
0101/0101 1 0 . 6 0 .27 1 2 .8 1 .19 0 0 .2 0. 22
0101/0102 1 2 .,1 0 . 60 2 2 .4 0 .05 3 1 .3 2 .45
0101/0103 4 3 .8 0 . 02 11 10 .0 0 .10 2 2 .4 0 .06
0101/0201 0 0 ., 1 0 .09 2 1 .6 0 . 12 0 0 .0 0. 00
0101/0301 3 2 . 8 0.01 8 5 .1 1 . 66 2 2 .1 0 .00
0101/0401 0 0 .,0 0 .00 0 0 .0 0 .00 0 0 .1 0. 06
0101/0501 4 4 .0 0 .00 4 4 .1 0. 00 0 0 .8 0 .81
0101/0601 0 0..0 0 .00 0 0 .2 0 .20 0 0 .0 0 .00
0102/0102 3 1 .9 0 . 63 2 0 .5 4 .70 3 1 .8 0 .83
0102/0103 7 6..7 0 .01 3 4 .,1 0 .31 3 6. 8 2 .11
0102/0201 0 0 ,.2 0 .15 1 0 .,7 0 .19 0 0 .0 0 .00
0102/0301 3 5 .0 0 .82 0 2 .,1 2 .10 6 5. 9 0 .00
0102/0401 0 0 ,.0 0 .00 0 0 .,0 0 .00 1 0 .2 3 .78
0102/0501 8 7 ,.2 0 .10 2 1..7 0 .05 1 2 .3 0 .75
0102/0601 0 0 ,.0 0 .00 0 0 .1 0. 08 0 0. 0 0 .00
0103/0103 9 5 ,.9 1. 63 9 8..8 0 .00 8 6..5 0 .37
0103/0201 0 0 ,.3 0.27 1 2 . 8 1 . 12 0 0 .0 0 .00
0103/0301 7 8,.9 0.39 11 9 ,.0 0 . 47 10 11 .2 0 . 13
0103/0401 0 0 ,.0 0 .00 0 0 .0 0 . 00 0 0 .3 0 .,34
0103/0501 8 12 .6 1 . 69 7 7 .2 0 ..00 7 4 .4 1 .,52
0103/0601 0 0 .0 0 .00 0 0 ,.3 0 ..34 0 0 .0 0 ..00
0201/0201 0 0 . 0 0.00 0 0 .2 0 . 22 0 0 .0 0..00
0201/0301 0 0 .2 0 .20 2 1 .4 0 . 25 0 0 .0 0 . 00
0201/0401 0 0 .0 0 .00 0 0 .0 0..00 0 0 .0 0 . 00
0201/0501 1 0..3 1.78 2 1 .1 0 . 66 0 0 .0 0 . 00
0201/0601 0 0 .0 0 .00 0 0 .1 0 ,.05 0 0 ,.0 0 ,.00
0301/0301 3 3 .3 0 .03 1 2 .3 0..72 6 4 .9 0 ,.27
0301/0401 0 0 ,.0 0 .00 0 0 .0 0 ,.00 0 0 .0 0 ,.00
0301/0501 14 9 . 5 2 .18 3 3 .7 0 ,.13 3 3 .8 0 ,.18
0301/0601 0 0,.0 0 .00 0 0 .2 0..18 0 0 .0 0 .00
0401/0401 0 0 .0 0.00 0 0 .0 0 .00 0 0 .0 0.00
0401/0501 0 0 .0 0.00 0 0 .0 0 .00 0 0 .1 0 . 12
0401/0601 0 0 .0 0 .00 0 0 .0 0 .00 0 0 .0 0.00
0501/0501 6 6.7 0 .08 1 1 .5 0 .16 1 0 .8 0.08
0501/0601 0 0 .0 0.00 1 0 .1 5.19 0 0.0 0.00
0601/0601 0 0 .0 0 oo 0 0 .0 0 .00 0 0 .0 0 oo
total 82 82 .0 10 a.94 74 74 .0 20 _ _ b.23 56 56 .0 14 .38
obs.: observed individuals having the genotype 
exp.: expected individuals having the genotype
a: for d.f.=20, p>0.90; b: for d.f.=28, p>0.75; c: for d.f.=19, p>0.75
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Table 3.3 Gene frequency (gf) of DRB alleles in three 
Aboriginal populations
Kimberley East Cape York West Cape York
2 ii 00 N=74 N=56
allele n gf % n gf % n gf %
DRBl
0101 a0 0.0 2 1.4 0 0.0
0103 0 0.0 1 0.7 0 0.0
1501 0 0.0 8 5.4 6 5.4
1502 24 14.6 5 3.4 12 10.7
1602 1 0.6 1 0.7 2 1.8
0301 1 0.0 9 6.1 1 0.9
0401 0 0.0 1 0.7 1 0.9
0403 0 0.0 2 1.4 1 0.9
0404 0 0.0 3 2.0 0 0.0
0405 7 4.3 10 6.8 12 10.7
0410 0 0.0 2 1.4 10 8.9
0411 1 0.6 3 2.0 0 0.0
0412 23 14.0 0 0.0 0 0.0
1201 6 3.7 1 0.7 1 0.9
1202 0 0.0 1 0.7 0 0.0
1301 1 0.6 3 2.0 0 0.0
1401 2 1.2 6 4.1 4 3.6
1402 3 0.2 9 6.1 11 9.8
1408 13 7.9 19 12.8 3 2.7
1409 32 20.7 0 0.0 0 0.0
1410 3 0.2 4 2.7 7 6.3
07 1 0.6 8 5.4 0 0.0
0801 0 0.0 0 0.0 1 0.9
0803 43 26.2 50 33.8 38 33.9
0901 0 0.0 0 0.0 1 0.9
1001 0 0.0 0 0.0 1 0.9
blank 0 0.0 0 0.0 0 0.0
total 164 100.0 148 100.0 112 100.0
DRB3
0101 42 25.0 24 16.2 19 17.0
0201 3 1.2 5 3.4 5 4.5
0202
blank
19 11.6
62.2
22 14.9
64.9
3 2.7
75.9
DRB5
0101 24 14.6 11 7.4 18 16.0
0102 0 0.0 2 1.4 0 0.0
02
blank
1 0.6
84.8
1 0.7
90.5
2 1.8
82.2
aNumber of chromosomes having the allele
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Table 3.4 Gene frequency (gf) of DQ alleles in three 
Aboriginal populations
Kimberley East Cape York West Cape York
N=82 N=7 4 N=56
Allele n gf % n gf % n gf %
DQAl
0101 a15 8.5 29 19.6 7 6.3
0102 25 15.2 12 8.1 20 17.9
0103 43 26.8 51 34.5 38 33.9
0201 1 0.6 8 5.4 0 0.0
0301 34 20.1 26 17.6 33 29.5
0401 0 0.0 0 0.0 1 0.9
0501 46 28.7 21 14.2 13 11.6
0601 0 0.0 1 6.8 0 0.0
blank 0 0.0 0 0.0 0 0.0
total 184 100.0 148 100.0 112 100.0
DQB1
0501 0 0.0 5 3.4 1 8.9
0502 1 1.2 1 0.7 2 1.8
0503 27 17.1 30 20.1 20 17.8
0601 55 32.9 46 30.4 37 33.0
0602 0 0.0 7 4.7 6 5.4
0603 1 0.6 4 2.7 0 0.0
0201 2 0.2 14 9.5 1 0.9
0301 6 3.7 13 8.8 11 9.8
0302 1 0.6 9 6.1 2 1.8
0303 0 0.0 3 2.0 1 0.9
0401 0 0.0 4 2.7 3 2.7
0402 71 43.3 12 8.1 28 25.0
blank 0 0.0 0 0.0 0 0.0
total 184 100.0 148 100.0 112 100.0
aNumber of chromosomes having the allele
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Table 3.5 Gene frequency (gf) of DPBl alleles in three 
Aboriginal populations
Kimberley
N=52
East Cape York 
N=71
West Cape York 
N=51
Allele n gf % n gf % n gf %
DPBl
0201 a9 8.7 27 19.0 10 9.8
0401 8 7.7 10 7.0 16 15.7
0501 77 74.0 58 40.9 56 54.9
2201 9 8.7 31 21.8 18 17.7
0101 0 0.0 2 1.4 0 0.0
0301 0 0.0 6 4.2 1 1.0
1101 0 0.0 2 1.4 0 0.0
1301 0 0.0 2 1.4 0 0.0
1501 0 0.0 2 1.4 1 1.0
1601 1 8.7 2 1.4 0 0.0
blank
total 104
0.0
100.0 142
0.0
100.0 102
0.0
100.0
aNumber of chromosomes having the allele
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Table 3.6 Two-locus DR,DQ haplotypes showing significant 
linkage disequilibrium in three Aboriginal populations
H a p l o t y p e
K i m b e r l e y
N = 8 2
E a s t C a p e  
N=7 4
Y o r k W e s t C a p e  Y o r k  
N=  5 6
h f  % D% x2 h f  % D% x 2 h f  % D% x 2
DRB1-DQA1
1501-0102 4.8 4.5 85.7 5.5 4.6 26.9
1502-0102 13.8 11.8 146.8 2.0 1.7 13.3 11.4 9.5 65.7
0301-0501 6.3 5.4 51.0
0403-0301 1.4 1.1 4.3
0404-0301 2.0 1.7 8.6
0405-0301 7.0 5.7 43.1 10.4 7.5 29.4
0410-0301 1.8 1.5 7.6 1.4 1.1 4.3 8.4 6.0 22.7
0411-0301 2.0 1.7 8.6
0412-0301 13.0 10.4 90.6
1201-0501 3.7 2.6 12.0
1401-0101 1.2 1.1 12.0 3.3 2.4 9.5 3 . 6 3.4 46.2
1402-0501 1.8 1.3 4.4 6.3 5.4 51.0 9.4 0.8 80.9
1408-0101 7.6 6.9 124.7 13.8 10.9 82 . 8 2.7 2.5 30.8
1409-0501 15.9 11.2 70.8
1410-0301 1.8 1.5 7.6 2.7 2.2 13.1 6.5 4.6 16.2
07 -0201 5.6 .5.3 129.6
0803-0103 21.9 16.4 131.2 31.2 20.1 118.1 31.9 21.7 107.4
DRB1-DQB1
0101-0501 1.4 1.3 31.7
1501-0602 4.1 3 . 9 104.9 5.5 5.2 93 . 6
1502-0601 13.8 9.6 56.8 11.4 7.1 21.2
0301-0201 6.3 5.7 79.3
0403-0302 1.4 1.3 16.5
0404-0302 2.0 1.9 31.4
0405-0401 2.7 2.5 41.7 2.7 2.4 18.0
0405-0402 4.4 2 . 6 8.6 4.0 3.5 31.5 6.7 4.2 9.2
0410-0402 1.4 1.3 13.0 8.4 6.3 27.4
0412-0402 13.0 7 . 8 33.3
1201-0301 3.1 3.0 89.3
1301-0603 2.0 2.0 75.7
1401-0503 1.2 1.0 5.0 3.3 2.4 9.5 3.6 2.3 4.6
1402-0301 6.3 5.7 86.5 9.4 8.5 100.5
1408-0503 8.3 6.9 67.7 13.8 10.9 82.8
1409-0402 21.9 13.0 64.4
1410-0402 2.7 2.5 37.4 6.5 4.9 19.8
07 -0201 3.3 2.7 17.9
0803-0503 8.0 3.8 9.2 12.9 6 . 6 14.2
0803-0601 18.7 11.1 51.3 26.2 16.8 88.6 22.6 10.7 25.6
hf%: haplotype frequency; D%: delta value
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Table 3.7 HLA-DR,-DQ haplotypes in three Aboriginal 
populations
Kimberley East C.Y. West C.Y.
Haplotype No hf % No hf % No hf %
DRBl DRB3 
0101
DRB5 DQAl DQB 
-0101-0501 oa o . o b 2 1.4 0 0.0
0103 -0101-0501 0 0.0 1 0.7 0 0.0
1501 0101-0102-0602 0 0.0 7 4.7 6 5.4
1501 0101-0102-0603 0 0.0 1 0.7 0 0.0
#1502 0101-0102-0601 24 14.6 3 2.0 12 10.7
1502 0102-0101-0501 0 0.0 2 1.4 0 0.0
1602 02 -0102-0502 1 0.6 1 0.7 2 1.8
0301-0101 -0501-0201 1 0.6 8 5.4 1 0.9
0301-0202 -0501-0201 0 0.0 1 0.7 0 0.0
0401 -0301-0302 0 0.0 1 0.7 1 0.9
0403 -0301-0302 0 0.0 2 1.4 1 0.9
0404 -0301-0302 0 0.0 3 2.0 0 0.0
0405 -0301-0401 0 0.0 4 2.7 3 4.8
#0405 -0301-0402 7 4.3 6 4.1 9 8.0
#0410 -0301-0402 0 0.0 2 1.4 10 8.9
#0411 -0301-0302 1 0.6 3 2.0 0 0.0
#0412 -0301-0402 23 14.0 0 0.0 0 0.0
#1201-0202 -0501-0301 5 3.1 1 0.7 0 0.0
#1201-0201 -0501-0402 1 0.6 0 0.0 1 0.9
1202-0301 -0601-0301 0 0.0 1 0.7 0 0.0
1301-0101 -0103-0603 0 0.0 3 2.0 0 0.0
1301-0202 -0103-0603 1 0.6 0 0.0 0 0.0
#1401-0201 -0101-0503 2 1.2 5 3.4 4 3.6
1401-0202 -0501-0301 0 0.0 1 0.7 0 0.0
#1402-0101 -0501-0301 1 0.6 9 6.1 11 9.8
#1402-0101 -0501-0402 3 1.8 0 0.0 3 2.7
#1408-0202 -0101-0503 13 7.9 19 12.8 0 0.0
#1409-0101 -0501-0402 34 20.7 0 0.0 0 0.0
#1410-0101 -0301-0402 3 1.8 4 2.7 7 6.3
07 -0201-0201 1 0.6 5 3.4 0 0.0
07 -0201-0303 0 0.0 3 2.0 0 0.0
0801 -0401-0402 0 0.0 0 0.0 1 0.9
#0803 -0103-0503 12 7.3 6 4.1 13 11.6
#0803 -0103-0601 31 18.9 43 29.1 25 22.3
0803 -0501-0301 0 0.0 1 0 .7) 0 0.0
0901 -0301-0303 0 0.0 0 0.0 1 0.9
1001 -0101-0501 0 0.0 0 0.0 1 0.9
#subtotal 160 97.6 101 68.2 95 84.8
total 164 100.0 14 8 100.0 112 100.0
aNumber of haplotypes observed
bHaplotype frequency is calculated by direct counting. 
#Haplotypes with obvious Aboriginal origin
CHAPTER 4
NUCLEOTIDE SEQUENCE DIVERSITY 
OF HLA CLASS II GENES 
IN POPULATIONS OF ASIA-OCEANIA
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4.1 Introduction
Human populations in the Pacific can be classified as 
three major groups, namely Melanesians, Polynesians and 
Micronesians (Figure 1.2). They can also be divided by 
linguistic affinities into Austronesian-speaking and non- 
Austronesian-speaking groups. The Austronesian-speaking (AN) 
group includes Polynesians, Micronesians and some coastal 
Melanesians. PNG Highlanders are non-Austronesian (NAN) 
speakers. The origin of these peoples and the relationships 
between them remain a matter for debate. Melanesia has a much 
longer history of human occupation than other areas of 
Oceania. Papua New Guinea was colonized at least 40,000 years 
ago (Groube et al 1986) by a group of people believed to share 
the same ancestors with Australian Aborigines (Bellwood 1989) . 
Melanesia has since experienced a number of waves of 
immigrants from island Southeast Asia (Bellwood 1989, 1991). 
Linguistic and archaeological evidence (Bellwood 1989) clearly 
separates the non-Austronesian-speaking New Guinea highland 
people from those of the Austronesian-speaking coastal 
populations, indicating a dichotomy of Melanesian prehistory. 
Among theories on the origins of Polynesians, some conclude on 
the basis of archeological evidence that Polynesians evolved 
out of Melanesia (Allen & White 1989; Houghton 1991), while 
others suggest a substantial Melanesian contribution on the 
basis of the high frequency of a Melanesian-specific a-globin 
deletion in Eastern Polynesia (Hill et al 1985). Linguistic 
reconstructions of Austronesian languages suggest a proto- 
Austronesian expansion from Taiwan and southern China to 
island Southeast Asia, which eventually led to the settlements 
in Oceania and Java by 3,000 years ago (Blust 1988). For 
Micronesia, linguistic and archaeological evidence suggest two 
separate waves of migration about 3,500 years ago, one from 
island Southeast Asia and another from island Melanesia, 
giving rise to Nuclear Micronesian languages that include
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those spoken in Nauru and Kiribati (Bellwood 1989).
HLA diversity can bee«- used as a powerful tool in 
population studies because of its extreme polymorphism, 
population-dependent distributions and linkage disequilibrium. 
Earlier investigations of HLA polymorphisms in Oceanic 
populations have revealed significant diversity among major 
ethnic groups (Serjeantson 1989b). The class II HLA 
distribution in these peoples is essentially confined to DR2, 
DR4, DR5, DR6, and DR8 allele types, whereas DR1, DR3, DR7 and 
DR10 were rarely observed or absent. The Oriental antigen DR9 
has been frequently detected in Polynesian populations 
(Roberts et al 1983). In Austronesian-speaking populations of 
Polynesians, Micronesians, and coastal Melanesians, DR5 has 
been found the most frequent DR allele, but is absent from PNG 
highlanders where only four DR alleles (DR2, DR4, DR6, and 
DR8) have been detected (Crane et al 1985). RFLP analysis 
(Kohonen-Corish & Serjeantson 1986; Jazwinska & Serjeantson 
1988; Serjeantson 1989b) have further discriminated these 
major allele groups into several subtypes or haplotypes on the 
basis of novel DR ß RFLP patterns or different DQ 
associations. Polynesians and Micronesians have very limited 
number of similarities between each other, but among 
populations within each group the HLA distribution is more or 
less the same. The class II HLA variation in Melanesian 
populations is marked by distinctive differences between NAN- 
speaking and AN-speaking groups. The highly restricted HLA 
class II profile of PNG highlanders reflects a total isolation 
of these people from their AN-speaking Melanesian neighbors. 
AN-speaking populations from New Guinean coastal areas and 
island Melanesia share many common HLA features and have NAN 
genetic elements overlaid with some AN genetic influence.
The origin of Pacific islanders is not clear but the 
generally accepted view among anthropologists favors an Asian 
or island Southeast Asian origin of Polynesians and
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Micronesians (Bellwood 1989). Investigation of HLA 
distributions in Asian populations may help to establish the 
genetic connections between these two groups of peoples. An 
early serological study in an Indonesian population from Bali 
has shown a very different HLA distribution compared with 
Oceanic populations. HLA-DR serological specificities in this 
group were confined to DR2, DR3, DR5, DR6, and DR7. DR1 was 
rarely seen and DR4, DR8, DR9 and DR10 were absent (Breguet et 
al 1982) . In contrast, Chinese populations have a much broader 
HLA repertoire with all serologically detected class II 
antigens (DR1 to DR10) represented. However, the distribution 
of gene frequencies shows remarkable variation between 
different Chinese populations, especially when southern and 
northern Chinese populations are compared (Sun et al 1986; Lee 
et al 1988). Very little is known about class II subtypes in 
Asian populations although a previous study of class II RFLP 
in Chinese from Hong Kong and Singapore has shown that the 
Chinese population shares with Pacific populations some 
unusual DR, DQ combinations which are not found in other 
ethnic groups (Kohonen-Corish et al 1987) .
The aim of this chapter is to investigate nucleotide 
sequence diversity of HLA class II genes in populations of 
Asia-Oceania. The ability to detect HLA variation at the 
nucleotide sequence level provides an unprecedented 
opportunity to investigate more precisely the HLA class II 
profiles of these populations. This may reveal further 
information regarding the genetic connections between them. 
Unusual DR and DQ linkage relationships revealed by earlier 
RFLP analysis could be the result of inter-locus 
recombination, or alternatively an indication of different 
allelic subtypes or novel mutations which can be resolved by 
analyzing the nucleotide sequences of these genes. Knowledge 
of HLA class II variation in general populations is also 
important for understanding HLA-associated autoimmune diseases
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and for the development of tissue-typing strategies for organ 
transplantations in these peoples.
4.2 Study populations
A total of 1,107 DNA samples were examined for HLA class 
II nucleotide polymorphisms in the work of the present 
chapter. The samples were from 16 populations representing 
seven major ethnic groups including Polynesians, Micronesians, 
PNG highlanders, coastal Melanesians, Javanese, southern and 
northern Chinese, and a minority Chinese group from 
northwestern China. The geographical distribution of these 
populations is shown in Figure 1.2.
Melanesians (N=304) from five locations were included in 
this study. In Papua New Guinea, donors were from Goroka 
(N=57) in the East Highlands Province, from Madang (N=65) on 
the north New Guinea mainland coast and from Rabaul (N=60) in 
New Britain, which forms part of the Bismarck Archipelago. The 
PNG material was collected under the auspices of the Papua New 
Guinea Institute of Medical Research. Melanesians from New 
Caledonia (N=65) were parents of families studied for HLA 
serology (Serjeantson 1983) in the Second Asia-Oceania 
Histocompatibility Workshop in 1981. The Fijian series (N=57) 
was provided by Professor R. Trent and represented donors from 
Viti Levu, the largest Fijian Island. Donors came from 
Colonial War Memorial Hospital, Suva (7%); Queen Elizabeth 
Army Barracks, Suva (8%); Lautoka Hospital (29%) and Mamoli 
village (55%) . The Melanesian study populations can be 
classified as AN-speakers (Rabaul, Fiji and New Caledonia) and 
NAN-speakers (PNG highland), while in the population from 
Madang, both Austronesian and non-Austronesian languages are 
represented.
Polynesians from Rarotonga (N=78) and Niue (N=64) in the 
Cook Islands were randomly sampled adults from among 
participants in a broadly-based medical survey as previously
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described (King et al 1986). These two series have not been 
examined previously for HLA distributions. Further DNA 
specimens from Niue (N=6) and from the central Polynesian 
populations of Western Samoa and Tokelau (N=51) were from 
cord-blood samples from newborns in Auckland, New Zealand, as 
reported previously in HLA class II RFLP analysis of a mixed 
Polynesian population (Serjeantson et al 1987) . These 
populations represent three of the four Polynesian linguistic 
subgroups (Clark 1979): Tongic (Niue), Samoic (Western Samoa 
and Tokelau) and Central-Eastern (Rarotonga). The fourth 
unrepresented subgroup is Easter Island.
Micronesians from the republic of Nauru (N=67) and 
Kiribati (N=62) were randomly sampled from among adult 
participants in comprehensive surveys of diabetes, as 
described for Nauru (Zimmet et al 1984) and Kiribati (King 
1984), previously known as Gilbert Islands. These populations 
speak languages classified as "Nuclear Micronesian", as 
distinct from the Western Malayo-Polynesian languages spoken 
in Western Micronesia (Palau and the Marianas). Nuclear 
Micronesian and Polynesian languages belong to the same 
subgroup of Austronesian, known as "Oceania" (Bellwood 1989). 
Although a Nauru series has been examined for HLA-DR serology 
(Serjeantson et al 1983) and for DR, DQ RFLP distributions 
(Serjeantson 1989b), the earlier series do not correspond with 
samples studied here. AN-speaking Javanese (N=77) were healthy 
volunteers at the Blood Transfusion Service Unit, Bethesda 
Hospital, Yogyakarta, Indonesia and samples were provided by 
Dr. Salam Sofro.
Southern Chinese (N=135) included two groups. Cantonese 
specimens from Hong kong (N=89) were provided by Dr. B. R. 
Hawkins, University of Hong Kong and were studied during the 
Third Asia-Oceania Histocompatibility Workshop as random 
controls in the IDDM study (Serjeantson et al 1986) . Chinese 
specimens from Singapore (n=46) were provided by Dr. S. Chan
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of WHO Immunology Center, University of Singapore, and Dr. M. 
Simons of Immunogene Typing Laboratories, Toorak. Twenty of 
these samples were from healthy donors and 26 were 
nasopharyngeal carcinoma patients. No difference of HLA class 
II distributions between the healthy donors and the patient 
group was observed either by previous RFLP analysis (Kohonen- 
Corish 1987) or by nucleotide sequence polymorphisms examined 
in this study.
Northern Chinese samples were provided by Dr. Y. P. Sun 
of the Institute of Clinical Sciences, China-Japan Friendship 
Hospital, Beijing. Two majority Han series were from Guan 
County near Beijing (N= 91), and from Xian (N=80) . A Chinese 
Muslim group Uygur (N=92) was sampled in Wulumuchi, the 
Xinjiang Uygur Autonomous Region in northwestern China. All 
three groups were randomly chosen healthy donors and have not 
been studied previously for HLA polymorphisms.
Some DNA samples were prepared in previous studies as 
described in relevant references. Genomic DNA of northern Han 
Chinese groups, the Uygur series and some PNG highlander 
samples was extracted in the present experiment from buffy 
coats or peripheral blood lymphocytes following the salting- 
out procedure described in Chapter 2.
4.3 Results
All samples were analyzed by PCR-SSO typing for HLA class 
II polymorphisms at DRB1, DQA1, and DQB1 loci. DRB3 and DRB5 
loci were examined in relevant subjects. Hardy-Weinberg 
equilibrium at the DRBl, DQA1, and DQBl loci was examined in 
all study populations separately. Genotype distributions in 
all these populations were in equilibrium. An example of 
Hardy-Weinberg analyses at the HLA-DQA1 locus in three Pacific 
populations is shown in Table 4.1. New alleles revealed by 
unusual SSO hybridization patterns were subjected to DNA 
sequencing. The DPB1 polymorphism was studied in a northern
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Chinese group. The DPB1 distribution in other study 
populations is currently under investigation by other 
researchers in the Human Genetics Group as a separate project 
and was not part of this study.
4.3.1 HLA class II allele distributions in Melanesians
4.3.1.1 DRB allele distributions in Melanesians
Altogether, 21 officially designated DRB1 alleles were 
found in the five Melanesian populations. In addition, two 
novel alleles were detected. One of the new alleles,
DRB1*1407, was included in the 11th IHW DNA typing protocol. 
The other new allele was DRB1*1408. Exon 2 of the latter new 
allele was sequenced in a PNG highlander sample PNH387. The 
derived sequence was identical to the DRB1*1408 allele 
sequenced in Australian Aborigines described in Chapter 3. The 
gene frequencies of the 23 DRBl alleles, together with the 
frequencies of two DRB3 and three DRB5 alleles detected in the 
five Melanesian groups are given in Table 4.2. Major allele 
groups detected in Melanesians included DR2, DR4, DR5, and 
DR14. In the DR2 group, DRB1*1502 was a common allele in all 
five populations although DRB1*1501 showed a higher frequency 
in New Caledonians and PNG highlanders. DRB1*1602 was another 
common DR2 subtype but was confined to the two coastal PNG 
populations of Madang and Rabaul. Three major subtypes were 
found in the DR4 group. DRB1*0403 was the most frequent 
subtype in Rabaul, Fiji and New Caledonia. DRB1*0405 was 
detected in all five populations but its variant 0410 was seen 
mainly in PNG highlanders and Fijians. DRB1*1101 showed the 
highest DRBl gene frequency in all four coastal Melanesian 
groups (33% to 45%) but only three PNG highlanders were found 
to have this allele. DRB1*1104 was mainly detected in Madang 
and DRB1*1201 was found with low frequencies in Fiji and PNG 
highlanders. In the DRl4-related group, DRB1*1401 showed the 
highest gene frequency (21%) in the Rabaul population but was
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rarely seen in other groups. The novel alleles DRB1*1407 and 
1408 were both found in New Caledonians and PNG highlanders.
In Fiji, only one individual was found to have a DR14 allele 
(DRB1*1407). In all five populations, DRB1*08032 was the only 
DR8-related allele except for one DRBl*0801-positive subject 
observed in New Caledonia. DR1, DR3 and DR7 alleles, probably 
reflecting Caucasoid admixture, occurred only sporadically and 
DRB1*0901 was confined to Fiji and New Caledonia.
DRB3*0202 was the most common DRB3 allele in all five 
populations and was associated with DRB1*1101, 1104, 1401,
1407 and 1408. The associations of DRB3*0101 with DRB1 alleles 
were DRB1*1101 and 1408 in New Caledonia, DRB1*0301, 1201 in 
Fiji, and DRB1*1201 in PNG highlanders. DRB3*0201 and 0301 
were not detected.
The DRB5 locus was dominated by DRB5*0101 which was 
associated with both DR15 alleles. DRB5*0102 was found in only 
three cases while DRB5*02 was found in DRB1*1602-positive 
individuals.
4.3.1.2 DQ allele distributions and DR,DQ associations in 
Melanesians
The gene frequencies of seven DQA1 and 12 DQBl alleles 
detected in Melanesian populations are given in Table 4.3. The 
linkage relationships between DRB1 and DQ loci are shown in 
Table 4.4 where the four coastal Melanesian groups are pooled. 
DQA1*0101 was mainly associated with DRB1*1401 and thus showed 
much higher gene frequencies in populations from Rabaul, New 
Caledonia and PNG highland than in populations from Madang and 
Fiji. DQA1*0102 was a common allele and was associated with 
all three DR2-related DRB1 alleles. DQA1*0103 was found only 
in DRB1*0803-positive subjects. DQA1*0301 was associated with 
DR4 and DR9 alleles and was a common allele in all populations 
except the Madang group where DR4 and DR9 were also rare. 
DQA1*0501, associated with DR11 and DR12 alleles, was the most
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common DQA1 allele in the four coastal populations with gene 
frequencies ranging from 33% to 52% but was rare in PNG 
Highlanders (6%).
At the DQB1 locus, DQB1*0301 was the most common allele in 
coastal Melanesians with gene frequencies ranging from 35.% to 
52%, but in PNG highlanders its frequency was only 6%, which 
corresponded with the distribution of the associated DRll and 
DR12 alleles. The DRB1*1602-associated DQB1*0601 was detected 
in all five series. DQB1*0502 was associated with DRB1*1602 
and 1401, and was commonly seen in coastal PNG groups from 
Madang and Rabaul. DQB1*0503, mainly associated with DRB1*14 
alleles showed the highest gene frequency in PNG highlanders 
(25%); this allele was also well represented in Rabaul and New 
Caledonia but was rare in Madang and Fiji. Both DQ4 alleles 
were found to be associated with DRB1*0405 but DQB1*0402 was 
more commonly seen than 0401 and was the only DQB1 allele 
associated with DRB1*0410.
4.3.2 Distribution of HLA class II alleles in Polynesians 
4.3.2.1 DRB allele distributions in Polynesians
Oligonucleotide hybridizations of PCR products detected 23 
of the 47 officially named (Bodmer et al 1991) DRB1 alleles in 
Polynesian populations. In addition, the newly-defined 
DRB1*1408 was detected in Polynesian samples. Sample HM1237 
with the DRB1*1408 SSO hybridization pattern was subjected to 
DNA sequencing analysis and showed an exon 2 sequence 
identical to the DRB1*1408 defined in Australian and PNG 
highlander samples. Three DRB3 and two DRB5 were found in 
these populations. Table 4.5 gives the gene frequencies of DRB 
alleles in the three Polynesian groups.
Thirteen of the detected DRB1 alleles were observed more 
than twice in at least one group. Two DR2-related alleles, 
DRB1*1501 and 1502, were equally represented in the three 
groups, although at relatively low frequencies compared to
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other study populations. The DR4 allele group was dominated by 
DRB1*0403 with gene frequencies ranging from 16% to 23%. 
DRB1*0405 was found in Polynesians from Rarotonga and Western 
Samoa but absent from the Niue samples. Other DR4 alleles, 
including DRB1*0401, 0402, 0404 and 0410, only occurred 
sporadically. Two DR5-related alleles were detected with high 
frequencies in all three groups. DRB1*1101 was the most 
frequent DRB1 allele in Rarotongan samples with a gene 
frequency of 21%, while DRB1*1201 was more commonly observed 
in populations from Niue (30%) and Western Samoa (19%). 
DRB1*1401 and the new allele DRB1*1408 were the major DR6- 
related alleles detected in Polynesians. DRB1*0803 was the 
most common DR8 allele and DRB1*0802 was also found in all 
three groups. All DRB1*0803 detected were DRB1*08032.
DRB1*0901 was well represented in Polynesian populations with 
similar gene frequencies ranging from 9% to 11%. Some rare 
alleles found in Polynesians suggest foreign admixture from 
Caucasoids, such as DR1, DR3, and DR13-related alleles, as 
well as the DRB1*0401 and 0404 subtypes of the DR4 group.
Three detected DRB3 alleles were DRB3*0101, 0202, and 0301 
found in DR3, DR5, and DR6-positive subjects. The DRB3 allele 
associated with DRB1*1408 was DRB3*0101 whereas in Australia 
and PNG highland it was DRB3*0202.
The DRB5 locus was dominated by DRB5*0101 and was 
associated with both DR2 subtypes (DRB1*1501 and 1502) found 
in Polynesians. DRB5*0102 was detected only once in a 
DRB1*1502-positive donor.
4.3.2.2 DQ allele distributions and DR, DQ associations in 
Polynesians
The gene frequencies of DQAl and DQB1 alleles in 
Polynesian populations are given in Table 4.6. DR, DQ linkage 
relationships in Polynesians, together with Micronesians and 
Javanese, are given in Table 4.10. At the DQAl locus, all
115
eight detectable alleles were found in Polynesians. DQA1*0301 
(allele frequencies ranging from 31% to 37%) and 0501 (allele 
frequencies ranging from 31% to 38%) were the two most common 
alleles in the three groups. They were associated with 
DRB1*0403 and 0901 (DQA1*0301) and with the two common DR5 
allele types DRB1*1101 and 1201 (DQA1*0501). Among other 
common DQAl alleles were the three DQA1*01 types (0101, 0102, 
and 0103) associated with DR14, DR2, and DR8 alleles 
respectively, while DQA1*0401 was observed in DRB1*0801 or 
0802-positive subjects only.
Among thirteen DQB1 alleles detected in Polynesians, two 
DQ3-associated alleles were the most common ones. DQB1*0301 
(allele frequencies ranging from 30% to 39%) showed the 
highest gene frequency in all three groups and was associated 
with all DR5-related DRB1 alleles. DQB1*0302 (allele 
frequencies ranging from 16% to 23%) was found in all 
DRBl*0403-positive individuals. The linkage relationships of 
major DQl-related DQB1 alleles were DQB1*0502 with DRB1*1501 
and 1401, DQB1*0503 with DRB1*1408, and DQB1*0601 with 
DRB1*1502 and 0803. DQB1*0303 were in linkage disequilibrium 
with both DRB1*07 and 0901, while DQB1*0401 was found on the 
DRB1*0405 haplotype only.
4.3.3 HLA class II allele distributions in Micronesians 
4.3.3.1 DRB allele distributions in Micronesians
Fifteen DRB1, three DRB3, two DRB5 were detected in two 
Micronesian populations. The gene frequencies of DRB alleles 
are given in Table 4.7. Ten DRB1 alleles were observed more 
than twice in either group. The two groups showed similar DR 
allele distributions with a few discrepancies. Both groups 
shared an extraordinarily high gene frequency of DRB1*1202 
(38% and 28%) which was only sporadically observed in other 
Oceanic populations. DRB1*1502 was the major DR2 subtype 
although DRB1*1501 was also detected. Both DR2 alleles were
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associated with DRB5*0101. Like Polynesians, DRB1*0403 
dominated the DR4 group and was the only DR4 subtype found in 
Kiribati. In contrast, the most frequent Polynesian allele 
DRB1*1201 was found in only two Micronesian subjects. Among 
three DR6-related alleles, DRB1*1401 and the Asian allele 
DRB1*1405 (Obata et al 1990) were detected with low 
frequencies in both groups, while the new allele DRB1*1408 was 
found only in Kiribati (11%) and was associated with DRB3*0101 
as in Polynesians. Another allele shared by both Micronesian 
groups was DRB1*08032. In three Nauruans with a known family 
history of African admixture, DRB1*0302 was detected.
4.3.3.2 DQ allele distributions and DR, DQ associations in 
Micronesians
Table 4.8 gives gene frequencies of seven DQA1 and 10 DQB1 
alleles detected in Micronesians. Their linkage relationships 
with DRB1 alleles are shown in Table 4.10. Among major DQA1 
alleles, DQA1*0101 was detected together with DRB1*1401 and 
1405; DQA1*0102 was the only DQA1 allele associated with DR2 
alleles; DQA1*0301 was found in all DR4-positive subjects; 
while DQA1*0601 were detected in DRB1*1202-positive subjects 
only. At the DQB1 locus, DQB1*0301 was the most frequent 
allele with allele frequencies of 37% (Nauru) and 40% 
(Kiribati), and was associated with DRB1*1101 and 1202. Other 
common DQB1 alleles included the DRB1*1502 and 0803-associated 
DQB1*0601 and the DRB1*0403-associated DQB1*0302. In the three 
DRB1*0302-positive Nauruans, a typical African DR, DQ 
haplotype, DQB1*0402-DQA1*0401-DRB1*0302-DRB3*0101 (Fernandez- 
Vina et al 1991b), could be deduced. In a previous study, 
these DRB1*0302-positive individuals were also found to have a 
typical African class I haplotype, A30, B42 (Serjeantson et al 
1983) .
117
4.3.4 HLA class II allele distributions in Javanese
4.3.4.1 DRB allele distributions in Javanese
As far as the HLA class II polymorphism is concerned, the 
Javanese population was highly homogeneous. As shown in Table 
4.9, among 18 detected DRB1 alleles, the three most frequent 
ones, DRB1*1502 (21%), 1202 (51%) and 07 (11%), had a combined 
gene frequency of 83%. This was the only Oceanic population 
with a significant frequency of DRB1*07 alleles. Ten DRBl 
alleles occurred only once and some DR allele types commonly 
seen in other Asia-Oceanic populations, such as DR4, DR6 and 
DR8-related alleles, were nearly absent in this group.
DRBl*1501, 0901 and 1001 were also detected with low 
frequencies. Three DRB3 alleles, DRB3*0101, 0202 and 0301 were 
detected with DRB3*0301 showing the highest gene frequency 
(49%) which was compatible with the frequency of its 
associated DRB1*1202. Two DRB5 alleles, DRB5*0101 and 0102 had 
similar gene frequencies. DRB5*0101 was associated with both 
DRB1*1501 and 1502, while DRB5*0102 was observed only in 
DRB1*1502-positive individuals.
4.3.4.2 DQ alleles and DR, DQ associations in Javanese
Seven DQAl and 12 DQB1 alleles were detected in Javanese. 
Their gene frequencies are given in Table 4.9. DR, DQ 
haplotypes showing significant linkage disequilibrium in 
Javanese are tabulated in Table 4.10. The most common DQAl 
allele was the DRBl*1202-associated DQA1*0601 (48%). Both 
DQA1*0101 and 0102 were found to be in linkage disequilibrium 
with DRB1*1502 although the DRB1*1502-DQA1*0101 haplotype was 
more commonly seen. DQA1*0201 was observed in DRBl*07-positive 
subjects only.
DQB1*0301 was associated with DRB1*1202 and showed the 
highest DQB1 gene frequency (49%) . Among other common DQB1 
alleles, the DR, DQ associations were: DQB1*0501 with 
DRB1*1502 and 1001, DQB1*0601 with DRB1*1502, DQB1*0502 with
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DRB1*1501, DQB1*0201 with DRB1*07, and DQB1*0303 with both 
DRBl*07 and 0901.
4.3.5 HLA class II allele distributions in Chinese 
4.3.5.1 DRB5*0203
In the subtyping of DR2-related DRB5 alleles in the 
southern Chinese population from Hong Kong, a new DRB5 allele 
was revealed in two DRB1*1602-positive individuals by the 
occurrence of an unusual SSO hybridization pattern. The new 
pattern showed positive hybridizations of probes SR-23 (codons 
26-32), SR-2 (codons 66-72), and SR-86 (codons 82-86), a 
pattern otherwise expected for DRB5*02 except that DRB5*02 was 
expected to hybridize with probe SR-87 instead of SR-86 in 
codons 82-86. The unusual SSO pattern meant that the new 
allele was different from DRB5*02 by two codons at positions 
85 and 86; instead of having GCT (85 Ala) and GTG (86 Val), 
the new allele had GTT (85 Val) and GGT (86 Gly). The new SSO 
pattern segregated in an informative family. To examine the 
entire exon 2 of the new allele, DNA sequencing was performed 
in sample HK55 with a DRB1 genotype of DRB1*1602/DRB1*1202.
The sequencing procedure used in this case was PCR 
amplification of DRB genes followed by ligation of PCR 
products into M13 vectors cleaved with EcoRI (Grooms et al 
1992). The nucleotide sequence, given in Figure 4.2, confirmed 
the SSO hybridization pattern and showed that except for 
codons 85 and 86 the new allele had an exon 2 identical to 
DRB5*0201 and 0202. The new sequence has been officially 
designated DRB5*0203 by the WHO Nomenclature Committee for HLA 
Factors.
Since DRB5*0203 differs from DRB5*0201 and 0202 by three 
nucleotide substitutions, the most parsimonious explanation of 
the phylogeny of DRB5*0203 is that it arose by intra-exonic 
recombination between a DRB5*01 and a DRB5*02 allele. The 
region of apparent recombination would be within the bounds of
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Figure 4.1. Nucleotide sequences (A) and deduced amino acid 
sequences (B) of DRB5*0203 and other DRB5 alleles.
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the shared nucleotide corresponding to residues 73 to 84. 
Alternatively it could be generated by a segmental transfer 
around codons 85 and 86 with a DRB5*02 gene as the recipient, 
a mechanism apparently involved in the generation of several 
DRB allelic subtypes at the same codons. However, DRB5*02 
alleles were not detected in southern Chinese populations, 
which may also indicate that DRB5*0203 is an ancient 
progenitor of DRB5*01 or DRB5*02 alleles.
4.3.5.2 DRB allele distributions in Chinese
Thirty-two DRB1, three DRB3 and four DRB5 alleles were 
detected in the five Chinese populations. The gene frequencies 
are given in Table 4.11. In the southern and northern Han 
Chinese populations, DRB1*1501, 0405, 1101, 1202, 1301, 1401, 
and 0803 were found to be the most common subtypes in the 
relevant allele groups. DRB1*07 was also commonly seen and 
DRB1*0901 was the most frequent DRB1 allele with gene 
frequencies ranging from 14% to 19%. Several alleles showed 
characteristic distributions between southern and northern 
Chinese populations. DRB1*1602, 0301, 0403, and 1202 were more 
frequently observed in southern Chinese, while DRB1*0101,
0401, 0406, 1101, and 07 showed higher gene frequencies in the 
north. The DRB1 distribution in the Uygur group featured the 
increased frequency of several alleles commonly seen in 
Caucasoids, such as DRB1*0101, 0301, 0404, 1301, 1302 and 07, 
as compared to the frequency in southern and northern Chinese. 
However, some typical Oriental DRBl alleles such as DRB1*0405, 
0803, and 0901 were also represented in this group, indicating 
that the HLA class II composition of this group has been 
substantially contributed to by both Caucasoids and Orientals.
Three DRB3 alleles were found in Chinese populations. The 
associations between DRB3 and DRBl loci were: DRB3*0101 with 
DRBl*1301; DRB3*0202 with DRB1*0301, 1101, 1104, 1201, 1401, 
and 1402; and DRB3*0301 with DRB1*1202, and 1302.
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Figure 4.2 PCR-RFLP typing for DRB5 alleles 
DRB5-specific PCR products were digested with Cfol before 
separation on a polyacrylamide gel. Samples tested were either 
DRBl homozygous or heterozygous with a non-DR2 haplotype.
269bp
103bp 
101 bp 
99bp
D 0 0 0 0 M 0 0 0 0 0 0 0 U
R 1 1 1 1 A 2 2 2 2 2 2 2 N
B 0 0 0 0 R C
5 1 1 1 1 K U
E T
D 1 1 1 1 R 1 1 1 1 1 1 1
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97bp
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Four DRB5 alleles including the newly-defined DRB5*0203 
were found in DR2-positive subjects. DRB1*1501 were invariably 
associated with DRB5*0101, but the DRB5 association with 
DRB1*1502 and 1602 showed remarkable differences between 
northern and southern populations. In the two northern Chinese 
populations and the Uygur series, DRB1*1502 and 1602 were 
associated with DRB5*0102 and 02 respectively. In the south, 
DRB1*1502 was associated with both DRB5*0101 and 0102, which 
was similar to the DRB1, DRB5 arrangements in Southeast Asian, 
Australian, and Pacific populations found in this study.
DRB5*02 (0201 or 0202) was not detected in southern Chinese;
instead, 15 out of 17 DRB1*1602 haplotypes observed in 
southern Chinese were associated with DRB5*0101 and the other 
two with the newly-defined DRB5*0203. The unusual DRB1-DRB5 
association was further confirmed using PCR-RFLP as shown in 
Figure 4.2.
4.3.5.3 DQ allele distributions and DR, DQ associations in 
Chinese
Table 4.12 gives the gene frequencies of eight DQAl and 14 
DQB1 alleles detected in the five Chinese groups. DR, DQ 
linkage relationships are shown in Table 4.13, in which the 
two southern and the two northern Chinese groups are pooled.
DQ allele distributions in southern, northern Chinese and the 
Uygur population corresponded to the associated DRB1 alleles. 
In southern Chinese, the DRB1*1501 and 1502-associated 
DQA1*0102 had much higher frequencies than in northern Chinese 
and the Uygur population where DRB1*1502 was associated with 
DQA1*0103. The DRBl*1202-associated DQA1*0601 was also more 
commonly seen in the south, whereas the DRB1*1502-associated 
DQA1*0103 and the DRB1*07-associated DQA1*0201 showed higher 
frequencies in northern Chinese and Uygur series.
DQB1 alleles showed similar distributions between southern 
and northern Chinese groups except for the DR2-associated
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DQB1*0502 and 0602. In northern Chinese and the Uygur group, 
there were three DR2-related DRB1-DQB1 haplotypes: DRB1*1501- 
DQBl*0602, DRB1*1502-DQB1*0 601, and DRB1*1602-DQB1*0502, while 
in southern Chinese, the DR15-related DRB1-DQB1 haplotypes 
were more complex; DRB1*1501 was associated with either 
DQB1*0502, 0601, 0602, or 0603; DRB1*1502 could be associated 
with DQB1*0501, 0502, 0601, or 0602; and DRB1*1602 was 
associated only with DQB1*0502. DQB1*0301 (allele frequencies 
ranging from 16% to 26%) was mainly associated with DR11,
DR12, and DR14 alleles and was found to be the most frequent 
allele in both southern and northern Chinese groups.
DQB1*0303, associated with DRB1*07 and 0901, showed higher 
frequencies in southern and northern Chinese than in the Uygur 
group. DQB1*0401 was found in all but one DRBl*0405-positive 
donors. The exceptional DRB1*0405 donor had a DQB1*0402 which 
was also associated with DRB1*0410. The most common DQBl 
allele in the Uygur group was DQB1*0201 (27%) which 
corresponded with the high frequencies of the associated 
DRB1*0301 and 07 alleles in this population.
4.5.3.4 DPBl allele distributionsin in a northern Chinese 
population
The DPBl polymorphism was examined in 88 northern Chinese 
individuals from Beijing. Twelve DPBl alleles were detected in 
this population and the gene frequencies are given in Table 
4.14. DPB1*0501 was found to be the most frequent DPBl allele 
with a gene frequency of 32%. Other major alleles included 
DPB1*0201, 0301, 0401, 0402, and 0701. Unlike DR, DQ 
combinations, linkage disequilibrium analysis revealed very 
weak linkage relationships for most DR-DP and DQ-DP 
combinations. Only two DRB1-DPB1 haplotypes, DRB1*0101- 
DPB1*0401 and DRB1*07-DPB1*1701, showed significant linkage 
disequilibrium as shown in Table 4.15.
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4.4. Discussion
This study, using nucleotide sequencing and SSO 
hybridization of PCR-amplified exon 2 segments of HLA class II 
genes, has characterized HLA-D region alleles in indigenous 
populations of Asia-Oceania. The results presented in this 
chapter demonstrated that HLA-DRB1 alleles in indigenous 
populations in the Pacific were essentially confined to DR2, 
DR4, DR5, DR6, and DR8 types, which was consistent with 
previous serological and RFLP analyses. However, the 
characteristic distribution of many sutypes which were 
difficult or impossible to detect with more traditional 
methods was previously unknown.
In the DR2 allele group, both DRB1*1501 and 1502 showed 
high relative frequencies in most study populations while 
DRB1*1602 was confined to Chinese and coastal Melanesians. 
Interestingly, the linkage relationship between DR2-related 
DRB1 and DRB5 loci was quite unusual compared with the DRB1- 
DRB5 linkage relationship reported in other ethnic groups. In 
Caucasoids, DRB1*1501, 1502 and DR16 (DRB1*1601) are 
invariably associated with DRB5*0101, 0102 and 02 (DRB1*0201 
or 0202) respectively (Wordsworth et al 1990; Fernandez-Vina 
et al 1991b). The same linkage relationships were observed in 
the present study in northern Chinese and the Uygur 
population. In southern Chinese, however, DRB1*1602 was 
associated with DRB5*0101 or the new allele DRB5*0203. In all 
other study populations including Australian Aborigines 
described in Chapter 3, both DRB1*1501 and 1502 were 
associated with DRB5*0101. The DR2-related DR, DQ linkage 
relationship in these populations were even more complex 
compared with Caucasoids and northern Chinese, which is 
described in Chapter 5. Strong linkage disequilibrium between 
HLA-DRBl, -DRB5, and -DQ alleles has hindered the assignment 
of functional epitopes to specific loci. The analysis of 
different HLA class II arrangements in different populations
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may help to resolve this problem. An example was the analysis 
of an Amerindian cell line that led to the conclusion that the 
DRB1 locus encodes Dw21 and Dw22 (Liu et al 1988). The novel 
DRB1 and DRB5 haplotypes in Oceanic and southern Chinese 
populations similarly invite speculation regarding the precise 
locus, or even the precise epitope that discriminates the MLC 
types associated with DR2 subtypes. Although MLC types are not 
known for the specimens examined in this study, the relative 
distributions of Dw2 and Dwl2 in Aborigines and coastal 
Melanesians (Honeyman et al 1983) and in PNG highlanders 
(Crane et al 1985) correspond to the relative proportions of 
DRB1*1501 and 1502 observed in this study. Both of these 
alleles are linked with DRB5*0101 in Oceania and Australia, so 
the discriminating determinant may be assigned to DRB1.
Further, the DRB1 molecules encoded by DRB1*1501 and 1502 
differ, in the first domain, by one amino acid residue only, 
at position 86. These data suggest that residue 86 is involved 
in T-cell recognition.
Oligonucleotide hybridizations of DRBl PCR products 
performed in the present experiments confirmed the earlier 
finding in MLC typing (Honeyman et al 1986) that Dwl5 is the 
predominant DR4 type in coastal Melanesians, and further 
revealed previously unsuspected diversity in DR4-related 
alleles in Oceanic populations. DRB1*0403 was found to be the 
dominant DR4 type in Polynesians, Micronesians and the 
Austronesian-speaking Melanesians. DRB1*0410, a variant of 
DRB1*0405, is a major DR4 subtype in Australian Aborigines 
from Cape York Peninsula as described in Chapter 3, and was 
also well represented here in Fijians and PNG highlanders. In 
all cases, DRB1*0410 was associated with DQB1*0402, whereas 
the related DRB1*0405 was invariably associated with DQB1*0401 
in PNG highlanders, so that the shared DRB1*0410-DQB1*0402 
haplotype in Australians and Melanesians reflect the ancestral 
affinities rather than a series of recent, independent
126
mutations. DRB1*0410 has previously been reported in one 
Hispanic donor, but was not associated with DQ4 (Petersdorf et 
al 1991).
Previous studies have demonstrated that DR5 is the most 
common DR type in Pacific islanders. In the present experiment 
using SSO typing, DR5 was further discriminated into three 
major subtypes and each subtype was representative for one of 
the three population groups in the Pacific, i.e. DRB1*1101 for 
coastal Melanesians, DRB1*1201 for Polynesians, and DRB1*1202 
for Micronesians. Heterogeneity in DR5-related HLA class II 
haplotypes in Pacific populations has been observed in 
previous RFLP analysis (Serjeantson et al 1987) by the 
occurrence of a novel DR ß RFLP pattern designated 
'DR5*NAURU', detected both in Polynesian and Micronesian 
populations, although it was associated with different HLA-B 
antigens and with different DQ a RFLPs in the two groups. The 
results presented here showed that the different DR, DQ 
haplotypes associated with 'DR5*NAURU' indicate different DRB1 
alleles: DRB1*1201 and 1202. The two DR12 alleles were 
associated not only with different DQAl alleles, but also with 
different DRB3 alleles.
Two new alleles were found in the DR6-related allele 
group. DRB1*1408 was widely detected in Oceanic populations as 
well as in Australian Aborigines. However, in Polynesians, 
Micronesians and coastal Melanesians, the DRBl*1408-associated 
DRB3 allele was different from that found in PNG highlanders 
and Australian Aborigines, indicating that more than one 
independent point mutation events may have given rise to this 
allele in the two groups of peoples. The other new DR6-related 
allele DRB1*1407 was found in both groups of Melanesians (PNG 
highlanders and coastal Melanesians) but was absent from other 
study populations, suggesting a Melanesian origin which was 
relatively new compared with DRB1*1408.
Marked diversity in HLA class II allele distributions was
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also reflected in the detected numbers of alleles and gene 
frequency distributions in the study populations. For example, 
28 DRB1 alleles were detected in the Uygur group from 
northwestern China with the highest allele frequency of 19% 
(DRB1*07) and 27 DRBl alleles were found in the northern 
Chinese population from Xians with the highest gene frequencie 
of 14% (DRB1*0901). The relatively high HLA heterogeneity in 
these populations and the frequent occurrence of the alleles 
more commonly seen in Caucasoids reflect the genetic 
contribution from Caucasoids into the northern Chinese gene 
pool, which is consistent with the findings in previous 
serological studies (Sun et al 1986; Lee et al 1988) that some 
typical HLA class I antigens and haplotypes such as A1-B8 and 
A3-B7 were detected with appreciable frequencies in the Han 
Chinese populations and in the minority Chinese groups from 
northern and northwestern China but were absent from southern 
Chinese populations.
The most homogeneous population was Javanese with only 
eight DRBl alleles detected more than once. The highest DRBl 
allele frequency in Javanese reached 51% (DRB1*1202), but some 
common allele types in other Asia-Oceanic populations were 
virtually absent in Javanese, indicating a very small founding 
population with little subsequent inward migration.
In Melanesia, linguistic and archaeological reconstruction 
has shown a dichotomy in the prehistory of Melanesian 
colonization. This dichotomy has been confirmed by genetic 
studies based on serum protein iso-electric focusing (Kamboh 
1984) and on HLA class II RFLPs (Serjeantson 1989b) that 
cluster PNG highlanders with Australian Aborigines rather than 
with coastal Melanesians. A similar dichotomy has been 
observed in this study, with the absence or near-absence in 
PNG highlanders of some alleles found commonly in coastal 
populations (DRB1*0403 and 1101) and with comparatively high 
frequencies of DRB1*0410 and 1408 that are found on the same
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haplotypes in Australian Aborigines. Among coastal and island 
Melanesians, significant variation in the HLA class II allele 
distributions was observed in the present study, which may 
partly reflect varied degrees of genetic contribution, along 
with Austronesian languages, from pre-Polynesians when they 
migrated eastward into the Pacific via coastal Melanesian 
areas (Bellwood 1989). For example, DRB1*0403 which reached 
gene frequencies of 16% to 23% in Polynesians, was well 
represented in Austronesian-speaking but not in non- 
Austronesian-speaking Melanesians DRB1*0901, a Mongoloid 
allele apparently carried into Oceania by pre-Polynesians also 
showed an appreciable frequency in Fijians. Despite regional 
differences, the high frequency of DRB1*1101 was a hallmark 
for all coastal Melanesian groups examined.
The HLA class II distribution presented in this chapter 
shows a common ancestry of Micronesia and Javanese which is 
compatible with linguistic and archaeological evidence that 
they derived from the same ancestral gene pool, since 
DRB1*1202 occurs commonly in southern Chinese. Further, the 
presence of DRB1*0403 in Micronesians, but not in Javanese, is 
compatible with linguistic evidence for dual settlement of 
Micronesia, because DRB1*0403 is common in coastal 
Melanesians. This supports findings based on HLA class I 
(Serjeantson et al 1983) and globin gene polymorphisms 
(0'Shaughnessy et al 1990) that there is a substantial 
Melanesian input into the Micronesian gene pool.
The HLA class II allele distributions in Polynesians are 
not readily reconciled with prehistoric linguistic and 
archaeological reconstructions. There is virtually no overlap 
between the HLA class II profiles in contemporary Polynesian 
and Javanese populations. Javanese, themselves a derivative 
population, may not be ideal for comparison with Polynesians. 
Mongoloid elements DRB1*0405, 1201, 0802, and 0901 could 
suggest an origin further north than insular Southeast Asia,
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which is not inconsistent with findings that Polynesians 
cluster with Ainu and Japanese on craniometric analyses (Brace 
1990) rather than with other peoples of Oceania. Polynesians 
and coastal Melanesians share some common alleles which were 
virtually absent in the non-Austronesian-speaking Melanesian 
population PNG highlanders and in Australia. This may reflect 
the genetic exchange between these two groups of peoples, 
although it is not clear whether these genes were carried into 
Oceania by pre-Polynesians or rather reflect a Melanesian 
contribution to the Polynesian HLA gene pool. Meanwhile, the 
genetic exchange between Polynesians and Micronesians was very 
little, since the most common DRB1 alleles in these two groups 
(DRB1*1201 in Polynesians and DRB1*1202 in Micronesians) were 
mutually exclusive.
Differentiation of HLA polymorphisms in human groups could 
be influenced by many factors, such as founder effect, 
population size, migration, genetic drift, selection, genetic 
bottleneck, and mutation. Pacific islanders have been 
particularly vulnerable to some of these factors. Non-HLA 
genetic markers indicate population bottlenecks or small 
population sizes have had a profound influence on the 
evolution of the Polynesians, as evidenced in the restricted 
variable nucleotide tandem repeat (VNTR) repertoire (Flint et 
al 1989) and by the near-loss of wild-type mitochondrial DNA 
(Hertzberg et al 1989) . The apparently unique and restricted 
HLA class II profile in Pacific islanders also suggests rapid 
evolution. However, despite the very different frequency 
distributions in the study populations, the HLA class II 
genetic repertoire in southeast Asian and Oceanic populations 
is each an extract of the mainland Asian (Chinese in this 
study) HLA gene pool, which reflects their remote Mongoloid 
origin. Except for the locally evolved DRB1*1408 and 1407 
alleles, and the African-derived DRB1*0302 in Micronesians, 
all DR, DQ alleles found in Oceanic populations were
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represented in Chinese.
While the rapid evolution of HLA gene frequencies in small 
human groups makes it more difficult to trace genetic 
connections in contemporary populations, the extended HLA-DR, 
-DQ haplotypes are considerably stable. The analysis of HLA 
class II haplotypes may provide more valuable information for 
population phylogeny which is one of the aims in the following 
chapter.
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Table 4.1 Hardy-Weinberg equilibrium of the HLA-DQAl locus 
in three Pacific populations
Rarotonga Nauru Madang
D Q A 1 / D Q A 1 o b s  ,. e x p • r o b s . e x p . X 2 o b s . e x p . X 2
0 1 0 1 / 0 1 0 1 1 1 .0 0 .00 0 0 .3 0 .31 0 0 .1 0 .06
0 1 0 1 / 0 1 0 2 2 0 . 8 1 .76 2 3 .0 0 . 31 2 1 .5 0 .14
0 1 0 1 / 0 1 0 3 0 1 .2 1 .15 2 0 . 5 4 . 98 0 0 .1 0 .06
0 1 0 1 / 0 2 0 1 0 0 . 1 0 .12 0 0 .0 0 . 00 0 0 .0 0 .00
0 1 0 1 / 0 3 0 1 6 6 . 6 0 .,05 1 1 .4 0 .12 1 0 .2 3 . 60
0 1 0 1 / 0 4 0 1 0 0 . 5 0 . 46 0 0 .3 0 .27 0 0 .0 0 .00
0 1 0 1 / 0 5 0 1 8 6 .7 0 . 26 0 0 .7 0 .74 1 2 .1 0 .57
0 1 0 1 / 0 6 0 1 0 0 . 1 0 . 12 4 2 . 6 0 . 82 0 0 .0 0 .00
0 1 0 2 / 0 1 0 2 0 0 .2 0 . 16 9 7 .2 0 .44 10 9 . 6 0 .02
0 1 0 2 / 0 1 0 3 0 0 . 5 0 . 45 1 2 .3 0 .73 1 0 .8 0 .07
0 1 0 2 / 0 2 0 1 0 0 . 0 0 . 05 0 0 .0 0 . 00 0 0 .0 0 .00
0 1 0 2 / 0 3 0 1 2 2 . 6 0 . 12 5 6 .9 0 . 52 3 2 .3 0 .21
0 1 0 2 / 0 4 0 1 1 0 .2 3 . 75 1 1 . 3 0 . 08 0 0 .,0 0 .00
0 1 0 2 / 0 5 0 1 2 2 . 6 0 . 14 6 3 .,6 1 . 58 24 2 6 .,2 0 .18
0 1 0 2 / 0 6 0 1 0 0 .0 0 ,.05 11 12 ., 5 0 . 18 0 0 . 0 0 . 00
0 1 0 3 / 0 1 0 3 0 0 .3 0 . 32 0 0 .2 0 .18 0 0 .0 0 .,02
0 1 0 3 / 0 2 0 1 0 0 . 1 0 ,.06 0 0 .,0 0 .,00 0 0 .1 0 . 09
0 1 0 3 / 0 3 0 1 4 3 .7 0 ,.03 0 1 . 1 1 .,10 0 0 .0 0 . 00
0 1 0 3 / 0 4 0 1 0 0 .,3 0 ,.26 1 0 .2 3 . 00 0 0 .0 0 . 00
0 1 0 3 / 0 5 0 1 5 3 ., 7 0 .44 1 0 . 6 0 . 32 1 1 ,.1 0 . 00
0 1 0 3 / 0 6 0 1 1 0 . 1 13 .66 7 6 .0 0 . 18 0 0 ,.0 0 . 00
0 2 0 1 / 0 2 0 1 0 0 . 0 0 .00 0 0 .0 0 . 00 0 0 ,.0 0 . 00
0 2 0 1 / 0 3 0 1 0 0 .4 0 .37 0 0 .0 0 . 00 0 0 .0 0 ,.00
0 2 0 1 / 0 4 0 1 0 0 . 0 0 .03 0 0 ,.0 0 ,.00 0 0 .0 0 ,.00
0 2 0 1 / 0 5 0 1 1 0 . 4 1 .06 0 0 .0 0 . 00 0 0 .0 0 ,.00
0 2 0 1 / 0 6 0 1 0 0 .0 0 .01 0 0 .0 0 ,.00 0 - 0 .0 0 .00
0 3 0 1 / 0 3 0 1 13 1 0 .4 0 . 64 3 1 .7 1 .12 0 0 .1 0 .14
0 3 0 1 / 0 4 0 1 1 1 ,.5 0 .15 1 0 .6 0 .22 0 0 .0 0 .00
0 3 0 1 / 0 5 0 1 18 2 1 ,.2 0 .48 1 1 .7 0 .30 2 3 .1 0 .41
0 3 0 1 / 0 6 0 1 0 0 ,.4 0 .37 7 6 .0 0 .18 0 0 .0 0 .00
0 4 0 1 / 0 4 0 1 0 0 . 1 0 .05 0 0 .1 0 .06 0 0 .0 0 .00
0 4 0 1 / 0 5 0 1 2 1 .5 0 .18 1 0 .3 0 .33 0 0 .0 0 .00
0 4 0 1 / 0 6 0 1 0 0 .0 0 .03 1 3 .1 0 .02 0 0 .0 0 .00
0 5 0 1 / 0 5 0 1 11 10 .8 0 .00 1 0 . 5 0 .66 20 17 .8 0 .28
0 5 0 1 / 0 6 0 1 0 0 .4 0 .37 1 3 .1 1 .44 0 0 .0 0 .00
0 6 0 1 / 0 6 0 1 0 0 .0 0 oo 6 5 .4 0 .07 0 0 .0 0 .00
total 78 78 .0 27 .13a 67 67 .0 20 . 05 b 56 56 .0 14 .38l
obs.: observed individuals having the genotype 
exp.: expected individuals having the genotype
a: for d.f.=36, p>50; b: for d.f.=28, p>0.75; c: for d.f.=16, p>0.50
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Table 4.2 HLA-DRB gene frequencies in five Melanesian 
populations
Madang
N=65
Rabaul
N=  60
Fij i
N =  57
New Caledonia
N=65
PNG highland
N=57
Allele n % n % n % n % n %
DRBl
0101 0 0 . 0 0 0 . 0 2 1 . 8 1 0 . 8 0 0 . 0
0103 0 0 . 0 0 0 . 0 0 0 . 0 1 0 . 8 0 0 . 0
1501 6 4 . 6 0 0 . 0 6 5 . 3 18 1 3 . 9 34 2 9 . 8
1502 26 2 0 . 0 12 1 0 . 0 19 1 6 . 7 15 1 1 . 5 15 1 3 . 2
1602 19 1 4 . 6 8 6 . 7 1 0 . 9 1 0 . 8 4 3 .5
0301 0 0 . 0 0 0 . 0 1 0 . 9 0 0 . 0 0 0 . 0
0401 0 0 . 0 0 0 . 0 0 0 . 0 4 3 . 1 0 0 . 0
0403 2 1 . 5 11 9 . 2 10 8 . 8 8 6 . 2 0 0 . 0
0404 0 0 . 0 0 0 . 0 1 0 . 9 0 0 . 0 0 0 . 0
0405 3 2 . 3 11 9 . 2 4 3 . 5 3 2 . 3 9 7 . 9
0408 0 0 . 0 0 0 . 0 0 0 . 0 1 0 . 8 0 0 . 0
0410 0 0 . 0 1 0 . 9 6 5 . 3 2 1 . 5 8 7 . 0
1101 59 4 5 . 4 44 3 6 . 7 38 3 3 . 3 43 3 3 . 1 3 2 . 6
1104 8 6 . 2 2 1 . 7 1 0 . 9 0 0 . 0 0 0 . 0
1201 1 0 . 8 0 0 . 0 5 4 . 4 0 0 . 0 4 3 .5
1301 0 0 . 0 0 0 . 0 1 0 . 9 0 0 . 0 0 0 . 0
1401 3 2 . 3 25 2 0 . 8 0 0 . 0 3 2 . 3 2 1 . 8
1407 0 0 . 0 0 0 . 0 1 0 . 9 11 8 . 5 4 3 . 5
1408 0 0 . 0 0 0 . 0 0 0 . 0 3 2 . 3 20 1 7 . 5
07 0 0 . 0 0 0 . 0 0 0 . 0 2 1 . 5 0 0 . 0
0801 0 0 . 0 0 0 . 0 0 0 . 0 1 0 . 8 0 0 . 0
0803 2 1 . 5 6 5 . 0 11 9 . 7 10 7 . 7 11 9 . 7
0901 1 0 . 8 0 0 . 0 7 6 . 1 3 2 . 3 0 0 . 0
blank 0 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0 0 0 . 0
total 130 1 0 0 . 0 120 1 0 0 . 0 114 1 0 0 . 0 130 1 0 0 . 0 114 1 0 0 . 0
DRB3
0101 0 0 . 0 0 0 . 0 6 6 . 1 11 8 . 5 4 3 . 5
0202 71 5 4 . 6 71 5 9 . 2 40 3 5 . 1 49 3 8 . 5 29 2 6 . 3
blank 59 4 5 . 4 49 4 0 . 8 68 5 8 . 8 70 5 3 . 0 81 7 0 . 2
total 130 1 0 0 . 0 120 1 0 0 . 0 114 1 0 0 . 0 130 1 0 0 . 0 114 1 0 0 . 0
DRB5
0101 31 2 3 . 8 13 1 0 . 8 25 2 1 . 9 31 1 3 . 8 49 4 3 . 0
0102 1 0 . 8 0 0 . 0 0 0 . 0 2 1 . 5 0 0 . 0
02 19 1 4 . 6 7 5 . 8 1 0 . 9 1 0 . 8 4 3 . 5
blank 79 6 0 . 8 100 8 3 . 4 88 7 7 . 2 96 8 3 . 9 60 5 3 . 5
total 130 1 0 0 . 0 120 1 0 0 . 0 114 1 0 0 . 0 130 1 0 0 . 0 114 1 0 0 . 0
a Number of chromosomes observed
bGene frequency obtained by direct gene counting
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Table 4.3 HLA-DRB gene frequencies in five Melanesian 
populations
Madang Rabaul Fij i New Caledonia PNG highland
N=65 N=60 N=57 N=65 N=57
Allele n % n % n % n % n %
DQAl
0101 a4 b3.1 25 20.8 3 2.6 19 14.6 26 22.8
0102 50 38.5 20 16.7 25 21.9 32 24.6 53 46.5
0103 2 1.5 6 5.0 13 11.4 12 9.2 11 9.7
0201 0 0.0 0 0.0 0 0.0 2 1.5 0 0.0
0301 6 4.6 23 19.2 28 24.6 21 16.2 17 14.9
0401 0 0.0 0 0.0 0 0.0 1 0.8 0 0.0
0501 68 52.3 46 38.3 45 39.5 43 33.1 7 6.1
blank 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
total 130 100.0 120 100.0 114 100.0 130 100.0 114 100.0
DQBl
0501 1 0.8 0 0.0 2 1.8 2 1.5 0 0.0
0502 22 16.9 20 16.7 1 0.9 4 3.1 5 4.4
0503 1 0.8 16 13.3 1 0.9 16 12.3 29 25.4
0601 30 23.1 15 12 . 5 30 26.3 23 17.7 22 19.3
0602 2 1.5 0 0.0 6 5.3 18 13.9 34 29.8
0603 0 0.0 0 0.0 1 0.9 0 0.0 0 0.0
0201 0 0.0 0 0.0 1 0.9 2 1.5 0 0.0
0301 68 52.3 46 38.3 44 38.6 46 35.4 7 6.1
0302 2 1.5 11 9.2 11 9.7 10 7.7 0 0.0
0303 1 0.8 0 0.0 7 6.1 3 2.3 0 0.0
0401 2 1.5 0 0.0 0 0.0 0 0.0 9 7.9
0402 1 0.8 12 10.0 10 8.8 6 4.6 8 7.0
blank 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
total 130 100.0 120 100.0 114 100.0 130 100.0 114 100.0
Number of chromosomes observed 
'bGene frequency obtained by direct gene counting
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Table 4.4 HLA-DR,-DQ haplotypes with significant 
linkage disequilibrium in Melanesians
coastal Melanesian PNG highlander
N =247 N =57
Haplotype hf% D% X2 hf% D% X“
DRB1-DQA1
1501-0102 5.8 4.2 75.8 31.2 17.0 59.0
1502-0102 13.8 10.1 207.7 12.1 6 . 6 16.5
1602-0102 5.6 4.2 79.5
0403-0301 6.3 5.3 175.4
0405-0301 4 . 1 3.5 110.8 7.3 6.2 43.2
0410-0301 1 . 8 1 . 6 44.6 7.3 6.2 43.2
1101-0501 36.0 21.3 400.0 2.7 2.5 37.3
1201-0501 1.2 0.7 6 . 8 3.6 2.7 55.9
1401-0101 6.1 5.4 256.0
1407-0101 2.5 2.2 94.7 3 . 6 2.7 8.8
1408-0101 0.6 0.5 16.8 19.4 14.6 77.3
07 -0201 0.4 0.4 277.5
0803-0103 5 . 6 5.3 423.2 7.3 6 . 8 99.7
0901-0301 2.3 1 . 9 56.3
DRB1-DQB1
1501-0602 5 . 3 5 .. 0 3 9 0 . 3 3 1 .,2 2 1 . 5 109 . 4
1502-0601 13 . 9 1 1 ., 1 308 . 4 12 .. 1 9 . 8 59 . 6
1602-0502 5 .,7 5 . 2 30 1 ., 1 2 .,7 2 . 6 58 ., 0
0403-0302 6 ., 4 5 .. 9 422 . 2
0405-0401 0 ., 4 0 . 4 26 .. 5 7 . 3 6 .. 8 99 . 7
0405-0402 3 .. 6 3 . 3 25 4 . 7
0410-0402 1 .,7 1 . 5 106 . 1 7 . 3 6 .. 8 99 . 7
1101-0301 36 .. 8 2 1 . 8 406 . 1 2 . 7 2 . 5 37 . 3
1104-0301 2 . 3 1 . 4 14 . 1
1201-0301 1 . 4 1 . 0 14 . 4 3 . 6 3 . 4 55 . 9
1401-0502 2 ,.9 2 ,.4 62 . 6
1401-0503 3 . 0 2 .5 8 1 . 2
1407-0503 2 ,.5 2 .3 145 ,. 4 3 .6 2 ,. 6 7 .7
1408-0503 0 ,.6 0 .6 26 .1 19 .4 1 4 . 1 68 .2
07 -0201 0 ,. 4 0 . 4 181 .2
0803-0601 4 . 6 3 . 6 72 .7 6 .2 4 . 8 20 .2
0901-0303 2 .3 2 .2 442 .3
hf: haplotype frequency; D: delta value
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Table 4.5 HLA-DRB gene frequencies in three Polynesian 
populations
Rarotonga Niue Western Samoa
N=7 8 N=70 N=51
Allele n % n % n %
DRB1
0101 la 0.6 0 0.0 1 1.0
0103 1 0.6 0 0.0 0 0.0
1501 2 1.3 3 2.1 4 3.9
1502 3 1.9 2 1.4 4 3.9
0301 1 0.6 0 0.0 2 2.0
0401 4 2.6 0 0.0 1 1.0
0402 1 0.6 0 0.0 0 0.0
0403 28 18.0 32 22 .9 16 15.7
0404 1 0.6 0 0.0 0 0.0
0405 8 5.1 0 0.0 8 7.8
0410 1 0.6 0 0.0 0 0.0
1101 32 20.5 11 7.9 11 10.8
1102 1 0.6 0 0.0 0 0.0
1201 23 14.7 42 30.0 19 18.6
1202 1 0.6 2 1.4 0 0.0
1302 3 1.9 0 0.0 2 2.0
1401 8 5.1 7 '4.3 3 2.9
1404 1 0.6 0 0.0 0 0.0
1408 8 5.1 6 5.0 7 6.9
07 1 0.6 2 1.4 2 2.0
0801 0 0.0 1 0.7 0 0.0
0802 4 2.6 6 4.3 1 1.0
0803 9 5.8 14 10.0 10 9.8
0901 14 9.0 12 8.6 11 10.8
blank 0 0.0 0 0.0 0 0.0
total 156 100.0 140 100.0 102 100.0
DRB3
0101 32 20.5 49 35.0 27 26.5
0202 42 26.9 17 12 .1 15 14.7
0301 4 2.6 2 1.4 2 2.0
blank
total 156 100.0 140 100.0 102 100.0
DRB5
0101 4 2.6 5 3.6 8 7.8
0102 1 0.6 0 0.0 0 0.0
blank 151 96.8 135 96.4 94 92.2
total 156 100.0 140 100.0 102 100.0
a Number of chromosomes observed
b Gene frequency obtained by direct gene counting
136
Table 4.6 HLA-DQ gene frequencies in three Polynesian 
populations
Rarotonga Niue Western Samoa
N=7 8 N=70 N=51
Allele n % n % n %
DQA1
0101 a18 b11.5 13 9.3 11 10.8
0102 7 4.5 5 3.6 10 9.8
0103 10 6.4 14 10.0 10 9.8
0201 1 0.6 2 1.4 2 2.0
0301 57 36.5 44 31.4 36 35.3
0401 4 2.6 7 5.0 1 1.0
0501 58 37.2 53 37.8 32 31.4
0601 1 0.6 2 2.1 0 0.0
blank 0 0.0 0 0.0 0 0.0
total 156 100.0 140 100.0 102 100.0
DQBl
0501 1 0.6 0 0.0 1 1.0
0502 5 3.2 6 4.3 1 1.0
0503 15 9.6 8 5.7 9 8.8
0601 9 5.8 16 11.4 14 13.7
0602 2 1.3 2 1.4 4 3.9
0604 2 0.0 0 0.0 2 2.0
0605 1 0.6 0 0.0 0 0.0
0201 2 1.3 2 1.4 4 3.9
0301 60 38.5 55 39.3 31 30.4
0302 32 20.5 32 22.9 16 15.7
0303 14 9.0 12 8.6 11 10.8
0401 1 0.6 0 0.0 0 0.0
0402 12 7.7 7 5.0 9 8.8
blank 0 0.0 0 0.0 0 0.0
total 156 100.0 140 100.0 102 100.0
aNumber of chromosomes observed
bGene frequecy obtained by direct gene counting
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Table 4.7 HLA-DRB gene frequencies in two 
Micronesian populations
Nauru
N=67
Kiribati
N=62
Allele n % n %
DRB1
1501 a11 b8.2 4 3.2
1502 32 23.9 14 11.3
0302 3 2.2 0 0.0
0401 5 3.7 0 0.0
0403 15 11.2 25 20.2
0405 1 0.8 0 0.0
1101 9 6.7 2 1.6
1201 1 0.8 1 0.8
1202 38 28.4 47 37.9
1302 2 1.5 0 0.0
1401 7 5.2 2 1.6
1405 1 0.8 2 1.6
1408 0 0.0 13 10.5
0801 2 1.5 0 0.0
0803 7 5.2 14 11.3
blank 0 0.0 0 0.0
total 134 100.0 124 100.0
DRB3
0101 4 3.0 14 11.3
0202 17 12.7 6 4.8
0301 40 29.9 47 37.9
blank
total
73
134 100.0 124 100.0
DRB5
0101 42 31.3 16 12.1
0102 1 0.8 2 1.6
blank
total 134 100.0 124 100.0
a
b Number of chromosomes observedGene frequency obtained by direct gene counting
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Table 4.8 HLA-DQ gene frequencies in two 
Micronesian populations
Nauru Kiribati
N=67 N= 62
Allele n % n %
DQA1
0101 a9 b6.7 19 15.3
0102 44 32.8 16 12 .9
0103 7 5.2 14 11.3
0301 21 15.7 25 20.2
0401 5 3.0 0 0.0
0501 10 8.2 3 2.4
0601 38 28.4 47 37.9
blank 0 0.0 0 0.0
total 134 100.0 124 100.0
DQB1
0501 1 0.8 2 1.6
0502 7 5.2 0 0.0
0503 1 0.8 18 14.5
0601 38 28.4 28 22 . 6
0602 11 8.2 2 1.6
0604 2 1.5 0 0.0
0301 49 36.6 49 39.5
0302 19 14.2 25 20.2
0401 1 0.8 0 0.0
0402 5 3.7 0 0.0
blank 0 0.0 0 0.0
total 134 100.0 124 100.0
a
b Number of chromosomes observedGene frequency obtained by direct gene counting
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Table 4.9 HLA-DR, and DQ gene frequencies in Javanese 
(N=77)
Allele n % Allele n %
DRB1 o. i° DQA10101 f 0101 29 18.8
1501 5 3.3 0102 20 13.0
1502 32 20.8 0103 4 2.6
1602 2 1.3 0201 17 11.0
0301 1 0.7 0301 7 4.6
0404 1 0.7 0501 3 2.0
0405 1 0.7 0601 74 48.1
0406 1 0.7 blank 0 0.0
1101 1 0.7 total 154 100.0
1201 1 0.7
1202 78 50.7 DQB1
1301 1 0.7 0501 26 16.9
1302 1 0.7 0502 13 8.5
1401 1 0.7 0503 1 0.7
07 17 11.0 0601 10 6.5
0803 2 1.3 0602 1 0.7
0901 4 2.6 0603 1 0.7
1001 4 2.6 0605 1 0.7
blank 0 0.0 0201 14 9.1
total 154 100.0 0301 76 49.4
0302 2 1.3
DRB3 0303 8 5.2
0101 1 0.7 0401 1 0.7
0202 7 4.6 blank 0 0.0
0301 76 49.4 total 154 100.0
blank 70 45.3
total 154 100.0
DRB5
0101 19 12.3
0102 20 13.0
blank 115 74.7
total 154 100.0
a Number of chromosomes observed 
Gene frequency obtained by direct gene counting
Table 4.10 HLA-DR,-DQ haplotypes with significant linkage 
disequilibrium in Polynesians, Micronesians and Javanese
Polynesians Micronesians Javanese
N =199 N =129 N =77
H a p l o t y p e h f  % D% X 2 h f  % D% X2 h f  % D% r
DRB1-DQA1
0101-0101 0 .5 0 .5 8 .8
1501-0102 . 2 .3 2 .2 160 .8 5 .6 4. 4 50. 1 3 .3 2 .8 25 .4
1502-0101 13 .7 10 .2 70 .3
1502-0102 2 .0 1. 9 122 .0 16 .9 12 .9 162 .4
1602-0102 1. 3 1. 1 6 .4
0302-0401 1. 2 1. 0 8 .6
0401-0301 1. 3 0 .8 7 .3 2 .0 1. 6 18 .3
0403-0301 17 .9 11. 9 169 .1 16 .0 13 .1 219 .3
0405-0301 4 .1 2 .7 30 .8
1101-0501 12 .3 8 .0 98 .7 4 .0 3 .7 175 .1
1201-0501 20 .7 13 .4 186 .4 0 .8 0 .7 20. 2
1202-0601 0 .8 0 .8 276 .0 31. 2 21. 5 253 .4
1401-0101 4 ., 1 3 .7 133 .8 3 .2 2 .8 67 .2
1405-0101 1. 2 1. 1 18. 8
1408-0101 5 . 4 4 . 8 182 .4 4 .0 3 .6 87 .6
07 -0201 1.,3 1..2 321. 9 11. 7 10 .4 144. 5
0801-0401 0 .8 0 .8 71.. 1
0802-0401 2 ., 8 2 .7 330 .6
0803-0103 8 . 4 7 .7 371.,7 8 ., 1 7 ., 4 244 ., 7 1. 3 1.. 3 41. 9
0901-0301 8 ., 9 5 ., 9 74., 3 2 .6 2 ., 5 64. 7
1001-0101 2 ., 6 2 .2 13 . 9
DRB1-DQB1
0101-0501 0 . 5 0 . 5 223 . 5
1501-0502 2 . 6 2 .3 23 .3
1501-0602 2 . 0 2 ,. 0 273 .3 5 .2 4.. 9 219 ,.5
1502-0501 12 .2 9 ,.2 63 ,.5
1502-0601 2 .3 2 . 1 73 ,. 5 17 .3 12 ,. 5 133 .5 5 ,. 1 3 . 8 18 ,. 8
1602-0502 1,.3 1 .2 11..2
0301-0201 0 . 8 0 .7 101 . 0
0302-0402 1 .2 1 . 1 105 . 6
0403-0302 17 . 6 14 .2 352 .2 16 .0 13 .2 226 . 6
0405-0402 3 . 8 3 . 5 173 . 5
1101-0301 12 .3 7 . 9 95 . 4 4 .0 2 . 5 15 .3
1201-0301 20 .7 13 .2 180 . 1
1202-0301 30 . 6 19 .0 182 . 4 49 . 0 23 .0 126 .5
1302-0604 0 . 8 0 .7 206 . 0 0 . 8 0 . 8 144 .7
1401-0502 3 . 1 2 . 9 269 .1 2 . 8 2 .7 192 . 9
1405-0503 1 .2 1 . 1 32 . 5
1408-0503 5 . 4 5 . 0 254 .8 4 .0 3 .7 149 .7
07 -0201 1 .3 1 .2 198 . 5 8 . 8 7 .7 93 . 4
07 -0303 2 .4 1 .9 8 .0
0801-0402 0 .8 0 . 8 56 .4
0802-0402 2 . 8 2 . 6 132 . 0
0803-0601 7 .3 6 . 4 227 . 1 8 . 1 6 . 0 59 . 4 1 .3 1 .2 15 .3
0901-0303 8 . 9 8 . 1 385 . 8 2 . 6 2 .5 64 .7
1001-0501 2 . 6 2 .2 16 .6
hf: haplotype frequency; D: delta value
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Table 4.11 HLA-DRB gene frequencies in five Chinese 
populations
Hong Kong Singapore Beijing Xian Uygur
2 ii 00 uo N=4 6 N=91 o00ii£ N=92
Allele n % n % n % n % n %
DRBl
0101 a1 b0.6 0 0.0 5 2.8 4 2.5 12 6.5
0102 0 0.0 0 0.0 2 1.1 0 0.0 2 1.1
1501 24 13.5 9 9.8 23 12.6 14 8.8 10 5.4
1502 14 7.9 2 2.2 14 7.7 4 2.5 13 7.1
1601 0 0.0 0 0.0 0 0.0 0 0.0 1 0.5
1602 15 8.4 2 2.2 5 2.8 3 1.9 1 0.5
0301 11 6.2 6 6.5 5 2.8 4 2.5 16 8.7
0401 0 0.0 0 0.0 3 1.6 3 1.9 5 2.7
0402 0 0.0 0 0.0 1 0.6 2 1.3 2 1.1
0403 7 3.9 5 5.4 2 1.1 4 2.5 3 1.6
0404 1 0.6 1 1.1 0 0.0 0 0.0 6 3.3
0405 10 5.6 6 6.5 8 4.4 9 5.6 3 1.6
0406 4 2.3 0 0.0 9 4.9 1 0.6 1 0.5
0408 0 0.0 0 0.0 0 0.0 1 0.6 1 0.5
0410 0 0.0 0 0.0 1 0.6 1 0.6 0 0.0
1101 5 2.8 6 6.5 12 6.6 20 12.5 13 7.1
1104 0 0.0 1 1.1 1 0.6 2 1.3 3 1.6
1201 9 5.1 5 5.4 4 2.2 9 5.6 2 1.1
1202 23 12.9 11 12.0 8 4.4 5 3.1 3 1.6
1301 3 1.7 2 2.2 3 1.7 3 1.9 12 6.5
1302 3 1.7 2 2.2 1 0.6 4 2.5 10 5.4
1303 0 0.0 1 1.1 0 0.0 1 0.6 2 1.1
1401 4 2.3 3 3.3 8 4.4 6 3.8 10 5.4
1402 0 0.0 0 0.0 1 0.6 0 0.0 1 0.5
1403 0 0.0 0 0.0 2 1.1 0 0.0 1 0.5
1404 0 0.0 0 0.0 0 0.0 2 1.3 1 0.5
1405 5 2.8 1 1.1 0 0.0 4 2.5 0 0.0
07 8 4.5 5 5.4 25 13.8 15 9.4 35 19.0
0802 1 0.6 1 1.1 2 1.1 1 0.6 6 3.3
0803 4 2.3 5 5.4 6 3.3 13 8.1 3 1.6
0901 25 14.0 17 18.4 27 14.8 23 14.4 6 3.3
1001 1 5.6 1 1.1 4 2.2 2 1.3 0 0.0
blank 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
total 178 100.0 92 100.0 182 100.0 160 100.0 184 100.0
DRB3
0101 12 6.7 4 4.4 6 3.3 11 6.9 21 11.4
0202 25 14.0 21 22.8 30 16.5 41 25.6 41 22.3
0301 26 14.6 13 14.1 9 5.0 8 5.0 12 6.5
blank 115 64.7 54 58.7 137 75.2 100 62.5 110 59.8
total 178 100.0 92 100.0 182 100.0 160 100.0 184 100.0
DRB5
0101 42 23 . 6 12 13.0 23 12.6 14 0000 10 5.4
0102 9 5.1 1 1.1 14 7.7 4 2.5 13 7.1
02 0 0.0 0 0.0 4 2.2 3 1.9 1 0.5
0203 2 1.1 0 0.0 0 0.0 0 0.0 0 0.0
blank 125 70.2 79 85.9 141 77.5 139 86.8 160 87.0
total 178 100.0 92 100.0 182 100.0 160 100.0 184 100.0
a Number of chromosomes observed 
Gene frequency obtained by direct gene counting
Table 4.12 HLA-DQ gene frequencies in five Chinese 
populations
Hong
N
Kong 
= 89
Singapore 
N= 4 6
Beijing
N=91
Xian
N=80
Uygur
N=92
Allele n % n % n % n % n %
DQAl
0101 a19 b10.7 7 7.6 22 12.1 19 11.9 25 14.0
0102 48 27.0 14 15.2 28 15.4 21 13 .1 22 12.0
0103 8 4.5 8 8.7 21 11.5 19 11.9 28 15.2
0201 8 4.5 5 5.4 25 13.7 15 9.4 35 19.0
0301 47 26.4 30 32.6 51 28.0 44 27.5 27 14.7
0401 2 1.1 1 1.1 2 1.1 1 0.6 6 3.3
0501 25 14.0 16 17.4 25 13.7 37 23 .1 38 20.7
0601 21 11.8 11 12.0 8 4.4 4 2.5 3 1.6
blank 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
total 178 100.0 92 100.0 182 100.0 160 100.0 184 100.0
DQB1
0501 7 3.9 3 3.3 14 7.7 6 3.8 14 7.6
0502 24 13.5 4 4.4 4 2.2 5 3.1 7 3.8
0503 6 3.4 3 3.3 8 4.4 10 6.3 7 3.8
0601 22 12.4 8 8.7 18 9.9 18 11.3 16 8.7
0602 9 5.1 7 7.6 22 12.1 13 8.1 9 5.0
0603 4 2.3 2 2.2 3 1.7 3 1.9 12 6.5
0604 1 0.6 0 0.0 0 0.0 2 1.3 7 3.8
0605 2 1.1 2 2.2 1 0.6 2 1.3 3 1.6
0201 19 10.7 8 8.7 26 14.3 16 10.0 50 27.2
0301 36 20.2 23 25.0 29 15.9 41 25.6 29 15.8
0302 13 7.3 6 6.5 14 7.7 7 4.4 14 7.6
0303 25 14.0 19 20.7 31 17.0 25 15.6 7 3.8
0401 9 0.6 6 6.5 7 3.9 9 5.6 3 1.6
0402 1 0.6 1 1.1 4 2.2 2 1.3 6 3.3
blank 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
total 178 100.0 92 100 . 182 100.0 160 100.0 184 100.0
d Number of chromosomes observed
bGene frequency obtained by direct gene counting
143
Table 4.13 HLA-DR,-DQ haplotypes with significant linkage 
disequilibrium in Chinese
southern Chinese northern Chinese Uygur
N =13 5 N =171 N =92
Haplotype hf% D% X2 hf% D% X2 hf% D% X
DRB1-DQA1
0101-0101 2.7 2.4 65.8 6.7 5.8 74.2
1501-0102 11.8 9.1 119.3 10.1 8.5 196.8 5 .0 4 .4 61.9
1502-0101 3 . 6 3 .0 48.9
1502-0103 4.1 3 .4 66.8 7.3 6.2 70.2
1602-0102 5.7 4 .4 51.7 2.4 2.0 40.9
0301-0501 6.1 5.1 82.3 2.7 2.2 38.1 9.1 7.2 63.3
0403-0301 4.5 3.3 29.5 1.8 1.3 12.5 1.6 1.4 12.3
0404-0301 3 . 3 2.9 31.7
0405-0301 6.1 4.4 41.5 5.1 3.7 43.9 1.6 1.4 12.3
0406-0301 1.5 1.1 7.2 3.0 2.1 23 . 5
1101-0501 3.7 3.1 44.2 9.2 7.6 155.5 7.3 5.8 48.9
1201-0501 4.9 4.1 62.8 3.6 2.9 53.4
1202-0601 11.8 10.3 240.7 3 . 6 3.4 288.0 1.6 1.6 127.4
1301-0103 1.9 1.8 73.3 1.8 1.6 36.6 6.7 5.7 63 . 6
1302-0102 1 .9 1.4 13.4 1.5 1.3 22.9 5.6 4.9 70.3
1401-0101 2.6 2.4 57.4 4.2 3.7 109.8 5.0 4.3 52.3
1405-0101 2.2 2.0 47.5 1.2 1.0 24.0
07 -0201 4.9 4.7 249.1 11.8 10.4 332.5 19.2 15.5 177.6
0802-0401 0.7 0.7 100.2 0.9 0.9 237.1 2.2 2.1 111.2
0803-0103 3 . 0 2.8 130.1 5.7 5.0 141.5 1.6 1.4 10.5
0901-0301 15.2 11.0 120.7 14.5 10.5 146.1 3.3 2 . 9 31.7
DRB1-DQB1
0101-0501 2.7 2.5 165.3 6.7 6.2 141.5
1501-0601 5.3 4.0 43.3
1501-0602 5.7 5 .0 103.4 10.2 9 .1 308.8 4 .4 4.2 141.9
1502-0501 2.6 2.4 60.9
1502-0502 1.9 1.3 9.3
1502-0601 1.9 1.2 4.7 4.4 3 . 8 90.8 7.3‘ 6.7 144.1
1602-0502 5.7 5.2 141.2 2.1 2.0 196.6
0301-0201 6.1 5.4 128.1 2.7 2.3 57.8 9.1 6 . 4 40.9
0403-0302 4.5 4.2 149.2 1.8 1.7 84.6 1.6 1.5 24.1
0404-0302 3.3 3 .1 60.9
0405-0401 5.7 5.4 234.5 4.8 4.5 300.1 1.6 1.6 127.4
0406-0302 1.5 1.4 39.0 3.0 2.8 154.9
1101-0301 3.7 2 .8 26.2 9.2 7.3 128.8 7.3 6 .1 66.8
1201-0301 5.3 4.2 49.0 3.2 2.5 32.9 1.1 0.9 5.0
1202-0301 12.2 9.4 120.2 3 . 9 3.1 48.4 1.6 1.4 9.9
1301-0603 1.8 1.7 286.9 6.7 6.3 168.5
1302-0604 0.6 0.6 75.3 3 . 9 3.7 107.5
1302-0605 1.5 1.5 163 . 9 0.9 0.9 140.6 1.6 1.6 35.3
1401-0502 1.4 1.1 10.8 2.7 2.5 53.0
1401-0503 1.1 1.0 21.0 3.6 3.3 169.6 2.2 2.0 35.9
1405-0503 2.2 2.2 148.0 1.2 1.1 53.7
07 -0201 4.5 4.0 88.7 9.4 8.0 190.8 19.2 13.6 101.7
0802-0402 0.7 0.7 151.5 0.9 0.9 116.5 2.2 2.1 111.2
0803-0601 3.0 2.7 58.9 5.7 5.1 156.0 1.6 1.5 22.2
0901-0303 15.2 12.8 245.4 14.2 11.9 282.9 3.3 3.2 130.8
hf: haplotype frequency; D : delta value
Table 4.14 HLA-DPBl gene frequencies in a northern 
Chinese population (N=88)
Allele n % Allele n %
DPB1 DPB1
0101 1 0.6 0601 1 0.6
0201 32 18.2 0901 1 0.6
0202 5 2.8 1301 9 5.1
0301 13 7.4 1401 4 2.3
0401 21 11.9 1701 11 6.3
0402 19 10.8 blank 0 0.0
0501 59 33.5 total 176 100.0
a Number of chromosomes observed
bGene frequency obtained by direct gene counting
Table 4.15 HLA-DRB1,-DPBl 
linkage disequilibrium in 
population (N=88)
haplotypes with significant 
a northern Chinese
Haplotype hf % D% x2
DRB1-DPB1
0101-0401 2.2 1.9 14.1
07 -1701 5.1 4.3 42.7
hf: haplotype frequency; D: delta value
CHAPTER 5
HLA CLASS IIHAPLOTYPES 
IN POPULATIONS OF 
AUSTRALIA , ASIA AND OCEANIA
145
5.1 Introduction
Alleles at polymorphic HLA loci are inherited in the form 
of haplotypes, a term introduced by Cepellini et al (1967) .
New haplotypes could be generated by mutation of any related 
locus or by inter-locus recombination. Theoretically, given 
enough time, any observed haplotype frequency in a population 
should be close to that expected from relevant allele 
frequencies due to recombination (Bodmer & Cavalli-Sforza 
1976). The maintenance of certain HLA haplotypes in 
populations will result in linkage disequilibrium which is one 
of the most prominent features of the HLA system. Linkage 
disequilibrium in the HLA system was first observed between 
class I loci of HLA-A, -B and -C. Selection was proposed to be 
the main reason for maintaining certain HLA haplotypes (Bodmer 
1972). When HLA class II loci were established, it was found 
that the class II region has much stronger linkage 
disequilibrium than the class I region (Albert et al 1984). In 
the class I region, linkage disequilibrium is usually confined 
to a few haplotypes in a given ethnic group, while the 
majority of haplotypes do not show such evidence (Bodmer & 
Cavalli-Sforza 1976) . In contrast, almost all DR and DQ 
alleles have significant linkage disequilibrium with one or 
more alleles of other loci in the HLA-DR, -DQ region, and many 
of these linkage relationships are exclusive (relative delta 
values close to 1). Some HLA-DR, or -DQ haplotypes are 
apparently frozen in all human groups (Klein et al 1991b). The 
highly conservative linkage relationship in the HLA class II 
region is not readily reconciled by synergism since no 
evidence indicates that the co-expression of certain types of 
class II MHC molecules on the cell surface will significantly 
lower the fitness of an individual, which is needed to 
maintain the strong linkage disequilibrium in the population 
and the putative selection pressure on HLA haplotypes does not 
eliminate those potentially deleterious phenotypic
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associations, which could be maintained by the 'hitch-hiking' 
phenomenon (Thomson 1981) . An alternative explanation is that 
some structural barriers in the HLA class II chromosomal 
region have suppressed inter-locus recombination, either 
because different lengths (Tokunaga et al 1988, 1989; Dunham 
et al 1989; Niven et al 1990; Kendall et al 1991) and gene 
organizations (Rollini et al 1985; Andersson et al 1987; Kawai 
et al 1989) of the haplotypes in the different groups will 
cause improper alignment of homologous chromosomes at meiosis, 
which may hinder genetic exchange between homologous 
chromosomes (Klein et al 1992), or due to the lack of some 
specialized recombination signals which promote inter-locus 
crossing-over (Jarman & Wells 1989) . According to their 
genomic organization, HLA class II haplotypes can be divided 
into three evolutionally related families or groups: the DRl/2 
family (including DR1, DR2, and DR10), the DR52 family 
(including DR3, DR5, DR6, and DR8), and the DR53 family 
(including DR4, DR7, and DR9). The DR8 group has a unique 
haplotype organization but on the basis of RFLP analyses and 
nucleotide sequence phylogeny of exon 2 and exon 3, DR8 has 
been considered a derivative from an ancestral DR52-related 
haplotype by deletion and fusion (Gorski 1989a). Extensive 
studies have failed to find any evidence of inter-group 
genetic exchange in the DR subregion of these haplotype 
families. The so-called 'frozen' DR haplotypes are believed 
the result of suppression of recombination events due to 
different chromosomal structures (Klein et al 1991b). In the 
DQ subregion, however, inter-group genetic exchange is 
evident, since the same DQA1 or DQB1 alleles can be found on 
haplotypes of different families. The analysis of the DR, DQ 
haplotype combinations has indicated that the DR, DQ linkage 
relationships in different haplotype families follow certain 
patterns and the putative recombination sites are haplotype 
dependent (Gregersen et al 1988). The recombinational events
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involving the DR53 and DR52 haplotype families may be 
localized to the region between DQAl and DQB1; the 
recombinational events involving the DRI/2 and DR52 families 
may take place between DRBl and DQAl; while the genetic 
exchange between the DR53 and DRI/2 families is prevented by 
different molecular organization of these haplotypes.
Further knowledge on HLA-DR,-DQ haplotypes has come from 
the analyses of ethnic groups, since many HLA class II 
haplotypes have ethnic group-specific distributions. The same 
DRBl allele can be associated with different DQ alleles in 
different populations, which may reflect different 
evolutionary histories of the DRBl genes and their related 
haplotypes. For example, HLA-DRB1*0405 (Dwl5) was originally 
considered an Oriental allele and is unanimously associated 
with DQ4 in Oriental populations (Gregersen et al 1986).
Later, it was found in Caucasoids (Gao et al 1990a, Lanchbury 
et al 1990) but with a different DQ association (DQB1*0302).
In populations from Israel (Gao et al 1991a), DRB1*0405 has 
also been detected with a DQ2 association. Differentiated HLA- 
DR, -DQ linkage relationships in ethnic groups are 
particularly useful for the clarification of the functional 
significance of different class II loci, for the 
identification of predisposing factors in HLA-associated 
diseases, and for the reconstruction of population phylogeny. 
In recent years, serologically detected DR and DQ alleles have 
been further split into DNA-defined subtypes, which has made 
it possible to examine more closely the HLA-DR, -DQ 
haplotypes.
Heterogeneity in HLA-DR, -DQ haplotypes in populations of 
Australia, Asia and Oceania have been observed in previous 
studies using serological and RFLP techniques (Serjeantson 
1989b) with unusual DR, DQ combinations in DR2, DR5, DR6 and 
DR8-related family groups found in particular populations. In 
Chapter 3 and Chapter 4 of this thesis, some of these unusual
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haplotypes are found to represent further splits of DRB1 
alleles such as DRB1*1201 and 1202 formally designated by RFLP 
as DRB5*NAURU which was associated with different DQ alleles 
in Micronesians, Polynesians and southern Chinese (Kohonen- 
Corish & Serjeantson 1986; Serjeantson et al 1987). Other 
haplotypes simply reflect inter-locus recombination, such as 
the multiple DQ associations of DR2-related DRB1 alleles. Two- 
locus linkage disequilibrium analysis performed in previous 
chapters revealed the highly characteristic distribution of 
DR, DQ haplotypes in the study populations. The analysis of 
the linkage relationship of the entire HLA-DR, -DQ region will 
provide further information for population phylogeny.
This chapter examines three- or four-locus HLA-DR, -DQ 
haplotypes in the study populations, which are potentially 
more informative in population studies than allele 
frequencies. Linkage relationships of DR allele groups 
including DR2, DR4, DR5, DR6 and DR8-related haplotypes, are 
intensively analyzed. The relative distribution of these 
haplotypes in ethnic groups of Australia, Asia and Oceania 
contains information not expected from allele frequencies.
This information provides further insight into the 
evolutionary history of HLA class II alleles and haplotypes. 
Finally, population affinity is estimated by the construction 
of phylogenetic trees based on DR, DQ haplotype frequencies.
5.2 Results
HLA-DR, -DQ haplotypes were assigned to all 1,319 random 
subjects from 19 study populations examined in the work of 
Chapter 3 and Chapter 4. A total of 2,638 haplotypes were 
available for analysis. In addition, 48 family members related 
to 80 donors in the northern Chinese population from Xian and 
the Uygur series were examined using the same typing procedure 
in order to analyze haplotype segregation but were not 
included in the further analysis. The assignment of haplotypes
149
was facilitated by the occurrence of 197 donors homozygous in 
all examined DR and DQ loci. In 31 donors, there was only one 
heterozygous locus while other loci were homozygous. In the 
remaining donors with more than one heterozygous locus, the 
assignment of haplotypes was equivocal in the absence of 
family material. Then the most likely allelic combinations 
were assigned, based on the most common haplotypes in the 
relevant populations revealed by linkage disequilibrium 
analyses performed in Chapter 3 and Chapter 4. In individuals 
heterozygous for major DR allele families, DRB3 alleles were 
assigned to DR3, DR5, and DR6-related haplotypes and DRB5 
alleles were assigned to DR2-related haplotypes. Three loci 
(DRB1, DQAl and DQBl) were assigned to DR1, DR4, DR7, DR8, DR9 
and DRlO-related haplotypes, and four loci (DRBl, DRB3/DRB5, 
DQAl and DQBl) were assigned to DR2, DR3, DR5 and DR6-related 
haplotypes. For those donors showing rare haplotypes (detected 
number < 5), SSO hybridizations were repeated to minimize the 
chance of typing error.
Altogether, 80 different DR, DQ allele combinations were 
established in the study populations. In the following 
sections, the relative distributions of HLA-DR, -DQ haplotypes 
of major DRBl allele groups are analyzed separately. In these 
analyses, the 19 study populations are pooled into nine major 
population groups. A Caucasoid population from a previous 
publication (Fernandez-Vina et al 1991b) is used for 
comparison.
5.2.1 Relative distribution of HLA-DR, -DQ haplotypes
5.2.1.1 DR2-related DR, DQ haplotypes
In the work of Chapter 3 and Chapter 4, HLA-DR2 was 
detected in 445 donors. With 70 DR2 homozygous individuals,
515 DR2-related haplotypes were available for analysis. In the 
present chapter, 16 DR2-related DR, DQ haplotypes were deduced 
and designated by numbers 1-16 in Table 5.1. The relative
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distribution of these haplotypes is given in Table 5.1.
DRB1*1501 was detected in all study populations and was 
invariably associated with DRB5*0101, but different DQ 
associations resulted in five DRBl*1501-associated DR, DQ 
haplotypes. Haplotype 3 (DRB1*1501-DRB5*0101-DQA1*0102-
DQB1*0602) was the only DR2-related haplotype represented in 
all study populations and the Caucasoid population, although 
in Javanese only one donor was found to have this haplotype.
In southern Chinese, a DQBl*0601-associated DRB1*1501 
haplotype (haplotype 2) was found in equal proportion to the 
DQB1*0602-associated one, but in other populations, it only 
occurred sporadically or was absent. Other DRBl*1501-related 
haplotypes were associated with DQA1*0103 (haplotype 4), 
DQB1*0502 (haplotype 1), or DQB1*0603 (haplotype 5), and were 
rarely seen.
Most heterogeneity was observed in DRB1*1502-related 
haplotypes. None of the seven such haplotypes was observed in 
all populations. DRB1*1502 was overwhelmingly associated with 
DRB5*0101 in Aborigines, Melanesians, Polynesians, and 
Micronesians, with both DRB5*0101 and 0102 in Javanese and 
southern Chinese. In northern Chinese and the Uygur 
population, DRB1*1502 was associated with DRB5*0102 only, 
which is also the case in Caucasoids. In these populations, 
haplotype 12 (DRB1*1502-DRB5*0102-DQA1*0103-DQB1*0601) was the
dominant (in northern Chinese) or the only (in Uygur and 
Caucasoids) DRB1*1502-related haplotype. In southern Chinese, 
however, six out of seven DRB1*1502 haplotypes were 
represented but all in relatively low percentages. In 
Javanese, DRB1*1502 was mainly associated with DQA1*0101 and 
DQB1*0501 (haplotype 10), a DQ combination otherwise confined 
to the DRl or DR10-positive individuals; this is of interest 
given the very low frequency of DRl and DR10 haplotypes (3%) 
in contemporary Javanese. In populations of Australia and 
Oceania, DRB1*1502 was overwhelmingly associated with
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DRB5*0101-DQA1*0102-DQB1*0601 (haplotype 8), a DRB5, DQ 
combination commonly seen on a DRB1*1501 haplotype (haplotype 
2) in southern Chinese.
All DRl6-positive individuals shared the same DQ 
association, DQA1*0102-DQB1*0502 but three DRB5-associations 
were observed. Except for southern Chinese, Javanese, and one 
Melanesian subject, DR16 was associated with DRB5*02 
(haplotype 15). In southern Chinese and Javanese, DRB1*1602 
was associated with DRB5*0101 (haplotype 14) and in two 
southern Chinese individuals it was associated with the new 
DRB5 allele, DRB5*0203 (haplotype 16).
In Caucasoids, only three kinds of DR2-related haplotypes 
were observed (haplotypes 3, 12 and 13). On these haplotypes 
three DR2 subtypes (DRB1*1501, 1502 and 1601) were each 
associated with a different DRB5 allele and a DQB1 allele. 
Northern Chinese and the Uygur population showed the same DR2- 
related DR, DQ combinations as in Caucasoids (in northern 
Chinese, DRB1*1602 was the only DR16 type) and the three kinds 
of DR2 haplotypes found in Caucasoids had combined relative 
frequencies of 91% (northern Chinese) and 96% (Uygur). In 
other study populations, a substantial proportion of DR2- 
related haplotypes did not overlap with northern Chinese,
Uygur and Caucasoids; the three classical DR2-related 
haplotypes had combined relative frequencies ranging from 21% 
to 72% (2.6% in Javanese). Southern Chinese showed the highest 
heterogeneity in DR2-related haplotypes with 12 of the 16 
haplotypes detected.
5.2.1.2 DR4-related DR, DQ haplotypes
In the oligonucleotide hybridizations described in Chapter 
3 and Chapter 4, ten DR4 subtypes including nine of the 11 
officially recognized alleles and the newly-designated 
DRB1*0412 were detected. Altogether, there were 372 DR4- 
positive donors (37 of them were DR4 homozygous) and 409 DR4-
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related DR, DQ haplotypes available for analysis. In this 
Chapter, 12 DR4-associated DR, DQ combinations were 
established, as designated by numbers 1-12 in Table 5.2. The 
relative distribution of DR4 haplotypes is given in Table 5.2.
All DR4 subtypes were invariably associated with 
DQA1*0301; among 406 haplotypes tested, there were no 
exceptions. At the DQB1 locus, however, the associated allele 
could be DQB1*0301, 0302, 0401, or 0402. Two DR4 subtypes, 
DRB1*0401 and 0405, were found to be associated with more than 
one DQB1 allele. As in the case of Caucasoids and Japanese 
(Todd et al 1990), DRB1*0401 could be associated with either 
DQB1*0301 (haplotype 1) or 0302 (haplotype 2). The ratio of 
DQB1*0301:0302 among DRB1*0401 types in Oceanic populations of 
Melanesia, Polynesia and Micronesia is 6:8, which is similar 
to that previously reported in Caucasoids (Sheehy et al 1989; 
Gao et al 1990a) , although in the Caucasoid controls used in 
Table 5.2, a higher proportion of DQB1*0301 can be seen. The 
dual DQ association and the low frequency of DRB1*0401 in 
these populations suggest recent Caucasoid admixture.
DRB1*0405 was associated with both DQB1*04 alleles but the 
distribution of the two haplotypes varied in populations. In 
Chinese and PNG highlanders, almost all DRB1*0405 alleles 
detected were associated with DQB1*0401 (haplotype 6) except 
that one northern Chinese donor had a DQB1*0402-associated 
haplotype. In contrast, DRB1*0405 was more usually found in 
association with DQB1*0402 (haplotype 7) in Australian 
Aborigines, coastal Melanesians, and Polynesians. Other DR4 
subtypes were all associated with a specific DQB1 allele, 
including the DQBl*0301-associated DRB1*0408 (haplotype 9), a 
DRB1*0404 variant formally known as Dwl4.2, the DQB1*0302- 
associated DRB1*0402, 0404, 0406, and 0411 (haplotypes 3, 8 
and 11), and the DQBl*0402-associated DRB1*0412 (haplotype 
12) .
Whereas DRB1*0403, invariably associated with DQB1*0302,
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was the dominant DR4 haplotype (haplotype 4) in Oceanic 
populations, DRB1*0407, a variant of DRB1*0403 formally known 
as Dwl3.2 (Gao et al 1990a; Lanchbury et al 1990), was not 
detected in this study. Three examples of DRB1*0408 were all 
associated with DQB1*0301 (haplotype 9). DRB1*0405 has 
previously been found associated with DQB1*0302 in Caucasoids 
(Gao et al 1990a; Lanchbury et al 1990) and with DQB1*02 in 
Israeli Jews (Gao et al 1991a), but these linkage 
relationships were not observed in the present study. The 
DRB1*0410-DQB1*0402 haplotype (haplotype 10) was confined to 
Australia, PNG highlands, and Melanesia. Given the dominant 
linkage relationship between DRB1*0405 and DQB1*0402 in these 
populations (except for PNG highlanders), DRB1*0405 and its 
variant DRB1*0410 apparently have closely related evolutionary 
histories. The newly-defined Aboriginal allele DRB1*0412 was 
also invariably associated with DQB1*0402 (haplotype 12), 
which is compatible with the assumption that this allele was 
generated in Australian Aborigines in a segmental transfer 
event with a DR4 haplotype as the recipient as proposed in 
Chapter 3. In fact, except for DRB1*0411, all the Aboriginal 
DR4 types were associated with DQ4. In Javanese, only three 
individuals were detected as DR4-positive and each.had a 
different DR4 haplotype, suggesting a recent foreign origin.
5.2.1.3 DR5-related DR, DQ haplotypes
HLA-DR5 was the most frequently detected DR allele in this 
study. In Chapter 3 and Chapter 4, 555 donors were detected as 
DR5-positive; with 124 DR5-homozygotes, 679 DR5 haplotypes 
were available for analysis. Table 5.3 gives the relative 
distribution of the 11 DR5-related four-locus DR, DQ 
combinations observed in the study populations, designated 
numbers 1-11, including four DRll-related and seven DR12- 
related haplotypes.
Three DR11 subtypes, DRB1*1101, 1102 and 1104 were
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associated with the same DQ combination, DQA1*0501-DQB1*0301. 
Two DRBl*1101-associated haplotypes (haplotypes 1 and 2) were 
mismatched only at the DRB3 locus (DRB3*0101 vs 0202). The 
DRB3*0202-associated haplotype (haplotype 2) was the dominant 
DR11 haplotype and was detected in all populations except for 
Australian Aborigines. The other three DR11 haplotypes only 
occurred sporadically.
DRB1*1201 showed a similar DRB, DQ linkage pattern as 
DRB1*1101. Except for two Australian samples with a DQ 
arrangement of DQA1*0501-DQB1*0402 (haplotype 6), all 
DRB1*1201 haplotypes were associated with DQA1*0501-DQB1*0301. 
The dominant DRB3 association of DRB1*1201 was DRB3*0101 
(haplotype 5) but the other three DRB3 allele, DRB1*0201,
0202, and 0301 were also found on DRB1*1201 haplotypes 
(haplotype 6, 7 and 8). The DRB3*0201 and DQBl*0402-associated 
DRB1*1201 haplotype (haplotype 6) existed in Australian 
Aborigines only.
DRB1*1202 was frequently detected in Chinese, Javanese and 
Micronesians. It was overwhelmingly associated with a unique 
DR, DQ combination, DRB1*1202.-DRB3*0301-DQA1*0601-DQB1*0301 
(haplotype 11). In this study, DQA1*0601 was found in 
DRBl*1202-positive individuals only. There were five examples 
of DRB1*1202 associated with DQA1*0102-DQB1*0502 (haplotype 
10), a DQ combination otherwise found on DR2-related 
haplotypes. Another DRB1*1202 haplotype had an alternative 
DRB3 allele, DRB3*0202 (haplotype 9) and was detected in six 
individuals. The restricted distribution and the unique DR, DQ 
arrangement of DRB1*1202 indicate a more recent origin of this 
haplotype than of other DR5-related haplotypes.
In general, DR5-related haplotypes had a highly conserved 
DQ association. Out of 463 DRB1*11- or 1201-associated 
haplotypes, only two Aboriginal samples had an alternative 
DQBl allele; in 216 DRB1*1202-associated haplotypes, only five 
had a different DQA1-DQB1 combination. In the 11 DR5-related
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DR, DQ combinations only two (haplotypes 6 and 10) were 
generated by different DQ associations. In contrast, the 
association between DRB1 and DRB3 loci seemed less stringent, 
with five haplotypes (haplotypes 1, 6, 7, 8, and 9) generated 
by alternative DRB3 alleles.
5.2.1.4 DR6-related DR, DQ haplotypes
HLA-DR6 was the most complex allele group. Twelve DR6 
subtypes including the three newly-defined alleles were 
detected in 337 donors (30 were DR6 homozygous) with 367 DR6- 
related haplotypes available for analysis. Twenty-four 
different combinations of DRB1, DRB3, DQA1, and DQBl alleles 
are identified in Table 5.4 as numbers 1-24. The relative 
distribution of these haplotypes in the study population 
groups are given in Table 5.4.
In Australian Aborigines and Pacific islanders, the DR6 
group was dominated by DR14-related haplotypes. In contrast, 
DR13-related haplotypes were frequently detected in northern 
and southern Chinese and outnumbered DRl4-related haplotypes 
both in the Uygur group and Caucasoid controls. None of the 
haplotypes was universally represented in all study 
populations. Haplotype 10 (DRB1*1401-DRB3*0202-DQA1*0101- 
DQB1*0503) was observed in all populations other than 
Aborigines. In Aborigines, DRB1*1401, the only DR6-related 
DRBl allele represented in all populations, was associated, 
unusually, with DRB3*0201 rather than DRB3*0202. Six 
haplotypes (numbers 8, 11, 12, 13, 23 and 24) were essentially 
confined to Aborigines, where they accounted for more than 
half of the DR6-related haplotypes. Haplotype 22 (DRB1*1408-
DRB3*0202-DQA1*0101-DQB1*0503) was seen exclusively (with one 
exception) in Aborigines and PNG highlanders with relative 
frequencies of 29% and 77% respectively. In all other Pacific 
populations, DRB1*1408 was associated with DRB3*0101 and this 
haplotype was absent both in PNG highlanders and in Australian
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Aborigines. In Aborigines, DQB1*0402, usually seen only on DR8 
haplotypes in other ethnic groups (Fernandez-Vina et al 
1991b), was found associated with three DR14-related alleles 
(DRB1*1402, 1409 and 1410) as well as with some DR4 alleles as 
describe in Section 5.2.2.2 of this chapter. The new DR52- 
related Aboriginal allele DRB1*1410, which had a first HVR 
identical to DR4, had HLA-DQ alleles typically associated with 
HLA-DR4 alleles in this population, generating the novel 
haplotype DRB1*1410-DRB3*0101-DQA1*0301-DQB1*0402. DQB1*0502, 
commonly associated with DR2 alleles was also associated with 
DRB1*1401. The number of DR6-related haplotypes varied in 
different populations. In northern Chinese, 12 of the 24 
haplotypes were represented, while in PNG highlanders only 
three DR6-related haplotypes were observed. In Javanese, three 
different DR6 subtypes were detected in three DR6-positive 
samples, indicating more recent foreign admixture.
DR14 alleles can be classified on the basis of nucleotide 
sequence homology of exon 2 as DRBl*1401-related alleles 
(DRB1*1401, 1404, 1405, 1407 and 1408) and DRB1*1402-related 
alleles (DRB1*1402, 1403 and 1409). Their DQ association was 
compatible with this classification. Except for one example, 
all the DRBl*1401-related DRB1 alleles were associated with 
DQA1*0101. At the DQB1 locus, the DRBl*1401-related alleles 
were associated with DQB1*0502 (DRB1*1401), or more commonly, 
with DQB1*0503. DRB1*1402-related alleles were invariably 
associated with DQA1*0101 at the DQA1 locus, but at the DQB1 
locus, two alleles, DQB1*0301 and 0402, were observed. Of 306 
DR14-related haplotypes examined in this study, only one 
example (haplotype 11) showed an alternative DQ arrangement.
In the DR13-related alleles, DRB1*1301 had a single DQ 
association, DQA1*0103-DQB1*0603. DRB1*1302 was associated 
with two DQB1 alleles, DQB1*0604 and 0605, but all had the 
same DQA1 association, DQA1*0102. DRB1*1303 was invariably 
associated with DQA1*0501 and DQB1*0301. These DR, DQ
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arrangements were the same as that found in Caucasoid 
controls. Together with the frequency distribution of the 
DR13-related haplotypes, the direction of gene flow of the 
DRl3-related alleles could apparently be traced to a Caucasoid 
origin.
At the DRB3 locus, all four alleles were found on DR6- 
related haplotypes, though DRB3*0201 were detected only in 
Australian Aborigines (haplotype 8) and DRB3*0301 was 
associated only with DRB1*1303 (haplotype 3 and 4). At the 
DRB3 locus on DR14-related haplotypes, the main alleles were 
usually DRB3 *0101 or DRB3*0202.
5.2.1.5 DR8-related DR, DQ haplotypes
HLA-DR8 was widely detected in the study populations as 
reported in Chapter 3 and Chapter 4. From 248 DR8-positive 
individuals (37 were DR8 homozygous), 285 DR8-related DR, DQ 
haplotypes were deduced. The relative distribution of DR8- 
associated DRB1, DQA1, and DQB1 combinations, is given in 
Table 5.5 where five different DR, DQ arrangements have been 
designated numbers 1-5.
Haplotype 4 (DRB1*0803-DQA1*0103-DQB1*0601) was 
represented in all study populations and was the dominant DR8- 
related haplotype in these groups. This haplotype is absent 
from Caucasoids where the DQ4-associated DRB1*0801 haplotype 
(haplotype 1) is the dominant DR8-related haplotype. The 
DRBl*0802-related haplotype (haplotype 2) sharing the same DQ 
association with DRB1*0801 was found in Polynesians and the 
three Chinese groups. Haplotype 3 had the same DQA1 
association as haplotype 4 but had a DQB1*0503 allele at the 
DQB1 locus instead of DQB1*0601. Haplotype 3 was detected in 
all Australian and Oceanic populations other than 
Micronesians. In Asian populations, the DQB1*0503-associated 
DR8 haplotype was not observed. Haplotype 5 (DRB1*0803- 
DQA1*0501-DQB1*0301) had a unique DQ association but it was
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seen in only one sample from Australia.
5.2.1.6 DRl, 3, 7, 9, 10-related DR, DQ haplotypes
Apart from major HLA-DR allele groups described in the 
above sections, DR, DQ haplotypes of other DR types were also 
analyzed. These DR groups included DRl, DR3, DR7, DR9, and 
DR10. Altogether, 383 haplotypes with these DR types were 
detected. A total of 12 DR, DQ allele combinations were 
established from these haplotypes, designated numbers 1-12 in 
Table 5.6. The distributions of these haplotypes are tabulated 
together in Table 5.6 where haplotype frequencies in relevant 
populations instead of relative percentages.
HLA-DR1 is one of the major DR types in Caucasoids. In 
this study, DRl was mainly detected in the Uygur series from 
northwestern China and in northern Chinese populations. In 
Australia and Oceania, DRl only sporadically occurred and was 
considered the result of recent Caucasoid admixture as 
described in previous Chapters of this thesis. Four kinds of 
DRl-related haplotypes were detected in the study populations. 
Three of them (haplotype 1-3) had the same DQ association, 
DQA1*0101-DQB1*0501, but had different DRl-related DRB1 
alleles. The fourth haplotype had a DRB1*0103 allele 
associated with DQA1*0501 and DQB1*0301.
HLA-DR3 has the similar high frequency as DRl in 
Caucasoids and was also commonly seen in all three Chinese 
groups in this study. In Australian Aborigines, DR3 was 
detected in Cape York where extensive foreign admixture has 
been recorded (see Chapter 3). In other study populations DR3 
was rarely detected or absent. Of the four DR3-related DR, DQ 
combinations (haplotypes 5-8), the DQ4-related DRB1*0302 
haplotype (haplotype 8) found in Micronesians had a known 
African origin as described in Chapter 4; the DQl-associated 
DRB1*0301 haplotype (haplotype 7) was found in only one 
example; haplotypes 5 and 6 were both DRB1*0301-associated and
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linked with the same DQ combination DQA1*0502-DQB1*0201 but 
had different DRB3 associations. In Caucasoids, DRB1*0301 is 
typically linked with DRB3*0101 (haplotype 5), while in 
Chinese, the DRB3*0202-associated haplotype (haplotype 6) 
dominated the DR3 group. In Australia and Oceania, except for 
one example of the Chinese DR3 haplotype (haplotype 6), all 
DRBl*0301-positive individuals were found to be the Caucasoid 
type (haplotype 5), which further indicated the origin of DR3 
in these populations.
HLA-DR7 was mainly confined to Asian populations (Chinese 
and Javanese) in this study. In Australia (Cape York 
Peninsula), coastal Melanesia and Polynesia, DR7 was also 
observed at low frequencies. Two DR7-associated haplotypes 
(haplotypes 9-10) shared the same DQAl allele (DQA1*0201) but 
had different DQBl associations (DQB1*0201 or 0303). In all 
these populations including Caucasoids, the DQB1*0201- 
associated DR7 haplotype was the major DR7 haplotype.
HLA-DR9 was mainly detected in southern (16%) and northern 
(15%) Chinese. In Polynesia, it was also observed with an 
appreciable frequency (9.3%) . The presence of DR9 (as well as 
DR7) in Polynesians has been considered to reflect the Asian 
origin of the Polynesian people rather than recent admixture 
(Serjeantson 1989b). All DR9-positive samples detected in this 
study had the same DR, DQ haplotype, DRB1*0901-DQA1*0301- 
DQB1*0303 (haplotype 11), without exception.
HLA-DR10 was a rare DRB1 allele in the study populations 
and was confined to southern and northern Chinese, and 
Javanese. DR10 had a single DQ association (DQA1*0101- 
DQB1*0501) which is the same as that found on DR1 haplotypes.
5.2.2 Inter-locus recombination in the HLA-DR, -DQ region
Crossing-over event in the HLA-DR, DQ region has never 
been directly recorded in family studies. However, the 
analysis of HLA-DR, -DQ haplotypes in different ethnic groups
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can provide indirect evidence for the inter-locus 
recombination in the HLA-DR, DQ region, which is believed 
responsible for the diversification of HLA class II 
haplotypes. Such analyses (Gregersen et al 1986, 1988) have 
led to the conclusion that recombination sites in the HLA 
class II region are haplotype-dependent; haplotype-specific 
recombination hot spots exist but at different locations in 
major HLA class II haplotype families. Similar analyses 
performed in the present study support these conclusions and 
provide further information regarding recombination sites in 
the HLA class II region. Although an ideal analysis of HLA 
haplotypes requires homozygous cells or family studies, 
linkage analysis in large scale population studies can also 
generate valuable information.
In the above sections of this chapter, a total of 80 HLA- 
DR, -DQ haplotypes were established in the study populations. 
In the DRI/2 family (including DR1, DR2 and DR10), the DQ 
polymorphisms were essentially confined to the DQl-related 
DQA1 and DQBl allele types in this study, except for a single 
instance of DRB1*0103 allele associated with DQA1*0501 and 
DQBl*0301. Two DRl5-related DRB1 alleles, DRB1*1501 and 1502, 
detected in all the study populations as well as in other 
ethnic groups were both associated with more than one DQA1 and 
DQBl allele in this study. These results indicate that inter­
locus recombination could happen between DRBl and DQAl and 
between DQAl and DQBl in the DR2 haplotype family. Between the 
DR2-related DRBl and DRB5 loci, recombination events have 
given rise to the DRB5*0101 and 0102-associated DRB1*1502 
haplotypes as well as the DRB5*0101 and 02-associated 
DRB1*1602 haplotypes, but DRB1*1501 was found associated with 
DRB5*0101 only.
In the DR52 haplotype family (including DR8), all DQAl 
allele types but DQA1*0201 were observed. In a previous report 
(Fernandez-Vina et al 1991b), DQA1*0201 were found on a DR13
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haplotype in a population of African origin. DQAl-association 
with the DR52-related DRB1 alleles also showed some 
combination patterns: DQA1*01 alleles were associated with 
DRB1*0803, 1301, 1302 and DRBl*1401-related DRBl alleles 
(DRB1*1401, 1404, 1405, 1407 and 1408); DQA1*0501 with 
DRB1*0301, 1303 and DRB1*1402-related DRBl alleles (DRB1*1402, 
1403 and 1409); DQA1*0601 was associated with DRB1*1202 only. 
At the DQBl locus, nine allele types were found on the DR52- 
related haplotypes. In several cases, more than one DQBl 
allele was found to be associated with the same DRBl, DQA1 
combination including DQB1*0604 and 0605 associated with 
DRBl*1302-DQA1*0102; DQB1*0502 and 0503 associated with 
DRB1*1401-DQA1*0101; DQB1*0301 and 0402 associated with 
DRB1*1201-DQA1*0501; DQB1*0301 and 0402 associated with 
DRB1*1402-DQA1*0501; and DQB1*0503 and 0601 associated with 
DRB1*0803. These haplotypes might have arisen through multiple 
mechanisms including inter-locus recombination between DRBl 
and DQA1, between DQA1 and DQBl, and point mutations. In this 
DRBl family, haplotypes can be further divided into DQ1- 
related and non-DQl-related. The DQAl, DQBl recombination 
event was not seen between these two groups of haplotypes. A 
substantial number of haplotypes in the DR52 family was 
generated by the DRB3 polymorphism. Most DRBl alleles in this 
family were associated with more than one DRB3 allele, 
indicating that recombination is possible between DRBl and 
DRB3 loci.
In the DR53 haplotype family, DR4, DR7 and DR9 were each 
associated with a single DQAl allele (DR4, DR9 with DQA1*0301 
and DR7 with DQA1*0201); there was no exception in the 15 
different DR, DQ combinations derived from 681 DR53-related 
haplotypes. At the DQBl locus, DR4-related haplotypes were 
associated with either DQ3 or DQ4. The DQBl*0201-associated 
DR4 haplotypes found in other ethnic groups (Gao et al 1991a; 
Magzoub et al 1991) were not observed in the present study.
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DR7 was found to be associated with both DQB1*0201 and 
DQB1*0303 which was also the only DQB1 allele found on DR9 
haplotypes. There was no DQl-related DQB1 allele in the DR53 
haplotype family. These results are consistent with previous 
findings (Gregerson et al 1988) that the recombination events 
giving rise to DR53-related haplotypes are confined to the 
region between DQA1 and DQB1 loci.
Between the DRI/2 haplotype family and the DR53 haplotype 
family, there was no evidence of genetic exchange, because 
neither the DQAl nor the DQB1 polymorphism between the two 
families overlapped. The exceptional DRBl*0103-associated 
DQA1*0501-DQB1*0301 combination was more likely derived as a 
block from the DR52 haplotype family. The same DQA1-DQB1 block 
was also found on the Amerindian DRB1*1602 haplotype (Liu et 
al 1988). The DRI/2 haplotype family and the DR52 haplotype 
family shared several DQ allele combinations such as the 
DQAl*0102-DQB1*0502 shared by DRB1*1501 and DRB1*1401; the 
DQAl*0103-DQB1*0601 shared by DRB1*1502 and DRB1*0803; and the 
DQA1*0501-DQB1*0301 shared by DRB1*0103 and several DR52- 
related haplotypes. DQA1*0101-DQB1*0501 was also found on 
DRBl*1201 haplotypes in other ethnic groups (Fernandez-Vina et 
al 1991b). These shared DQ linkage relationships could be 
derived by inter-locus recombination between DRBl and DQAl 
loci as proposed previously (Gregersen et al 1988). However, 
there was no unequivocal evidence that inter-locus 
recombination between DQAl and DQB1 loci was inhibited between 
DRI/2 and DR52 haplotype families. The multiple DQA1-DQB1 
combinations found in both families could be derived by DQAl, 
DQB1 recombination either within or between the two families. 
Between the DR52 and the DR53 haplotype families, inter-locus 
genetic exchanges could only have happened between DQAl and 
DQB1 loci, since the DQAl alleles in these two families were 
mutually exclusive. The only exception was the DQA1*0301- 
associated DRB1*1410 haplotype found in Australian Aborigines
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but this haplotype, together with the new DRB1*1410 allele, 
was generated in an unusual intra-exonic recombination event 
within the DRBl locus involving a DQA1*0301 and DQB1*0402- 
linked DR4 haplotype and a DR52-linked DR14 haplotype (see 
Chapter 3). Whereas the DR52 family had four of the six DQBl 
alleles found in the DR53 family, the DQl-related DQBl alleles 
(DQB1*05 and 06 allele types) were missing from the DR53 
family in the study populations and DQ1-associated DR4, DR7 
and DR9 haplotypes have not been reported in other ethnic 
groups either. What was evident from these analyses was that a 
DQA1, DQBl recombination apparently never happened between 
DQl-related and non-DQl-related haplotypes. This was true in 
all three haplotype families, both within and between them.
The DR, DQ combination patterns observed in this study are 
schematically demonstrated in Figure 5.1.
5.2.3 Population phylogeny based on HLA-DR, -DQ haplotype 
frequencies
Based on HLA class II haplotype frequencies, population 
affinities were evaluated between the 19 study populations of 
Australia, Asia and Oceania. In addition, a Caucasoid 
population from a previous publication (Fernandez-Vina et al 
1991b) was included for comparison. Table 5.7 gives the 
haplotype frequencies in the 20 populations. Table 5.8 gives 
the genetic distance coefficients between the 20 populations 
calculated according to Nei1s (1973) genetic distance 
statistic and distances were clustered according to average 
similarities using UPGMA, or the unweighted pair-group method 
using arithmetic averages (Sneath & Sokal 1973). The tree 
given in Figure 5.2 is according to Lalouel (1973) and Figure
5.3 was drawn using the PHYLIP package (J. Felsenstein, 
University of Washington) maintained by ANGIS (Australian 
National Genome Information Service) at the University of 
Sydney.
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10 11 12
Polynesians
AN Melanesians Southern
Northern
Chinese
Caucasoids
NAN Melanesians
Micronesians/
Javanese
Australian
Aborigines
1: Kimberley 7 : 
2: East Cape York 8 : 
3,4: West Cape York 9: 
5: PNG highland 10: 
6: Madamg 11:
Rabual
New Caledonia
Fiji
Niue
Rarotonga
12: Western Samoa 
13: Kiribati 
14: Narau 
15: Java 
16: Singapore
17: Hong Kong 
18: Beijing 
19: Xian 
20: Xinjian 
21: Europe
Figure 5.3 Population phylogeny based on HLA-DR, -DQ haplotype 
frequencies (2)
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The derived genetic distances calculated on the basis of HLA- 
DR, -DQ haplotype frequencies varied from 3.99 (between 
Australian Aborigines from the Kimberley region and 
Caucasoids) to 0.09 (between Polynesian populations from 
Rarotonga and Western Samoa). In the phylogenetic trees 
constructed using these genetic distance coefficients, the 20 
populations clustered as several groups which corresponded 
with their known ethnic groups. The genetic distances within 
each ethnic group were significantly shorter than those 
between groups. Three Australian Aboriginal populations 
clustered together, even though a high percentage of HLA-DRB1 
alleles were unique to the Kimberley region Aborigines. The 
unique HLA class II allele and haplotype distributions in 
Australian populations resulted in their relatively long 
genetic distances from other ethnic groups, the non- 
Austronesian-speaking Melanesians from PNG highlands showed 
closer affinity with Australian Aborigines than with any of 
the Austronesian-speaking Melanesian populations. The three 
Oceanic ethnic groups (coastal Melanesians, Polynesians and 
Micronesians) also clustered accordingly. However, the 
complete separation of Javanese from Polynesian groups is not 
predicted from linguistic data and the extraordinarily long 
genetic distance of this group of Javanese and Micronesians 
from all other populations seemed over-exaggerated due to the 
extremely high frequencies of a single haplotype, DRB1*1202- 
DRB3*0301-DQA1*0601-DQB1*0301, in the three populations. The 
clustering of the four Han Chinese populations corresponded 
with their geographical distributions, while the Uygur series 
from northwestern China, with known Caucasoid ancestry 
correctly clustered with the Caucasoid population.
5.3 Discussion
HLA-class II haplotypes have been undergoing a dynamic 
process of evolution. The characteristic distribution of HLA
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haplotypes in human groups can be used as a powerful indicator 
for analyzing population affinities. In genetic distance 
analysis, HLA-DR, -DQ haplotype frequencies with combined 
information of all related polymorphic loci are usually more 
useful than allele frequencies of individual DR and DQ loci 
(Serjeantson 1989b). Genetic distances calculated on the basis 
of HLA haplotype frequencies between contemporary human groups 
reflect their evolutionary history. This is evident in the 
phylogenetic trees constructed in the present analysis, in 
which populations cluster in a manner expected from 
linguistic, anthropological, and archaeological evidence. 
However, the genetic distance based on frequency (gene 
frequency or haplotype frequency) distributions in populations 
can sometimes be exaggerated by chance when the analysis is 
between populations whose HLA profiles have been profoundly 
shaped by evolutionary forces of founder effect, genetic drift 
and bottle-necks. In the phylogenetic trees constructed in 
this chapter, chance effect is reflected in the unusually long 
genetic distances between the Javanese/Micronesian group and 
other populations due to the uniquely high frequency of a 
single haplotype in the Javanese/Micronesian group.
Population affinity can also be traced by analyzing 
special DR, DQ linkage relationships in different human 
groups. For example, the DR2-related DR15 and 16 alleles can 
be found in most ethnic groups but the unusual DRB1, DRB5 and 
DQ linkage relationships observed in the study populations 
contained further information for the analysis of population 
affinity. The DRB1*1502 allele is overwhelmingly associated 
with DRB5*0101 and with several DQ combinations in the study 
populations of Australian Aborigines, Pacific islanders and 
southern Chinese. In other ethnic groups, it is invariably 
associated with DRB5*0102, DQA1*0103 and DQB1*0601, a 
haplotype virtually absent in most Australian and Oceanic 
populations. Similarly, the DRB1*1602 allele detected in this
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study can be further discriminated from the same allele found 
in Amerindians (Liu et al 1986) by different DQ associations. 
By comparing the HLA class II profiles in the study 
populations, it was found that with only three exceptions ( 
DRB1*1407, 1408 haplotypes and the DQB1*0503-associated 
DRB1*0803 haplotype), all major haplotypes found in Pacific 
populations including Melanesians, Polynesians, Micronesians 
and Javanese were represented in Chinese. Each Pacific 
population has a subset of the Chinese repertoire of DR, DQ 
haplotypes, reflecting their Asian origin. In contrast, eight 
of the 15 Australian Aboriginal DR, DQ haplotypes detected in 
the Kimberley group were found exclusively in Australia, 
reflecting the long history of isolation and independent 
evolution of the Australian Aborigines. The number of 
haplotypes in a given population reflects some historic events 
such as population mixing, founder effect, genetic drift, and 
bottle-necks. In this study, a total of 80 DR, DQ haplotypes 
was found in the study populations, but the number of 
haplotypes in each population varied significantly. Some 
haplotypes could be lost from a population due to those 
historic events, while others could become well-established. 
For instance, a total of 12 DR4-associated DR, DQ combinations 
was observed in Asia, Oceania and Australia. Ten of these 
haplotypes were seen in Chinese, reflecting an extensive 
ancestral mixing of populations, but only two were represented 
in PNG highlanders, a different two in Micronesians and only 
three in Polynesians. With very few exceptions, haplotype 
families in Pacific populations have different dominant 
haplotypes. The DR5 haplotype family, for instance, is 
dominated by the DRB1*1101 haplotype in coastal Melanesians, 
by the DRB1*1201 haplotype in Polynesians, and by the 
DRB1*1202 haplotype in Micronesians and Javanese.
HLA-DR, -DQ haplotypes can be generated by multiple 
mechanisms. Novel haplotypes emerge with any mutation of
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related DR or DQ alleles. The analysis of haplotype 
distributions in human groups may help to identify these 
events. For example, there were two DRB1*1302-related 
haplotypes detected in this study. They share identical DRBl, 
DRB3 and DQAl associations, but at the DQB1 locus the two 
haplotypes are associated with DQB1*0604 and DQB1*0605 
respectively. DQB1*0604 and 0605 have only two nucleotide 
mismatches between their exon 2 sequences and none of them was 
found on other haplotypes. It is therefore likely that one of 
the two haplotypes was generated by when point mutation gave 
rise to the new DQB1 allele. Similar events have given rise to 
some unusual haplotypes observed in this study and the 
mutation could happen at the DRB1 locus (the haplotypes 
bearing the newly-defined DRBl alleles in Aborigines), at the 
DRB5 locus (DRB5*0203-associated DRB1*1602 haplotype), or at 
the DQB1 locus (DQB1*0401 and 0402-associated DRB1*0405 
haplotypes). In the latter case, however, the two DQ4 alleles 
can be found on other haplotypes; their associated haplotypes 
could also be generated through inter-locus recombination.
The DR, DQ haplotype combination patterns observed in this 
study (Figur 5.1) can be summarized as the following: (i)
Inter-locus genetic exchange of the DR53-associated haplotypes 
and other haplotypes is confined to the region between DQAl 
and DQBl. This is consistent with the previous conclusion 
(Gregersen et al 1988), since the DQAl polymorphism between 
the DR53 family and the other two families are mutually 
exclusive as observed in all populations examined in this 
study as well as in most other studied ethnic groups, but the 
DQBl alleles found on the DR53-associated haplotypes can also 
be seen in the DR52 haplotype family. However, this 
restriction is not absolute, since DQA1*0201 and DQA1*0301 
alleles have been found on DR52-associated haplotypes in a few 
American Black donors (Fernandez-Vina et al 1991b), and a 
DQAl*0501-associated DRB1*0405 haplotype has also been
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reported recently as the major DR4-related haplotype in 
Sardinians (Carcass et al 1992). (ii) Between non-DR53- 
associated haplotypes, inter-locus genetic exchange can happen 
in regions between DRB1 and DQA1, as well as between DQA1 and 
DQB1 (but is subject to point 3). This is somewhat different 
from the previous conclusion (Gregersen et al 1988) that the 
recombination site between DRl/2 and DR52 haplotype families 
is located between DRBl and DQA1. In this study, many new DR2- 
associated and DR52-associated haplotypes were established. 
Some haplotypes indicate the DQA1-DQB1 recombination (such as 
the DQB1*0502-associated DR14 haplotype, haplotype 56 in Table 
5.7), while some others can be explained by recombination 
either between DRBl and DQA1 or between DQA1 and DQB1. It is 
possible, however, that the DRB1-DQA1 recombination happened 
more frequently. Within the DRl/2 or DR52 haplotype families 
the genetic exchange between DQAl and DQB1 is most evident. 
(iii) Within the DQ subregion, inter-locus recombination has 
been essentially suppressed between DQ1 and non-DQl 
haplotypes, because the DQl-related DQA and DQB alleles never 
appear on the same haplotype. This phenomenon exists not only 
between the DR53 and DRl/2 haplotype families but also between 
the DR53 family and the DQl-associated DR52 family members, 
between the DRl/2 family and the non-DQl-related DR52 family 
members, and between the DQl-associated and non-DQl-associated 
DR52 family members. The lack of DQA1-DQB1 recombination 
between DQl-associated and non-DQl-associated haplotypes may 
involve some DQl-specific chromosomal structure in the DQ 
subregion, or haplotype dependent recombination signals.
Finally, while these appear to be constraints placed on 
certain recombination events by the genomic organization of 
the DR, DQ region, this does not negate the possibility that 
certain DQ aß heterodimers are defective. Putative defective 
DQAl, DQB1 combinations would have been a powerful 
evolutionary force in generating the observed haplotype-
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specific genomic organization. It has been demonstrated in 
transfectants that the DQ1 a chain could not pair with either 
DQ2 or DQ3 ß chains to form the DQ heterodimer (Kwok et al 
1989). This functional barrier may have profound influence on 
the evolution of DQ1 haplotypes.
This Chapter has shown the power of haplotype analysis in 
the study of HLA. The multi-locus information contained in HLA 
class II haplotype frequencies is more discriminative than 
allele frequencies of individual gene loci in population 
studies and has permitted more precise analysis of population 
genetic affinity. The differential linkage relationships in 
populations have also provided further understanding of 
allelic phylogeny, and evolutionary events of HLA-class II 
genes.
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CHAPTER 6 
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Final discussion
This thesis examined the nucleotide sequence polymorphism 
of HLA class II genes in indigenous peoples of Australia, Asia 
and Oceania. Using PCR-based technologies, previously unknown 
diversity in HLA-DR, -DQ and -DP gene loci was revealed. The 
information derived from the present study provides further 
insight into the HLA contribution to autoimmune diseases and 
the potential impact of the population heterogeneity on 
transplantation.
In the present study, PCR-SSO typing was the major 
technique used to analyze the class II HLA polymorphism in the 
study populations. Although the construction of the whole 
panel of SSO probes is a monumental effort for individual 
laboratories, compared to more traditional methods for HLA 
class II typing, PCR-SSO typing has several obvious 
advantages: (1) Like all PCR-based techniques, PCR-SSO typing
selectively amplifies a fragment of the gene of interest from 
a small amount of blood. (2) The highly sensitive 
oligonucleotide hybridization discriminates single nucleotide 
substitutions, thus providing the highest typing resolution 
possible, which could be achieved previously only by DNA 
sequencing. (3) Instead of recognizing one or two epitopes as 
in the case of serology and MLC, or a few enzyme cutting sites 
as in the case of RFLP, SSO probes are able to detect all 
allelic variations. Together with allele-specific or group- 
specific PCR amplification, SSO hybridization patterns can 
clearly reveal homozygosity as well as heterozygosity of the 
samples tested. A population well defined by the PCR-SSO 
typing procedure should leave no room for blanks which has 
been an unavoidable aspect of the class II HLA typing. (4) New 
alleles can be recognized by the occurrence of unusual SSO 
hybridization patterns. The novel HLA-DR and DP alleles 
defined in this thesis were first revealed by SSO 
hybridizations in large-sample screening, which were otherwise
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difficult to discover. (5) The ability of the PCR-SSO 
technique to handle large number of samples makes it 
particularly attractive for population studies. This is due to 
its much easier performance compared to more traditional 
typing techniques for HLA class II typing.
Several factors can affect the PCR-SSO typing result.
First and the most important is the specificity and efficiency 
of PCR amplification. In this thesis, HLA class II genes were 
amplified using generic, locus-specific or group-specific 
primers. Most of these PCR amplifications were satisfactory 
with specific and sufficient PCR products for SSO 
hybridization including DQA1, DPB1 and all DRB amplifications. 
In these cases, the target alleles or genes shared identical 
sequence regions which were used for priming. Single or a few 
nucleotide mismatches in the primer are usually not a problem 
in PCR amplifications as long as the mismatches are not close 
to the 3 1 end of the primer and all target alleles of a given 
sample share the identical sequence in the priming region. In 
some cases, however, oligonucleotide primers containing 
nucleotide mismatches (including single mismatches) between 
target alleles or different gene loci will result in unequal 
amplifications of these alleles or genes. For example, the 
original 3 1 DQB1 primer SE-8A used in this study was designed 
according the sequence of DQBl*01-related alleles but 
contained two nucleotide mismatches to DQB1*02, 03 and 04- 
related alleles at the 5' part of the probe. For samples 
heterozygous for both allele types, this primer preferentially 
amplified DQBl*01-related alleles while for samples with two 
non-DQBl*01-related alleles it amplified the DQB2 gene more 
efficiently. Subtyping for DQB1*03 and 04-related alleles in 
this study was accomplished by group-specific PCR 
amplifications.
The second factor which may cause difficulty in the PCR- 
SSO typing procedure is cross-hybridization. SSO hybridization
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is a highly sensitive technique; with the correct experimental 
conditions, especially the correct washing stringency 
following hybridization, this technique can unequivocally 
discriminate any nucleotide sequence variation. As observed in 
the present experiments, the washing stringency was 
particularly critical for probes with single nucleotide 
mismatches with the PCR products especially when the 
mismatched nucleotide in the probe was an adenine or a 
thymine. This phenomenon is probably caused by different 
molecular structures, molecular weights and numbers of 
hydrogen bond required to form base-pairs between nucleotides 
AT and GC. In the present experiments, several procedures were 
used to recognize and correct cross-hybridizations including 
using proper positive and negative controls with known allele 
types, increasing the washing temperature for probes likely to 
give cross-hybridizations and using multiple probes to 
hybridize all known variations for those sensitive gene 
regions.
Among other PCR-based DNA typing techniques, PCR-RFLP has 
been successfully used to examine the HLA class II 
polymorphisms of DQAl (Maeda et al 1989; Ota et al 1991), DQB1 
(Uryu et al 1990; Nomura et al 1991), DP (Dekker & Easteal 
1990; al-Daccak et al 1991; Ota et al 1991), and DRBl (Uryu et 
al 1990; Yunis et al 1991). In the present experiments, PCR- 
RFLP was used as a complementary method to SSO hybridization. 
Like SSO hybridization, PCR-RFLPs were accurate, reliable and 
produced high-resolution typing results. Homozygosity and 
heterozygosity of DNA samples could be clearly revealed by 
fragment length polymorphisms. Novel alleles with unusual 
nucleotide sequence variation at the enzyme cutting site could 
also be recognized. Compared with the SSO hybridization 
method, the PCR-RFLP typing procedure is faster when a small 
number of samples are involved and the procedure is non-radio­
active. These advantages make PCR-RFLP a suitable alternative
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to the current tissue typing procedure for clinical 
transplantation. On the other hand, the detectable 
polymorphism in PCR-RFLP typing is limited by the available 
enzymes and the efficiency of this technique to deal with 
large sample sizes, like in the present study, is far below 
SSO hybridization.
PCR-SSCP is a newly^developed technique. Efforts using 
this technique to analyze HLA class II polymorphisms have been 
reported (Hoshino et al 1992 ; Carrington et al 1992) . Single- 
stranded DNA conformation polymorphisms can be visualized 
directly after electrophoresis of PCR products requiring 
neither SSO probes nor restriction enzymes. Therefore, it is 
potentially a more rapid, simpler, and more economical option 
for HLA typing. With correct experimental conditions, PCR-SSCP 
could be very sensitive for some minor nucleotide variations. 
In the present study, the single nucleotide mismatch between 
the new allele DRB1*1409 and DRB1*1402 was recognized by SSCP 
(Figure 3.4). However, SSCP is influenced by virtually all the 
factors involved in electrophoresis including the 
concentration of polyacrylamide gels, electric current, 
voltage, pH, temperature and denaturation buffers. Different 
combinations of these factors, even the modest changes of some 
of these factors, will result in totally different results. 
Furthermore, the electrophoretic conditions used in the 
present experiments were adjusted according to different 
lengths of PCR products, the positions of mismatched 
nucleotides and nucleotide compositions in the sequence in 
order to get the optimal resolution. More often, however, 
single nucleotide substitutions could not be recognized. If 
these electrophoresis factors can be standardized, PCR-SSCP 
can be useful in discriminating HLA alleles with substantial 
nucleotide mismatches. At this stage, PCR-SSCP is still far 
from being a practical alternative for HLA typing.
Characterization of the novel HLA class II alleles
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revealed in the present experiments by unusual SSO 
hybridization patterns were greatly facilitated by using 
direct DNA sequencing of double-stranded PCR products. Direct 
sequencing of entire exon 2 of DRB1 genes was made possible by 
publication of intronic sequences, especially primer CRX37 
(Scharf et al 1991) which selectively amplifies particular 
DRB1 alleles. When cloned products of GH46 and CRX37 were 
sequenced, in one instance, DRB6 pseudogene was found, which 
has one base mismatch from CRX37. In the direct sequencing 
procedure, the rather minor non-specific amplification is not 
a problem. This sequencing procedure is simple, accurate and 
rapid. In the present experiments using an automated nucleic 
acid sequencer, the whole sequencing procedure could be 
completed within 12 hours. In situations when a small number 
of samples need to be typed for the HLA class II polymorphism 
and the entire coding sequence is important, the PCR-direct- 
sequencing procedure can be a practical alternative or 
supplementary typing method.
In general, the PCR-based typing technology is a powerful 
technique in discriminating nucleotide sequence variation. 
Compared to more traditional HLA class II typing methods, the 
PCR-based typing procedures are more accurate, easier to 
perform, more reliable and highly sensitive. Given that 
intensive comparison between DNA typing of the nucleotide 
sequence polymorphism and other typing techniques has shown a 
totally compatible HLA class II typing result (Kimura et al 
1992), the PCR-based typing techniques can satisfactorily 
replace traditional typing methods in the investigation of HLA 
polymorphisms such as population diversity, HLA-related 
diseases and unrelated donor registries. With modification of 
the DNA preparation procedure and SSO hybridization (non­
radio-active methods for example), these techniques are also 
suitable for tissue typing for clinical purposes.
The nucleotide sequence diversity of HLA class II genes of
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the study populations revealed in this thesis has important 
implications for the HLA-related clinical investigations in 
these peoples. It has long been a puzzle that some well known 
HLA-associated autoimmune diseases have extremely low 
incidence or are absent in native populations of Australia and 
Oceania. For example, in these populations, insulin-dependent 
diabetes mellitus (IDDM) is absent or rare, although at least 
some of the appropriate environmental triggering factors would 
seem to be present as evidenced by IDDM in some Asian Indians 
born and resident in Fiji (Serjeantson 1989b), as well as in 
white Australians (Martin et al 1986) . Some investigators 
(Todd et al 1987, 1990) have argued in favor of an exclusive 
effect of HLA-DQ in IDDM, with DQA1*0301 and DQB1*0302 the 
high-risk alleles in DR4-positive people and the incidence of 
IDDM in a given population was correlated to the frequency 
distribution of these DQ alleles (Dorman et al 1990) .
Meanwhile, others (Sheehy et al 1989; Monos et al 1988; 
Serjeantson & Easteal 1989; Erlich et al 1990) have suggested 
that HLA-DRB1 alleles also contribute to IDDM. It has been 
found (Sheehy et al 1989) that the only IDDM-associated DR4 
haplotypes were those carrying DRB1*0401 as well as DQB1*0302; 
DQB1*0302 and DRB1*0401 did not alone predispose to IDDM. This 
study has shown that although DQB1*0302 was rare among DR4- 
positive Australian Aborigines and PNG highlanders, the 
DQA1*0301, DQB1*0302 haplotype was common in DR4-positive 
coastal Melanesians (51%), Polynesians (80%), and Micronesians 
(96%), where DQB1*0302 was usually associated with DRB1*0403. 
This DQ haplotype also had considerably high population 
distributions in these peoples (haplotype frequencies ranging 
from 7% to 17%), but DRB1*0401 only sporadically occurred in 
these populations as the result of more recent Caucasoid 
admixture. This suggests that HLA-DQ does not have an 
exclusive role in IDDM susceptibility and that additional HLA- 
DR and/or non-HLA genetic factors interact with HLA-DQ alleles
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in the pathogenesis of IDDM.
Rheumatoid arthritis (RA) is also a rare disease in 
Australia and Oceania (Richens et al 1988), although HLA-B27- 
related arthropathies, especially Reiter's disease, do occur 
in Melanesians (Richens et al 1988) . Studies of HLA 
associations with RA have implicated highly homologous HVR 3 
epitopes shared by several DRBl alleles (Gregesen et al 1987; 
Nepom et al 1987 ; Stastny et al 1991) . The predisposing 
alleles included DRB1*0401, 0404, 0405, 0101 and 1001 (Nepom 
et al 1986; Wordsworth et al 1989; Gao et al 1990b; 1991a 
1991b; Nelson et al 1991) in Caucasoids, DRB1*0405 in 
Orientals (Takeuchi et al 1989; Seglias et al 1992) and 
DRB1*1402 in Ameridians (Willkens et al 1991), with DRB1*0401 
or DRBl*0401 and 0404 showing the highest susceptibility to 
RA. DR4 was also a common antigen in Australia and Oceania but 
the DR4 subtyping performed in this thesis showed a 
predominant low-risk DR4 subtype DRB1*0403 in coastal 
Melanesians, Micronesians, and Polynesians, while the high- 
risk DR4 subtypes DRB1*0401 and 0404 and most other RA-related 
DRBl alleles were absent or only sporadically occurred. The 
lack of predisposing HLA factors may partly explain the lack 
of susceptibility to RA in these populations. However,
DRBl*0405 was a comparatively common DR4 subtype in Australian 
Aborigines and Melanesians, while DRB1*1402 and 1409 were 
common DRBl alleles in Australian Aborigines. These allele$ 
share with DRB1*0404 an identical HVR 3 which differs from 
DRB1*0401 by a single amino acid substitution. The association 
of the DRB1*0404 type of epitope (including DRB1*0101, 0404, 
0405, 1402 and 1409) with RA was less consistent than 
DRB1*0401. Indeed, several reports (Gao et al 1990b; Nelson et 
al 1991) have suggested that in Caucasoids, where DRB1*0401 
was the predominant DR4 subtype, DRB1*0404 was less efficient 
or irrelevant in predisposing to RA, especialy to those 
rheumatoid factor-positive and more severe clinical types.
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DRB1*0405 has been found a major RA-risk factor in Japanese 
(Takeuchi et al 1989) and Chinese (Seglias et al 1992), but in 
these ethnic groups, RA is also a rare disease. More recently, 
DRB1*0803 has been suggested as an RA-protective factor in 
Japanese (see Nelson et al 1992). In the present experiments, 
DRB1*0803 was found to be the most common DRBl allele in 
Aborigines. In Aborigines from the Kimberley region, DRB1*0803 
was detected with a gene frequency of 26%. Furthermore, the 
novel allele DRB1*0412 carrying the DRB1*0803-like HVR 3 
accounted for 74% of the DR4 alleles found in this group. 
Overall, the two alleles were detected in 65% of the 
Aboriginal individuals in this series, which may also 
contribute to the immunity of Aborigines to RA.
However, the role played by HLA in autoimmune diseases has 
not been clarified; the lack of susceptibility to IDDM and RA 
in native Australian and Oceanic populations dispite the 
existence of some HLA alleles which are disease-associated in 
other populations suggests that multiple factors contribute to 
the development of these diseases. Apart from HLA, the 
pathogeny of IDDM and RA may involve some non-HLA genes and 
differential environmental factors in different populations.
The growing number of established HLA alleles have 
profound impact on the donor/recipient matching for unrelated 
organ transplantations. While more accurate matching is 
technically feasible, the chance of finding perfectly matched 
donor/recipient pairs becomes less. Given that most newly- 
defined nucleotide sequence polymorphisms of HLA class II 
genes are functionally meaningful and have restricted 
distributions in ethnic groups, knowledge of the HLA 
polymorphism in different human groups becomes more important 
for the optimal searching and matching procedure when donors 
and recipients from different racial or ethnic groups are 
involved. Further implication of the HLA polymorphism of 
different human groups for the HLA matching in clinical
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transplantations came from the analysis of HLA haplotypes. It 
has been known that the outcome of bone marrow transplantation 
is directly related to the number of matched HLA loci (Hansen 
et al 1989, Tiercy et al 1991b). In a given ethnic group, the 
same DRBl allele detected in different individuals is usually 
associated with an identical DR-DQ haplotype because of the 
strong linkage disequilibrium within this region. Further, 
unrelated individuals sharing identical HLA haplotypes have 
more chance of sharing the whole MHC including non-classical 
HLA genes, other histocompatibility genes, and genes of 
unknown function, which may also contribute to the improved 
graft outcome.
Histocompatibility differences between human groups have 
significant influence on graft outcome. It has been reported 
that the survival rate for cadaver donor renal transplants had 
significant variation in different races (Koyama & Cecka 1991; 
Kerman et al 1992). One of the main reasons for the lower 
survival rate in some non-Caucasoid patients was their reduced 
chance of obtaining HLA-matched donors from the primarily 
Caucasoid cadaver donor pool because of the substantial 
histocompatibility differences between these races and the 
lack of racially matched donors (Barger et al 1992; Lazda 
1992). The result from the Australian transplantation 
programmes has also consistently showed a lower survival rate 
in Aboriginal patients receiving graft from Caucasoid donors 
(J. Chapman, personal communication). The HLA frequency 
difference between races or ethnic groups means that better 
donor/recipient HLA matches can be achieved when both donor 
and recipient are of the same race or ethnic group. The 
remarkable HLA class II diversity revealed in the study 
populations of this thesis can be useful in establishing 
unrelated donor registries and searching suitable donors for 
clinical transplantation in these peoples. The HLA-DRB1 
polymorphism of Australian Aborigines, for example, had
191
virtually no overlap with the DRB1 polymorphism of Caucasoids 
(Figure 6.1); a substantial proportion of the DRB1 
polymorphism was also not shared between Aborigines from 
different areas. Therefore, for unrelated bone marrow 
transplantation for an Aboriginal patient, the best place to 
search for an HLA-matched donor is in the same tribe of the 
patient. Oceanic populations also showed highly characteristic 
HLA distributions compared with other major ethnic groups but 
had a close relationship with Mongoloid populations, which may 
suggest the direction in searching donor registries for HLA- 
matched donor/recipient pairs for patients with these ethnic 
backgrounds. The highly differentiated HLA polymorphism in 
human groups has yet another evident implication: the 
importance of recruiting more individuals from different 
racial and ethnic backgrounds in the donor registry for the 
unrelated bone marrow transplantation cannot be over­
estimated .
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